id	sid	tid	token	lemma	pos
easat-9432	1	1	edelweiss	edelweiss	PROPN
easat-9432	1	2	applied	apply	VERB
easat-9432	1	3	science	science	NOUN
easat-9432	1	4	and	and	CCONJ
easat-9432	1	5	technology	technology	NOUN
easat-9432	1	6	issn	issn	PROPN
easat-9432	1	7	:	:	PUNCT
easat-9432	1	8	2576	2576	NUM
easat-9432	1	9	-	-	SYM
easat-9432	1	10	8484	8484	NUM
easat-9432	1	11	vol	vol	NOUN
easat-9432	1	12	.	.	PROPN
easat-9432	2	1	9	9	NUM
easat-9432	2	2	,	,	PUNCT
easat-9432	2	3	no	no	INTJ
easat-9432	2	4	.	.	NOUN
easat-9432	2	5	8	8	NUM
easat-9432	2	6	,	,	PUNCT
easat-9432	2	7	744	744	NUM
easat-9432	2	8	-	-	SYM
easat-9432	2	9	751	751	NUM
easat-9432	2	10	2025	2025	NUM
easat-9432	2	11	publisher	publisher	NOUN
easat-9432	2	12	:	:	PUNCT
easat-9432	2	13	learning	learn	VERB
easat-9432	2	14	gate	gate	NOUN
easat-9432	2	15	doi	doi	PROPN
easat-9432	2	16	:	:	PUNCT
easat-9432	2	17	10.55214/2576	10.55214/2576	NUM
easat-9432	2	18	-	-	SYM
easat-9432	2	19	8484.v9i8.9432	8484.v9i8.9432	NOUN
easat-9432	3	1	©	©	PROPN
easat-9432	3	2	2025	2025	NUM
easat-9432	3	3	by	by	ADP
easat-9432	3	4	the	the	DET
easat-9432	3	5	authors	author	NOUN
easat-9432	3	6	;	;	PUNCT
easat-9432	3	7	licensee	licensee	PROPN
easat-9432	3	8	learning	learning	NOUN
easat-9432	3	9	gate	gate	NOUN
easat-9432	3	10	©	©	PROPN
easat-9432	3	11	2025	2025	NUM
easat-9432	3	12	by	by	ADP
easat-9432	3	13	the	the	DET
easat-9432	3	14	authors	author	NOUN
easat-9432	3	15	;	;	PUNCT
easat-9432	3	16	licensee	licensee	PROPN
easat-9432	3	17	learning	learning	NOUN
easat-9432	3	18	gate	gate	NOUN
easat-9432	3	19	history	history	NOUN
easat-9432	3	20	:	:	PUNCT
easat-9432	3	21	received	receive	VERB
easat-9432	3	22	:	:	PUNCT
easat-9432	3	23	4	4	NUM
easat-9432	3	24	june	june	PROPN
easat-9432	3	25	2025	2025	NUM
easat-9432	3	26	;	;	PUNCT
easat-9432	3	27	revised	revise	VERB
easat-9432	3	28	:	:	PUNCT
easat-9432	3	29	8	8	NUM
easat-9432	3	30	july	july	NOUN
easat-9432	3	31	2025	2025	NUM
easat-9432	3	32	;	;	PUNCT
easat-9432	3	33	accepted	accept	VERB
easat-9432	3	34	:	:	PUNCT
easat-9432	3	35	11	11	NUM
easat-9432	3	36	july	july	NOUN
easat-9432	3	37	2025	2025	NUM
easat-9432	3	38	;	;	PUNCT
easat-9432	3	39	published	publish	VERB
easat-9432	3	40	:	:	PUNCT
easat-9432	3	41	13	13	NUM
easat-9432	3	42	august	august	PROPN
easat-9432	3	43	2025	2025	NUM
easat-9432	3	44	*	*	PUNCT
easat-9432	3	45	correspondence	correspondence	NOUN
easat-9432	3	46	:	:	PUNCT
easat-9432	3	47	rizkid.anggraeni@gmail.com	rizkid.anggraeni@gmail.com	X
easat-9432	3	48	transformation	transformation	NOUN
easat-9432	3	49	of	of	ADP
easat-9432	3	50	sclc	sclc	PROPN
easat-9432	3	51	into	into	ADP
easat-9432	3	52	nsclc	nsclc	NOUN
easat-9432	3	53	-	-	PUNCT
easat-9432	3	54	squamous	squamous	ADJ
easat-9432	3	55	type	type	NOUN
easat-9432	3	56	with	with	ADP
easat-9432	3	57	invasive	invasive	ADJ
easat-9432	3	58	fungal	fungal	ADJ
easat-9432	3	59	co	co	NOUN
easat-9432	3	60	-	-	NOUN
easat-9432	3	61	infection	infection	NOUN
easat-9432	3	62	rizki	rizki	NOUN
easat-9432	3	63	diah	diah	NOUN
easat-9432	3	64	anggraeni1	anggraeni1	PROPN
easat-9432	3	65	*	*	PROPN
easat-9432	3	66	,	,	PUNCT
easat-9432	3	67	ungky	ungky	ADJ
easat-9432	3	68	agus	agus	PROPN
easat-9432	3	69	setyawan2	setyawan2	PROPN
easat-9432	3	70	,	,	PUNCT
easat-9432	3	71	yani	yani	PROPN
easat-9432	3	72	jane	jane	PROPN
easat-9432	3	73	r.	r.	PROPN
easat-9432	3	74	sugiri3	sugiri3	PROPN
easat-9432	3	75	,	,	PUNCT
easat-9432	3	76	dini	dini	NOUN
easat-9432	3	77	rachma	rachma	NOUN
easat-9432	3	78	erawati4	erawati4	PROPN
easat-9432	3	79	,	,	PUNCT
easat-9432	4	1	hendy	hendy	NOUN
easat-9432	4	2	setyo	setyo	PROPN
easat-9432	4	3	yudhanto5	yudhanto5	PROPN
easat-9432	4	4	1,2,3,4,5department	1,2,3,4,5department	NUM
easat-9432	4	5	of	of	ADP
easat-9432	4	6	pulmonology	pulmonology	NOUN
easat-9432	4	7	and	and	CCONJ
easat-9432	4	8	respiratory	respiratory	ADJ
easat-9432	4	9	medicine	medicine	NOUN
easat-9432	4	10	,	,	PUNCT
easat-9432	4	11	medical	medical	ADJ
easat-9432	4	12	faculty	faculty	NOUN
easat-9432	4	13	of	of	ADP
easat-9432	4	14	universitas	universitas	PROPN
easat-9432	4	15	brawijaya	brawijaya	PROPN
easat-9432	4	16	,	,	PUNCT
easat-9432	4	17	dr	dr	PROPN
easat-9432	4	18	.	.	PROPN
easat-9432	4	19	saiful	saiful	PROPN
easat-9432	4	20	anwar	anwar	PROPN
easat-9432	4	21	general	general	PROPN
easat-9432	4	22	hospital	hospital	PROPN
easat-9432	4	23	,	,	PUNCT
easat-9432	4	24	malang	malang	PROPN
easat-9432	4	25	,	,	PUNCT
easat-9432	4	26	indonesia	indonesia	PROPN
easat-9432	4	27	;	;	PUNCT
easat-9432	4	28	rizkid.anggraeni@gmail.com	rizkid.anggraeni@gmail.com	X
easat-9432	4	29	(	(	PUNCT
easat-9432	4	30	r.d.a	r.d.a	NOUN
easat-9432	4	31	.	.	PUNCT
easat-9432	4	32	)	)	PUNCT
easat-9432	5	1	dr_ungky_paru@ub.ac.id	dr_ungky_paru@ub.ac.id	PUNCT
easat-9432	5	2	(	(	PUNCT
easat-9432	5	3	u.a.s	u.a.s	PROPN
easat-9432	5	4	.	.	PUNCT
easat-9432	5	5	)	)	PUNCT
easat-9432	5	6	jani@ub.ac.id	jani@ub.ac.id	PROPN
easat-9432	5	7	(	(	PUNCT
easat-9432	5	8	y.j.r.s	y.j.r.s	PROPN
easat-9432	5	9	.	.	PUNCT
easat-9432	5	10	)	)	PUNCT
easat-9432	6	1	dr.erawati@ub.ac.id	dr.erawati@ub.ac.id	NOUN
easat-9432	6	2	(	(	PUNCT
easat-9432	6	3	d.r.e	d.r.e	NOUN
easat-9432	6	4	.	.	PUNCT
easat-9432	6	5	)	)	PUNCT
easat-9432	7	1	hendysetyoyudhanto@gmail.com	hendysetyoyudhanto@gmail.com	X
easat-9432	7	2	(	(	PUNCT
easat-9432	7	3	h.s.y	h.s.y	NOUN
easat-9432	7	4	.	.	PUNCT
easat-9432	7	5	)	)	PUNCT
easat-9432	7	6	.	.	PUNCT
easat-9432	8	1	abstract	abstract	ADJ
easat-9432	8	2	:	:	PUNCT
easat-9432	8	3	small	small	ADJ
easat-9432	8	4	cell	cell	NOUN
easat-9432	8	5	lung	lung	NOUN
easat-9432	8	6	cancer	cancer	NOUN
easat-9432	8	7	(	(	PUNCT
easat-9432	8	8	sclc	sclc	PROPN
easat-9432	8	9	)	)	PUNCT
easat-9432	8	10	is	be	AUX
easat-9432	8	11	a	a	DET
easat-9432	8	12	neuroendocrine	neuroendocrine	ADJ
easat-9432	8	13	tumor	tumor	NOUN
easat-9432	8	14	with	with	ADP
easat-9432	8	15	and	and	CCONJ
easat-9432	8	16	poor	poor	ADJ
easat-9432	8	17	prognosis	prognosis	NOUN
easat-9432	8	18	.	.	PUNCT
easat-9432	9	1	transformation	transformation	NOUN
easat-9432	9	2	commonly	commonly	ADV
easat-9432	9	3	occurs	occur	VERB
easat-9432	9	4	from	from	ADP
easat-9432	9	5	nsclc	nsclc	NOUN
easat-9432	9	6	to	to	ADP
easat-9432	9	7	sclc	sclc	PROPN
easat-9432	9	8	,	,	PUNCT
easat-9432	9	9	that	that	PRON
easat-9432	9	10	caused	cause	VERB
easat-9432	9	11	by	by	ADP
easat-9432	9	12	chemotherapy	chemotherapy	NOUN
easat-9432	9	13	,	,	PUNCT
easat-9432	9	14	immunotherapy	immunotherapy	NOUN
easat-9432	9	15	,	,	PUNCT
easat-9432	9	16	and	and	CCONJ
easat-9432	9	17	targeted	target	VERB
easat-9432	9	18	therapy	therapy	NOUN
easat-9432	9	19	resistance	resistance	NOUN
easat-9432	9	20	.	.	PUNCT
easat-9432	10	1	this	this	DET
easat-9432	10	2	case	case	NOUN
easat-9432	10	3	shows	show	VERB
easat-9432	10	4	a	a	DET
easat-9432	10	5	5	5	NUM
easat-9432	10	6	%	%	NOUN
easat-9432	10	7	rare	rare	ADJ
easat-9432	10	8	case	case	NOUN
easat-9432	10	9	transformation	transformation	NOUN
easat-9432	10	10	from	from	ADP
easat-9432	10	11	sclc	sclc	PROPN
easat-9432	10	12	to	to	ADP
easat-9432	10	13	nsclc	nsclc	NOUN
easat-9432	10	14	.	.	PUNCT
easat-9432	11	1	a	a	DET
easat-9432	11	2	69	69	NUM
easat-9432	11	3	-	-	PUNCT
easat-9432	11	4	year	year	NOUN
easat-9432	11	5	-	-	PUNCT
easat-9432	11	6	old	old	ADJ
easat-9432	11	7	man	man	NOUN
easat-9432	11	8	had	have	VERB
easat-9432	11	9	hemoptysis	hemoptysis	NOUN
easat-9432	11	10	,	,	PUNCT
easat-9432	11	11	dyspnea	dyspnea	NOUN
easat-9432	11	12	,	,	PUNCT
easat-9432	11	13	and	and	CCONJ
easat-9432	11	14	chest	chest	NOUN
easat-9432	11	15	pain	pain	NOUN
easat-9432	11	16	for	for	ADP
easat-9432	11	17	a	a	DET
easat-9432	11	18	month	month	NOUN
easat-9432	11	19	.	.	PUNCT
easat-9432	12	1	in	in	ADP
easat-9432	12	2	2017	2017	NUM
easat-9432	12	3	,	,	PUNCT
easat-9432	12	4	the	the	DET
easat-9432	12	5	history	history	NOUN
easat-9432	12	6	of	of	ADP
easat-9432	12	7	sclc	sclc	PROPN
easat-9432	12	8	received	receive	VERB
easat-9432	12	9	6	6	NUM
easat-9432	12	10	series	series	NOUN
easat-9432	12	11	of	of	ADP
easat-9432	12	12	cisplatin	cisplatin	NOUN
easat-9432	12	13	-	-	PUNCT
easat-9432	12	14	etoposide	etoposide	NOUN
easat-9432	12	15	chemotherapy	chemotherapy	NOUN
easat-9432	12	16	.	.	PUNCT
easat-9432	13	1	ct	ct	PROPN
easat-9432	13	2	-	-	PUNCT
easat-9432	13	3	scan	scan	ADJ
easat-9432	13	4	thorax	thorax	NOUN
easat-9432	13	5	recist	recist	NOUN
easat-9432	13	6	was	be	AUX
easat-9432	13	7	stable	stable	ADJ
easat-9432	13	8	disease	disease	NOUN
easat-9432	13	9	,	,	PUNCT
easat-9432	13	10	and	and	CCONJ
easat-9432	13	11	the	the	DET
easat-9432	13	12	rest	rest	NOUN
easat-9432	13	13	of	of	ADP
easat-9432	13	14	the	the	DET
easat-9432	13	15	treatment	treatment	NOUN
easat-9432	13	16	was	be	AUX
easat-9432	13	17	.	.	PUNCT
easat-9432	14	1	in	in	ADP
easat-9432	14	2	april	april	PROPN
easat-9432	14	3	2022	2022	NUM
easat-9432	14	4	,	,	PUNCT
easat-9432	14	5	recist	recist	NOUN
easat-9432	14	6	showed	show	VERB
easat-9432	14	7	that	that	SCONJ
easat-9432	14	8	the	the	DET
easat-9432	14	9	mass	mass	NOUN
easat-9432	14	10	increased	increase	VERB
easat-9432	14	11	.	.	PUNCT
easat-9432	15	1	koh	koh	PROPN
easat-9432	15	2	sputum	sputum	PROPN
easat-9432	15	3	obtained	obtain	VERB
easat-9432	15	4	hyphae	hypha	NOUN
easat-9432	15	5	and	and	CCONJ
easat-9432	15	6	conidia	conidia	NOUN
easat-9432	15	7	.	.	PUNCT
easat-9432	16	1	forceps	forceps	NOUN
easat-9432	16	2	biopsy	biopsy	PROPN
easat-9432	16	3	found	find	VERB
easat-9432	16	4	aspergillus	aspergillus	NOUN
easat-9432	16	5	.	.	PUNCT
easat-9432	17	1	re	re	VERB
easat-9432	17	2	-	-	NOUN
easat-9432	17	3	biopsy	biopsy	ADJ
easat-9432	17	4	was	be	AUX
easat-9432	17	5	squamous	squamous	ADJ
easat-9432	17	6	cell	cell	NOUN
easat-9432	17	7	carcinoma	carcinoma	NOUN
easat-9432	17	8	.	.	PUNCT
easat-9432	18	1	sclc	sclc	PROPN
easat-9432	18	2	transformation	transformation	NOUN
easat-9432	18	3	is	be	AUX
easat-9432	18	4	characterized	characterize	VERB
easat-9432	18	5	by	by	ADP
easat-9432	18	6	tp53	tp53	PROPN
easat-9432	18	7	and	and	CCONJ
easat-9432	18	8	rb1	rb1	PROPN
easat-9432	18	9	gene	gene	NOUN
easat-9432	18	10	mutations	mutation	NOUN
easat-9432	18	11	.	.	PUNCT
easat-9432	19	1	interferon	interferon	ADJ
easat-9432	19	2	-	-	PUNCT
easat-9432	19	3	ỿ	ỿ	NOUN
easat-9432	19	4	(	(	PUNCT
easat-9432	19	5	infỿ	infỿ	NOUN
easat-9432	19	6	)	)	PUNCT
easat-9432	19	7	production	production	NOUN
easat-9432	19	8	impairment	impairment	NOUN
easat-9432	19	9	due	due	ADP
easat-9432	19	10	to	to	ADP
easat-9432	19	11	il12rb1	il12rb1	ADJ
easat-9432	19	12	mutation	mutation	NOUN
easat-9432	19	13	caused	cause	VERB
easat-9432	19	14	macrophages	macrophage	NOUN
easat-9432	19	15	to	to	PART
easat-9432	19	16	eliminate	eliminate	VERB
easat-9432	19	17	intracellular	intracellular	ADJ
easat-9432	19	18	fungi	fungus	NOUN
easat-9432	19	19	.	.	PUNCT
easat-9432	20	1	fungal	fungal	ADJ
easat-9432	20	2	interaction	interaction	NOUN
easat-9432	20	3	(	(	PUNCT
easat-9432	20	4	integrin	integrin	NOUN
easat-9432	20	5	-	-	PUNCT
easat-9432	20	6	β1	β1	PROPN
easat-9432	20	7	)	)	PUNCT
easat-9432	20	8	on	on	ADP
easat-9432	20	9	alveolar	alveolar	ADJ
easat-9432	20	10	epithelial	epithelial	ADJ
easat-9432	20	11	cells	cell	NOUN
easat-9432	20	12	increases	increase	VERB
easat-9432	20	13	egfr	egfr	ADJ
easat-9432	20	14	activation	activation	NOUN
easat-9432	20	15	,	,	PUNCT
easat-9432	20	16	cell	cell	NOUN
easat-9432	20	17	damage	damage	NOUN
easat-9432	20	18	,	,	PUNCT
easat-9432	20	19	and	and	CCONJ
easat-9432	20	20	the	the	DET
easat-9432	20	21	development	development	NOUN
easat-9432	20	22	of	of	ADP
easat-9432	20	23	fungal	fungal	ADJ
easat-9432	20	24	invasion	invasion	NOUN
easat-9432	20	25	.	.	PUNCT
easat-9432	21	1	patient	patient	NOUN
easat-9432	21	2	was	be	AUX
easat-9432	21	3	given	give	VERB
easat-9432	21	4	fluconazole	fluconazole	NOUN
easat-9432	21	5	and	and	CCONJ
easat-9432	21	6	carboplatin	carboplatin	NOUN
easat-9432	21	7	-	-	PUNCT
easat-9432	21	8	paclitaxel	paclitaxel	PROPN
easat-9432	21	9	chemotherapy	chemotherapy	NOUN
easat-9432	21	10	6	6	NUM
easat-9432	21	11	series	serie	NOUN
easat-9432	21	12	,	,	PUNCT
easat-9432	21	13	then	then	ADV
easat-9432	21	14	maintenance	maintenance	NOUN
easat-9432	21	15	paclitaxel	paclitaxel	NOUN
easat-9432	21	16	,	,	PUNCT
easat-9432	21	17	currently	currently	ADV
easat-9432	21	18	stable	stable	ADJ
easat-9432	21	19	.	.	PUNCT
easat-9432	22	1	keywords	keyword	NOUN
easat-9432	22	2	:	:	PUNCT
easat-9432	22	3	invasive	invasive	ADJ
easat-9432	22	4	fungal	fungal	ADJ
easat-9432	22	5	infection	infection	NOUN
easat-9432	22	6	,	,	PUNCT
easat-9432	22	7	squamous	squamous	ADJ
easat-9432	22	8	cell	cell	NOUN
easat-9432	22	9	lung	lung	NOUN
easat-9432	22	10	cancer	cancer	NOUN
easat-9432	22	11	,	,	PUNCT
easat-9432	22	12	transformation	transformation	NOUN
easat-9432	22	13	sclc	sclc	PROPN
easat-9432	22	14	.	.	PROPN
easat-9432	23	1	1	1	X
easat-9432	23	2	.	.	X
easat-9432	23	3	introduction	introduction	NOUN
easat-9432	23	4	lung	lung	NOUN
easat-9432	23	5	cancer	cancer	NOUN
easat-9432	23	6	is	be	AUX
easat-9432	23	7	a	a	DET
easat-9432	23	8	cell	cell	NOUN
easat-9432	23	9	growth	growth	NOUN
easat-9432	23	10	that	that	PRON
easat-9432	23	11	is	be	AUX
easat-9432	23	12	uncontrolled	uncontrolled	ADJ
easat-9432	23	13	and	and	CCONJ
easat-9432	23	14	causes	cause	VERB
easat-9432	23	15	excessive	excessive	ADJ
easat-9432	23	16	and	and	CCONJ
easat-9432	23	17	abnormal	abnormal	ADJ
easat-9432	23	18	pathological	pathological	ADJ
easat-9432	23	19	damage	damage	NOUN
easat-9432	23	20	is	be	AUX
easat-9432	23	21	included	include	VERB
easat-9432	23	22	in	in	ADP
easat-9432	23	23	malignant	malignant	ADJ
easat-9432	23	24	tumors	tumor	NOUN
easat-9432	24	1	[	[	X
easat-9432	24	2	1	1	NUM
easat-9432	24	3	]	]	PUNCT
easat-9432	24	4	.	.	PUNCT
easat-9432	25	1	lung	lung	NOUN
easat-9432	25	2	cancer	cancer	NOUN
easat-9432	25	3	is	be	AUX
easat-9432	25	4	the	the	DET
easat-9432	25	5	leading	lead	VERB
easat-9432	25	6	cause	cause	NOUN
easat-9432	25	7	of	of	ADP
easat-9432	25	8	cancer	cancer	NOUN
easat-9432	25	9	death	death	NOUN
easat-9432	25	10	worldwide	worldwide	ADV
easat-9432	25	11	,	,	PUNCT
easat-9432	25	12	with	with	ADP
easat-9432	25	13	an	an	DET
easat-9432	25	14	estimated	estimate	VERB
easat-9432	25	15	2.1	2.1	NUM
easat-9432	25	16	million	million	NUM
easat-9432	25	17	new	new	ADJ
easat-9432	25	18	cases	case	NOUN
easat-9432	25	19	and	and	CCONJ
easat-9432	25	20	1.8	1.8	NUM
easat-9432	25	21	million	million	NUM
easat-9432	25	22	deaths	death	NOUN
easat-9432	25	23	in	in	ADP
easat-9432	25	24	2018	2018	NUM
easat-9432	25	25	.	.	PUNCT
easat-9432	26	1	the	the	DET
easat-9432	26	2	incidence	incidence	NOUN
easat-9432	26	3	of	of	ADP
easat-9432	26	4	lung	lung	NOUN
easat-9432	26	5	cancer	cancer	NOUN
easat-9432	26	6	in	in	ADP
easat-9432	26	7	indonesia	indonesia	PROPN
easat-9432	26	8	at	at	ADP
easat-9432	26	9	a	a	DET
easat-9432	26	10	young	young	ADJ
easat-9432	26	11	age	age	NOUN
easat-9432	26	12	is	be	AUX
easat-9432	26	13	increasing	increase	VERB
easat-9432	26	14	compared	compare	VERB
easat-9432	26	15	to	to	ADP
easat-9432	26	16	other	other	ADJ
easat-9432	26	17	countries	country	NOUN
easat-9432	26	18	[	[	X
easat-9432	26	19	2	2	NUM
easat-9432	26	20	]	]	PUNCT
easat-9432	26	21	.	.	PUNCT
easat-9432	27	1	in	in	ADP
easat-9432	27	2	2018	2018	NUM
easat-9432	27	3	,	,	PUNCT
easat-9432	27	4	who	who	PRON
easat-9432	27	5	reported	report	VERB
easat-9432	27	6	30,023	30,023	NUM
easat-9432	27	7	new	new	ADJ
easat-9432	27	8	cases	case	NOUN
easat-9432	27	9	of	of	ADP
easat-9432	27	10	lung	lung	NOUN
easat-9432	27	11	cancer	cancer	NOUN
easat-9432	27	12	in	in	ADP
easat-9432	27	13	indonesia	indonesia	PROPN
easat-9432	27	14	and	and	CCONJ
easat-9432	27	15	26,095	26,095	NUM
easat-9432	27	16	deaths	death	NOUN
easat-9432	27	17	,	,	PUNCT
easat-9432	27	18	about	about	ADV
easat-9432	27	19	2.6	2.6	NUM
easat-9432	27	20	%	%	NOUN
easat-9432	27	21	of	of	ADP
easat-9432	27	22	total	total	ADJ
easat-9432	27	23	deaths	death	NOUN
easat-9432	27	24	in	in	ADP
easat-9432	27	25	indonesia	indonesia	PROPN
easat-9432	27	26	[	[	X
easat-9432	27	27	3	3	NUM
easat-9432	27	28	]	]	PUNCT
easat-9432	27	29	.	.	PUNCT
easat-9432	28	1	small	small	ADJ
easat-9432	28	2	cell	cell	NOUN
easat-9432	28	3	carcinoma	carcinoma	NOUN
easat-9432	28	4	lung	lung	NOUN
easat-9432	28	5	cancer	cancer	NOUN
easat-9432	28	6	(	(	PUNCT
easat-9432	28	7	sclc	sclc	PROPN
easat-9432	28	8	)	)	PUNCT
easat-9432	28	9	has	have	VERB
easat-9432	28	10	a	a	DET
easat-9432	28	11	prevalence	prevalence	NOUN
easat-9432	28	12	of	of	ADP
easat-9432	28	13	approximately	approximately	ADV
easat-9432	28	14	250,000	250,000	NUM
easat-9432	28	15	new	new	ADJ
easat-9432	28	16	cases	case	NOUN
easat-9432	28	17	and	and	CCONJ
easat-9432	28	18	at	at	ADP
easat-9432	28	19	least	least	ADJ
easat-9432	28	20	200,000	200,000	NUM
easat-9432	28	21	deaths	death	NOUN
easat-9432	28	22	globally	globally	ADV
easat-9432	28	23	each	each	DET
easat-9432	28	24	year	year	NOUN
easat-9432	29	1	[	[	X
easat-9432	29	2	2	2	NUM
easat-9432	29	3	]	]	PUNCT
easat-9432	29	4	.	.	PUNCT
easat-9432	30	1	research	research	NOUN
easat-9432	30	2	by	by	ADP
easat-9432	30	3	chozin	chozin	PROPN
easat-9432	30	4	et	et	PROPN
easat-9432	30	5	al	al	PROPN
easat-9432	30	6	.	.	PROPN
easat-9432	30	7	mentioned	mention	VERB
easat-9432	30	8	that	that	SCONJ
easat-9432	30	9	the	the	DET
easat-9432	30	10	profile	profile	NOUN
easat-9432	30	11	of	of	ADP
easat-9432	30	12	sclc	sclc	PROPN
easat-9432	30	13	patients	patient	NOUN
easat-9432	30	14	at	at	ADP
easat-9432	30	15	saiful	saiful	PROPN
easat-9432	30	16	anwar	anwar	PROPN
easat-9432	30	17	malang	malang	PROPN
easat-9432	30	18	hospital	hospital	PROPN
easat-9432	30	19	was	be	AUX
easat-9432	30	20	lower	low	ADJ
easat-9432	30	21	at	at	ADP
easat-9432	30	22	around	around	ADP
easat-9432	30	23	8.1	8.1	NUM
easat-9432	30	24	%	%	NOUN
easat-9432	30	25	,	,	PUNCT
easat-9432	30	26	while	while	SCONJ
easat-9432	30	27	the	the	DET
easat-9432	30	28	type	type	NOUN
easat-9432	30	29	of	of	ADP
easat-9432	30	30	non	non	ADJ
easat-9432	30	31	-	-	ADJ
easat-9432	30	32	small	small	ADJ
easat-9432	30	33	cell	cell	NOUN
easat-9432	30	34	carcinoma	carcinoma	NOUN
easat-9432	30	35	lung	lung	NOUN
easat-9432	30	36	cancer	cancer	NOUN
easat-9432	30	37	(	(	PUNCT
easat-9432	30	38	nsclc	nsclc	NOUN
easat-9432	30	39	)	)	PUNCT
easat-9432	30	40	,	,	PUNCT
easat-9432	30	41	such	such	ADJ
easat-9432	30	42	as	as	ADP
easat-9432	30	43	squamous	squamous	ADJ
easat-9432	30	44	cell	cell	NOUN
easat-9432	30	45	carcinoma	carcinoma	NOUN
easat-9432	30	46	,	,	PUNCT
easat-9432	30	47	amounted	amount	VERB
easat-9432	30	48	to	to	ADP
easat-9432	30	49	16.2	16.2	NUM
easat-9432	30	50	%	%	NOUN
easat-9432	31	1	[	[	X
easat-9432	31	2	4	4	NUM
easat-9432	31	3	]	]	PUNCT
easat-9432	31	4	.	.	PUNCT
easat-9432	32	1	lung	lung	NOUN
easat-9432	32	2	cancer	cancer	NOUN
easat-9432	32	3	patients	patient	NOUN
easat-9432	32	4	often	often	ADV
easat-9432	32	5	experience	experience	VERB
easat-9432	32	6	opportunistic	opportunistic	ADJ
easat-9432	32	7	infections	infection	NOUN
easat-9432	32	8	.	.	PUNCT
easat-9432	33	1	invasive	invasive	ADJ
easat-9432	33	2	infections	infection	NOUN
easat-9432	33	3	of	of	ADP
easat-9432	33	4	aspergillus	aspergillus	NOUN
easat-9432	33	5	fungi	fungus	NOUN
easat-9432	33	6	,	,	PUNCT
easat-9432	33	7	pneumocystis	pneumocystis	NOUN
easat-9432	33	8	cryptococcus	cryptococcus	NOUN
easat-9432	33	9	often	often	ADV
easat-9432	33	10	occur	occur	VERB
easat-9432	33	11	in	in	ADP
easat-9432	33	12	immunocompromised	immunocompromise	VERB
easat-9432	33	13	patients	patient	NOUN
easat-9432	33	14	,	,	PUNCT
easat-9432	33	15	such	such	ADJ
easat-9432	33	16	as	as	ADP
easat-9432	33	17	lung	lung	NOUN
easat-9432	33	18	cancer	cancer	NOUN
easat-9432	33	19	,	,	PUNCT
easat-9432	33	20	who	who	PRON
easat-9432	33	21	are	be	AUX
easat-9432	33	22	given	give	VERB
easat-9432	33	23	chemotherapy	chemotherapy	NOUN
easat-9432	33	24	[	[	X
easat-9432	33	25	5	5	NUM
easat-9432	33	26	]	]	PUNCT
easat-9432	33	27	.	.	PUNCT
easat-9432	34	1	some	some	DET
easat-9432	34	2	fungal	fungal	ADJ
easat-9432	34	3	pathogens	pathogen	NOUN
easat-9432	34	4	initiate	initiate	VERB
easat-9432	34	5	infection	infection	NOUN
easat-9432	34	6	through	through	ADP
easat-9432	34	7	surface	surface	NOUN
easat-9432	34	8	proteins	protein	NOUN
easat-9432	34	9	from	from	ADP
easat-9432	34	10	pathogen	pathogen	NOUN
easat-9432	34	11	-	-	PUNCT
easat-9432	34	12	host	host	NOUN
easat-9432	34	13	interactions	interaction	NOUN
easat-9432	34	14	and	and	CCONJ
easat-9432	34	15	cause	cause	VERB
easat-9432	34	16	multiple	multiple	ADJ
easat-9432	34	17	lesions	lesion	NOUN
easat-9432	34	18	,	,	PUNCT
easat-9432	34	19	especially	especially	ADV
easat-9432	34	20	in	in	ADP
easat-9432	34	21	tissues	tissue	NOUN
easat-9432	34	22	[	[	X
easat-9432	34	23	6	6	NUM
easat-9432	34	24	]	]	PUNCT
easat-9432	34	25	.	.	PUNCT
easat-9432	35	1	nsclc	nsclc	NOUN
easat-9432	35	2	patients	patient	NOUN
easat-9432	35	3	often	often	ADV
easat-9432	35	4	transform	transform	VERB
easat-9432	35	5	into	into	ADP
easat-9432	35	6	sclc	sclc	PROPN
easat-9432	35	7	[	[	X
easat-9432	35	8	7	7	NUM
easat-9432	35	9	]	]	PUNCT
easat-9432	35	10	.	.	PUNCT
easat-9432	36	1	however	however	ADV
easat-9432	36	2	,	,	PUNCT
easat-9432	36	3	in	in	ADP
easat-9432	36	4	this	this	DET
easat-9432	36	5	case	case	NOUN
easat-9432	36	6	,	,	PUNCT
easat-9432	36	7	there	there	PRON
easat-9432	36	8	was	be	VERB
easat-9432	36	9	a	a	DET
easat-9432	36	10	change	change	NOUN
easat-9432	36	11	in	in	ADP
easat-9432	36	12	transformation	transformation	NOUN
easat-9432	36	13	from	from	ADP
easat-9432	36	14	sclc	sclc	PROPN
easat-9432	36	15	to	to	ADP
easat-9432	36	16	nsclc	nsclc	NOUN
easat-9432	36	17	,	,	PUNCT
easat-9432	36	18	with	with	ADP
easat-9432	36	19	a	a	DET
easat-9432	36	20	very	very	ADV
easat-9432	36	21	rare	rare	ADJ
easat-9432	36	22	incidence	incidence	NOUN
easat-9432	36	23	of	of	ADP
easat-9432	36	24	about	about	ADV
easat-9432	36	25	5	5	NUM
easat-9432	36	26	%	%	NOUN
easat-9432	36	27	[	[	X
easat-9432	36	28	8	8	NUM
easat-9432	36	29	]	]	SYM
easat-9432	36	30	.	.	PUNCT
easat-9432	37	1	2	2	X
easat-9432	37	2	.	.	X
easat-9432	37	3	method	method	PROPN
easat-9432	37	4	patient	patient	PROPN
easat-9432	37	5	mr	mr	PROPN
easat-9432	37	6	.	.	PROPN
easat-9432	37	7	p	p	PROPN
easat-9432	37	8	was	be	AUX
easat-9432	37	9	69	69	NUM
easat-9432	37	10	years	year	NOUN
easat-9432	37	11	old	old	ADJ
easat-9432	37	12	,	,	PUNCT
easat-9432	37	13	working	work	VERB
easat-9432	37	14	as	as	ADP
easat-9432	37	15	a	a	DET
easat-9432	37	16	welder	welder	NOUN
easat-9432	37	17	in	in	ADP
easat-9432	37	18	a	a	DET
easat-9432	37	19	factory	factory	NOUN
easat-9432	37	20	for	for	ADP
easat-9432	37	21	30	30	NUM
easat-9432	37	22	years	year	NOUN
easat-9432	37	23	.	.	PUNCT
easat-9432	38	1	in	in	ADP
easat-9432	38	2	april	april	PROPN
easat-9432	38	3	2022	2022	NUM
easat-9432	38	4	,	,	PUNCT
easat-9432	38	5	the	the	DET
easat-9432	38	6	patient	patient	NOUN
easat-9432	38	7	had	have	VERB
easat-9432	38	8	a	a	DET
easat-9432	38	9	bloody	bloody	ADJ
easat-9432	38	10	cough	cough	NOUN
easat-9432	38	11	with	with	ADP
easat-9432	38	12	accumulation	accumulation	NOUN
easat-9432	38	13	of	of	ADP
easat-9432	38	14	200	200	NUM
easat-9432	38	15	ml	ml	NOUN
easat-9432	38	16	per	per	ADP
easat-9432	38	17	day	day	NOUN
easat-9432	38	18	for	for	ADP
easat-9432	38	19	1	1	NUM
easat-9432	38	20	month	month	NOUN
easat-9432	38	21	.	.	PUNCT
easat-9432	39	1	he	he	PRON
easat-9432	39	2	felt	feel	VERB
easat-9432	39	3	shortness	shortness	NOUN
easat-9432	39	4	of	of	ADP
easat-9432	39	5	745	745	NUM
easat-9432	39	6	edelweiss	edelweiss	PROPN
easat-9432	39	7	applied	apply	VERB
easat-9432	39	8	science	science	NOUN
easat-9432	39	9	and	and	CCONJ
easat-9432	39	10	technology	technology	NOUN
easat-9432	39	11	issn	issn	PROPN
easat-9432	39	12	:	:	PUNCT
easat-9432	39	13	2576	2576	NUM
easat-9432	39	14	-	-	SYM
easat-9432	39	15	8484	8484	NUM
easat-9432	39	16	vol	vol	NOUN
easat-9432	39	17	.	.	PROPN
easat-9432	40	1	9	9	NUM
easat-9432	40	2	,	,	PUNCT
easat-9432	40	3	no	no	INTJ
easat-9432	40	4	.	.	NOUN
easat-9432	40	5	8	8	NUM
easat-9432	40	6	:	:	PUNCT
easat-9432	40	7	744	744	NUM
easat-9432	40	8	-	-	SYM
easat-9432	40	9	751	751	NUM
easat-9432	40	10	,	,	PUNCT
easat-9432	40	11	2025	2025	NUM
easat-9432	40	12	doi	doi	NOUN
easat-9432	40	13	:	:	PUNCT
easat-9432	40	14	10.55214/2576	10.55214/2576	NUM
easat-9432	40	15	-	-	SYM
easat-9432	40	16	8484.v9i8.9432	8484.v9i8.9432	NOUN
easat-9432	41	1	©	©	PROPN
easat-9432	41	2	2025	2025	NUM
easat-9432	41	3	by	by	ADP
easat-9432	41	4	the	the	DET
easat-9432	41	5	authors	author	NOUN
easat-9432	41	6	;	;	PUNCT
easat-9432	41	7	licensee	licensee	NOUN
easat-9432	41	8	learning	learn	VERB
easat-9432	41	9	gate	gate	NOUN
easat-9432	41	10	breath	breath	NOUN
easat-9432	41	11	for	for	ADP
easat-9432	41	12	3	3	NUM
easat-9432	41	13	weeks	week	NOUN
easat-9432	41	14	,	,	PUNCT
easat-9432	41	15	and	and	CCONJ
easat-9432	41	16	right	right	ADJ
easat-9432	41	17	chest	chest	NOUN
easat-9432	41	18	pain	pain	NOUN
easat-9432	41	19	for	for	ADP
easat-9432	41	20	the	the	DET
easat-9432	41	21	last	last	ADJ
easat-9432	41	22	1	1	NUM
easat-9432	41	23	month	month	NOUN
easat-9432	41	24	.	.	PUNCT
easat-9432	42	1	he	he	PRON
easat-9432	42	2	has	have	AUX
easat-9432	42	3	decreased	decrease	VERB
easat-9432	42	4	appetite	appetite	NOUN
easat-9432	42	5	,	,	PUNCT
easat-9432	42	6	weight	weight	NOUN
easat-9432	42	7	loss	loss	NOUN
easat-9432	42	8	of	of	ADP
easat-9432	42	9	3	3	NUM
easat-9432	42	10	kg	kg	NOUN
easat-9432	42	11	in	in	ADP
easat-9432	42	12	1	1	NUM
easat-9432	42	13	month	month	NOUN
easat-9432	42	14	.	.	PUNCT
easat-9432	43	1	patient	patient	NOUN
easat-9432	43	2	has	have	VERB
easat-9432	43	3	a	a	DET
easat-9432	43	4	history	history	NOUN
easat-9432	43	5	of	of	ADP
easat-9432	43	6	smoking	smoke	VERB
easat-9432	43	7	5	5	NUM
easat-9432	43	8	cigarettes	cigarette	NOUN
easat-9432	43	9	/	/	SYM
easat-9432	43	10	day	day	NOUN
easat-9432	43	11	for	for	ADP
easat-9432	43	12	30	30	NUM
easat-9432	43	13	years	year	NOUN
easat-9432	43	14	(	(	PUNCT
easat-9432	43	15	brinkman	brinkman	PROPN
easat-9432	43	16	's	's	PART
easat-9432	43	17	index	index	NOUN
easat-9432	43	18	150	150	NUM
easat-9432	43	19	,	,	PUNCT
easat-9432	43	20	light	light	NOUN
easat-9432	43	21	smoker	smoker	NOUN
easat-9432	43	22	)	)	PUNCT
easat-9432	43	23	,	,	PUNCT
easat-9432	43	24	quit	quit	VERB
easat-9432	43	25	since	since	SCONJ
easat-9432	43	26	2017	2017	NUM
easat-9432	43	27	.	.	PUNCT
easat-9432	44	1	this	this	DET
easat-9432	44	2	patient	patient	NOUN
easat-9432	44	3	also	also	ADV
easat-9432	44	4	diagnosed	diagnose	VERB
easat-9432	44	5	with	with	ADP
easat-9432	44	6	copd	copd	NOUN
easat-9432	44	7	since	since	SCONJ
easat-9432	44	8	2017	2017	NUM
easat-9432	44	9	according	accord	VERB
easat-9432	44	10	to	to	ADP
easat-9432	44	11	vital	vital	ADJ
easat-9432	44	12	lung	lung	NOUN
easat-9432	44	13	capacity	capacity	NOUN
easat-9432	44	14	test	test	NOUN
easat-9432	44	15	fev1	fev1	PROPN
easat-9432	44	16	66	66	NUM
easat-9432	44	17	%	%	NOUN
easat-9432	44	18	(	(	PUNCT
easat-9432	44	19	gold	gold	NOUN
easat-9432	44	20	2	2	NUM
easat-9432	44	21	)	)	PUNCT
easat-9432	44	22	.	.	PUNCT
easat-9432	45	1	patient	patient	ADJ
easat-9432	45	2	with	with	ADP
easat-9432	45	3	history	history	NOUN
easat-9432	45	4	of	of	ADP
easat-9432	45	5	sclc	sclc	PROPN
easat-9432	45	6	in	in	ADP
easat-9432	45	7	2017	2017	NUM
easat-9432	45	8	with	with	ADP
easat-9432	45	9	6	6	NUM
easat-9432	45	10	series	series	NOUN
easat-9432	45	11	of	of	ADP
easat-9432	45	12	cisplatin	cisplatin	NOUN
easat-9432	45	13	-	-	PUNCT
easat-9432	45	14	etoposide	etoposide	NOUN
easat-9432	45	15	chemotherapy	chemotherapy	NOUN
easat-9432	45	16	,	,	PUNCT
easat-9432	45	17	advised	advise	VERB
easat-9432	45	18	to	to	PART
easat-9432	45	19	rest	rest	VERB
easat-9432	45	20	chemotherapy	chemotherapy	NOUN
easat-9432	45	21	with	with	ADP
easat-9432	45	22	evaluation	evaluation	NOUN
easat-9432	45	23	of	of	ADP
easat-9432	45	24	thorax	thorax	NOUN
easat-9432	45	25	ct	ct	PROPN
easat-9432	45	26	scan	scan	NOUN
easat-9432	46	1	+	+	CCONJ
easat-9432	46	2	recist	recist	NOUN
easat-9432	46	3	every	every	DET
easat-9432	46	4	3	3	NUM
easat-9432	46	5	months	month	NOUN
easat-9432	46	6	.	.	PUNCT
easat-9432	47	1	but	but	CCONJ
easat-9432	47	2	the	the	DET
easat-9432	47	3	patient	patient	NOUN
easat-9432	47	4	did	do	AUX
easat-9432	47	5	not	not	PART
easat-9432	47	6	control	control	VERB
easat-9432	47	7	it	it	PRON
easat-9432	47	8	again	again	ADV
easat-9432	47	9	.	.	PUNCT
easat-9432	48	1	on	on	ADP
easat-9432	48	2	physical	physical	ADJ
easat-9432	48	3	examination	examination	NOUN
easat-9432	48	4	,	,	PUNCT
easat-9432	48	5	vital	vital	ADJ
easat-9432	48	6	signs	sign	NOUN
easat-9432	48	7	were	be	AUX
easat-9432	48	8	within	within	ADP
easat-9432	48	9	normal	normal	ADJ
easat-9432	48	10	limits	limit	NOUN
easat-9432	48	11	,	,	PUNCT
easat-9432	48	12	and	and	CCONJ
easat-9432	48	13	oxygen	oxygen	NOUN
easat-9432	48	14	saturation	saturation	NOUN
easat-9432	48	15	was	be	AUX
easat-9432	48	16	normal	normal	ADJ
easat-9432	48	17	;	;	PUNCT
easat-9432	48	18	right	right	ADJ
easat-9432	48	19	lung	lung	NOUN
easat-9432	48	20	sounds	sound	NOUN
easat-9432	48	21	were	be	AUX
easat-9432	48	22	found	find	VERB
easat-9432	48	23	to	to	PART
easat-9432	48	24	be	be	AUX
easat-9432	48	25	decreased	decrease	VERB
easat-9432	48	26	,	,	PUNCT
easat-9432	48	27	and	and	CCONJ
easat-9432	48	28	percussion	percussion	NOUN
easat-9432	48	29	was	be	AUX
easat-9432	48	30	faint	faint	ADJ
easat-9432	48	31	.	.	PUNCT
easat-9432	49	1	laboratory	laboratory	NOUN
easat-9432	49	2	dated	date	VERB
easat-9432	49	3	11/05/2022	11/05/2022	NUM
easat-9432	49	4	found	find	VERB
easat-9432	49	5	an	an	DET
easat-9432	49	6	increase	increase	NOUN
easat-9432	49	7	in	in	ADP
easat-9432	49	8	tumor	tumor	NOUN
easat-9432	49	9	markers	marker	NOUN
easat-9432	49	10	nse	nse	PROPN
easat-9432	49	11	54.43	54.43	NUM
easat-9432	49	12	ng	ng	PROPN
easat-9432	49	13	/	/	SYM
easat-9432	49	14	ml	ml	PROPN
easat-9432	49	15	(	(	PUNCT
easat-9432	49	16	n	n	X
easat-9432	49	17	<	<	X
easat-9432	49	18	16.3	16.3	NUM
easat-9432	49	19	)	)	PUNCT
easat-9432	49	20	but	but	CCONJ
easat-9432	49	21	normal	normal	ADJ
easat-9432	49	22	in	in	ADP
easat-9432	49	23	cea	cea	PROPN
easat-9432	49	24	2.71	2.71	NUM
easat-9432	49	25	ng	ng	PROPN
easat-9432	49	26	/	/	SYM
easat-9432	49	27	ml	ml	PROPN
easat-9432	49	28	(	(	PUNCT
easat-9432	49	29	n	n	X
easat-9432	49	30	<	<	X
easat-9432	49	31	5.0	5.0	NUM
easat-9432	49	32	)	)	PUNCT
easat-9432	49	33	and	and	CCONJ
easat-9432	49	34	afp	afp	PROPN
easat-9432	49	35	1.38	1.38	NUM
easat-9432	49	36	mmol	mmol	NOUN
easat-9432	49	37	/	/	SYM
easat-9432	49	38	l	l	NOUN
easat-9432	49	39	(	(	PUNCT
easat-9432	49	40	n	n	CCONJ
easat-9432	49	41	≤	≤	NUM
easat-9432	49	42	7.0	7.0	NUM
easat-9432	49	43	)	)	PUNCT
easat-9432	49	44	.	.	PUNCT
easat-9432	50	1	chest	chest	NOUN
easat-9432	50	2	x	x	NOUN
easat-9432	50	3	-	-	NOUN
easat-9432	50	4	ray	ray	NOUN
easat-9432	50	5	(	(	PUNCT
easat-9432	50	6	cxr	cxr	NOUN
easat-9432	50	7	)	)	PUNCT
easat-9432	50	8	from	from	ADP
easat-9432	50	9	2017	2017	NUM
easat-9432	50	10	to	to	ADP
easat-9432	50	11	2022	2022	NUM
easat-9432	50	12	revealed	reveal	VERB
easat-9432	50	13	an	an	DET
easat-9432	50	14	enlarged	enlarged	ADJ
easat-9432	50	15	right	right	ADJ
easat-9432	50	16	lung	lung	NOUN
easat-9432	50	17	mass	mass	NOUN
easat-9432	50	18	(	(	PUNCT
easat-9432	50	19	figure	figure	NOUN
easat-9432	50	20	1	1	NUM
easat-9432	50	21	)	)	PUNCT
easat-9432	50	22	.	.	PUNCT
easat-9432	51	1	figure	figure	NOUN
easat-9432	51	2	1	1	NUM
easat-9432	51	3	.	.	PUNCT
easat-9432	52	1	a.	a.	NOUN
easat-9432	52	2	right	right	PROPN
easat-9432	52	3	lung	lung	PROPN
easat-9432	52	4	mass	mass	PROPN
easat-9432	52	5	;	;	PUNCT
easat-9432	52	6	b.	b.	PROPN
easat-9432	52	7	homogeneous	homogeneous	ADJ
easat-9432	52	8	opacity	opacity	NOUN
easat-9432	52	9	,	,	PUNCT
easat-9432	52	10	well	well	ADV
easat-9432	52	11	-	-	PUNCT
easat-9432	52	12	circumscribed	circumscribed	ADJ
easat-9432	52	13	,	,	PUNCT
easat-9432	52	14	irregular	irregular	ADJ
easat-9432	52	15	edge	edge	NOUN
easat-9432	52	16	,	,	PUNCT
easat-9432	52	17	perihilar	perihilar	ADJ
easat-9432	52	18	dextral	dextral	NOUN
easat-9432	52	19	,	,	PUNCT
easat-9432	52	20	looking	look	VERB
easat-9432	52	21	like	like	ADP
easat-9432	52	22	a	a	DET
easat-9432	52	23	right	right	ADJ
easat-9432	52	24	lung	lung	NOUN
easat-9432	52	25	mass	mass	NOUN
easat-9432	52	26	with	with	ADP
easat-9432	52	27	left	left	ADJ
easat-9432	52	28	lung	lung	NOUN
easat-9432	52	29	emphysematous	emphysematous	ADJ
easat-9432	52	30	.	.	PUNCT
easat-9432	53	1	the	the	DET
easat-9432	53	2	patient	patient	ADJ
easat-9432	53	3	underwent	underwent	NOUN
easat-9432	53	4	ct	ct	NOUN
easat-9432	53	5	-	-	PUNCT
easat-9432	53	6	scan	scan	ADJ
easat-9432	53	7	thorax	thorax	NOUN
easat-9432	53	8	with	with	ADP
easat-9432	53	9	repeat	repeat	NOUN
easat-9432	53	10	contrast	contrast	NOUN
easat-9432	53	11	in	in	ADP
easat-9432	53	12	april	april	PROPN
easat-9432	53	13	2022	2022	NUM
easat-9432	53	14	and	and	CCONJ
easat-9432	53	15	obtained	obtain	VERB
easat-9432	53	16	a	a	DET
easat-9432	53	17	lung	lung	NOUN
easat-9432	53	18	mass	mass	NOUN
easat-9432	53	19	of	of	ADP
easat-9432	53	20	110	110	NUM
easat-9432	53	21	mm	mm	NOUN
easat-9432	53	22	(	(	PUNCT
easat-9432	53	23	figure	figure	NOUN
easat-9432	53	24	2	2	NUM
easat-9432	53	25	)	)	PUNCT
easat-9432	53	26	.	.	PUNCT
easat-9432	54	1	746	746	NUM
easat-9432	54	2	edelweiss	edelweiss	PROPN
easat-9432	54	3	applied	apply	VERB
easat-9432	54	4	science	science	NOUN
easat-9432	54	5	and	and	CCONJ
easat-9432	54	6	technology	technology	NOUN
easat-9432	54	7	issn	issn	PROPN
easat-9432	54	8	:	:	PUNCT
easat-9432	54	9	2576	2576	NUM
easat-9432	54	10	-	-	SYM
easat-9432	54	11	8484	8484	NUM
easat-9432	54	12	vol	vol	NOUN
easat-9432	54	13	.	.	PROPN
easat-9432	55	1	9	9	NUM
easat-9432	55	2	,	,	PUNCT
easat-9432	55	3	no	no	INTJ
easat-9432	55	4	.	.	NOUN
easat-9432	55	5	8	8	NUM
easat-9432	55	6	:	:	PUNCT
easat-9432	55	7	744	744	NUM
easat-9432	55	8	-	-	SYM
easat-9432	55	9	751	751	NUM
easat-9432	55	10	,	,	PUNCT
easat-9432	55	11	2025	2025	NUM
easat-9432	55	12	doi	doi	NOUN
easat-9432	55	13	:	:	PUNCT
easat-9432	55	14	10.55214/2576	10.55214/2576	NUM
easat-9432	55	15	-	-	SYM
easat-9432	55	16	8484.v9i8.9432	8484.v9i8.9432	NOUN
easat-9432	56	1	©	©	PROPN
easat-9432	56	2	2025	2025	NUM
easat-9432	56	3	by	by	ADP
easat-9432	56	4	the	the	DET
easat-9432	56	5	authors	author	NOUN
easat-9432	56	6	;	;	PUNCT
easat-9432	56	7	licensee	licensee	PROPN
easat-9432	56	8	learning	learn	VERB
easat-9432	56	9	gate	gate	NOUN
easat-9432	56	10	figure	figure	NOUN
easat-9432	56	11	2	2	NUM
easat-9432	56	12	.	.	PUNCT
easat-9432	56	13	a.	a.	NOUN
easat-9432	56	14	right	right	PROPN
easat-9432	56	15	lung	lung	PROPN
easat-9432	56	16	mass	mass	PROPN
easat-9432	56	17	with	with	ADP
easat-9432	56	18	involvement	involvement	NOUN
easat-9432	56	19	of	of	ADP
easat-9432	56	20	a.	a.	NOUN
easat-9432	56	21	pulmonic	pulmonic	NOUN
easat-9432	56	22	,	,	PUNCT
easat-9432	56	23	attached	attach	VERB
easat-9432	56	24	to	to	ADP
easat-9432	56	25	v.	v.	NOUN
easat-9432	56	26	cava	cava	NOUN
easat-9432	56	27	superior	superior	ADJ
easat-9432	56	28	,	,	PUNCT
easat-9432	56	29	obliterating	obliterate	VERB
easat-9432	56	30	the	the	DET
easat-9432	56	31	right	right	ADJ
easat-9432	56	32	main	main	ADJ
easat-9432	56	33	bronchus	bronchus	NOUN
easat-9432	56	34	,	,	PUNCT
easat-9432	56	35	causing	cause	VERB
easat-9432	56	36	obstructive	obstructive	ADJ
easat-9432	56	37	atelectasis	atelectasis	NOUN
easat-9432	56	38	of	of	ADP
easat-9432	56	39	the	the	DET
easat-9432	56	40	right	right	ADJ
easat-9432	56	41	lung	lung	PROPN
easat-9432	56	42	,	,	PUNCT
easat-9432	56	43	b.	b.	PROPN
easat-9432	57	1	right	right	ADJ
easat-9432	57	2	pleural	pleural	ADJ
easat-9432	57	3	effusion	effusion	NOUN
easat-9432	57	4	,	,	PUNCT
easat-9432	57	5	c.	c.	PROPN
easat-9432	57	6	mediastinal	mediastinal	PROPN
easat-9432	57	7	lymphadenopathy	lymphadenopathy	PROPN
easat-9432	57	8	.	.	PUNCT
easat-9432	58	1	the	the	DET
easat-9432	58	2	results	result	NOUN
easat-9432	58	3	of	of	ADP
easat-9432	58	4	koh	koh	PROPN
easat-9432	58	5	sputum	sputum	PROPN
easat-9432	58	6	culture	culture	PROPN
easat-9432	58	7	for	for	ADP
easat-9432	58	8	3	3	NUM
easat-9432	58	9	days	day	NOUN
easat-9432	58	10	in	in	ADP
easat-9432	58	11	may	may	PROPN
easat-9432	58	12	2022	2022	NUM
easat-9432	58	13	showed	show	VERB
easat-9432	58	14	conidia	conidia	NOUN
easat-9432	58	15	and	and	CCONJ
easat-9432	58	16	hyphae	hyphae	ADJ
easat-9432	58	17	morphology	morphology	NOUN
easat-9432	58	18	.	.	PUNCT
easat-9432	59	1	table	table	NOUN
easat-9432	59	2	1	1	NUM
easat-9432	59	3	.	.	PUNCT
easat-9432	60	1	the	the	DET
easat-9432	60	2	results	result	NOUN
easat-9432	60	3	of	of	ADP
easat-9432	60	4	koh	koh	PROPN
easat-9432	60	5	sputum	sputum	PROPN
easat-9432	60	6	culture	culture	PROPN
easat-9432	60	7	for	for	ADP
easat-9432	60	8	3	3	NUM
easat-9432	60	9	days	day	NOUN
easat-9432	60	10	in	in	ADP
easat-9432	60	11	may	may	PROPN
easat-9432	60	12	2022	2022	NUM
easat-9432	60	13	obtained	obtain	VERB
easat-9432	60	14	conidia	conidia	NOUN
easat-9432	60	15	and	and	CCONJ
easat-9432	60	16	hyphae	hyphae	ADJ
easat-9432	60	17	morphology	morphology	NOUN
easat-9432	60	18	.	.	PUNCT
easat-9432	61	1	11/05/22	11/05/22	NUM
easat-9432	61	2	12/5/22	12/5/22	NUM
easat-9432	61	3	13/5/22	13/5/22	NUM
easat-9432	61	4	no	no	DET
easat-9432	61	5	budding	bud	VERB
easat-9432	61	6	cell	cell	NOUN
easat-9432	61	7	,	,	PUNCT
easat-9432	61	8	hyphae	hyphae	ADJ
easat-9432	61	9	,	,	PUNCT
easat-9432	61	10	or	or	CCONJ
easat-9432	61	11	conidia	conidia	NOUN
easat-9432	61	12	morphology	morphology	NOUN
easat-9432	61	13	found	find	VERB
easat-9432	61	14	(	(	PUNCT
easat-9432	61	15	typical	typical	ADJ
easat-9432	61	16	fungal	fungal	ADJ
easat-9432	61	17	morphology	morphology	NOUN
easat-9432	61	18	)	)	PUNCT
easat-9432	61	19	found	find	VERB
easat-9432	61	20	morphology	morphology	NOUN
easat-9432	61	21	of	of	ADP
easat-9432	61	22	conidia	conidia	NOUN
easat-9432	61	23	and	and	CCONJ
easat-9432	61	24	hyphae	hyphae	ADJ
easat-9432	61	25	no	no	DET
easat-9432	61	26	budding	bud	VERB
easat-9432	61	27	cell	cell	NOUN
easat-9432	61	28	,	,	PUNCT
easat-9432	61	29	hyphae	hyphae	ADJ
easat-9432	61	30	,	,	PUNCT
easat-9432	61	31	or	or	CCONJ
easat-9432	61	32	conidia	conidia	NOUN
easat-9432	61	33	morphology	morphology	NOUN
easat-9432	61	34	found	find	VERB
easat-9432	61	35	(	(	PUNCT
easat-9432	61	36	typical	typical	ADJ
easat-9432	61	37	fungal	fungal	ADJ
easat-9432	61	38	morphology	morphology	NOUN
easat-9432	61	39	)	)	PUNCT
easat-9432	61	40	figure	figure	NOUN
easat-9432	61	41	3	3	NUM
easat-9432	61	42	.	.	PUNCT
easat-9432	61	43	a.	a.	NOUN
easat-9432	61	44	fnab	fnab	PROPN
easat-9432	62	1	of	of	ADP
easat-9432	62	2	the	the	DET
easat-9432	62	3	right	right	ADJ
easat-9432	62	4	chest	chest	NOUN
easat-9432	62	5	of	of	ADP
easat-9432	62	6	saiful	saiful	PROPN
easat-9432	62	7	anwar	anwar	PROPN
easat-9432	62	8	hospital	hospital	PROPN
easat-9432	62	9	12/12/2017	12/12/2017	NUM
easat-9432	62	10	showed	show	VERB
easat-9432	62	11	small	small	ADJ
easat-9432	62	12	cell	cell	NOUN
easat-9432	62	13	carcinoma	carcinoma	NOUN
easat-9432	62	14	with	with	ADP
easat-9432	62	15	hyperchromatic	hyperchromatic	ADJ
easat-9432	62	16	ovalshaped	ovalshape	VERB
easat-9432	62	17	cell	cell	NOUN
easat-9432	62	18	nuclei	nucleus	NOUN
easat-9432	62	19	,	,	PUNCT
easat-9432	62	20	some	some	PRON
easat-9432	62	21	without	without	ADP
easat-9432	62	22	cell	cell	NOUN
easat-9432	62	23	nuclei	nucleus	NOUN
easat-9432	62	24	,	,	PUNCT
easat-9432	62	25	scant	scant	ADJ
easat-9432	62	26	cytoplasm	cytoplasm	NOUN
easat-9432	62	27	,	,	PUNCT
easat-9432	62	28	and	and	CCONJ
easat-9432	62	29	molding	molding	NOUN
easat-9432	62	30	pattern	pattern	NOUN
easat-9432	62	31	.	.	PUNCT
easat-9432	63	1	b.	b.	PROPN
easat-9432	63	2	result	result	NOUN
easat-9432	63	3	of	of	ADP
easat-9432	63	4	transbronchial	transbronchial	ADJ
easat-9432	63	5	needle	needle	NOUN
easat-9432	63	6	aspiration	aspiration	NOUN
easat-9432	63	7	(	(	PUNCT
easat-9432	63	8	ttna	ttna	NOUN
easat-9432	63	9	)	)	PUNCT
easat-9432	63	10	on	on	ADP
easat-9432	63	11	19/05/2022	19/05/2022	NUM
easat-9432	63	12	showed	show	VERB
easat-9432	63	13	atypical	atypical	ADJ
easat-9432	63	14	cells	cell	NOUN
easat-9432	63	15	with	with	ADP
easat-9432	63	16	well	well	ADV
easat-9432	63	17	-	-	PUNCT
easat-9432	63	18	differentiated	differentiate	VERB
easat-9432	63	19	keratinization	keratinization	NOUN
easat-9432	63	20	and	and	CCONJ
easat-9432	63	21	presence	presence	NOUN
easat-9432	63	22	of	of	ADP
easat-9432	63	23	cytoplasm	cytoplasm	NOUN
easat-9432	63	24	,	,	PUNCT
easat-9432	63	25	which	which	PRON
easat-9432	63	26	is	be	AUX
easat-9432	63	27	squamous	squamous	ADJ
easat-9432	63	28	-	-	PUNCT
easat-9432	63	29	type	type	NOUN
easat-9432	63	30	carcinoma	carcinoma	NOUN
easat-9432	63	31	cells	cell	NOUN
easat-9432	63	32	.	.	PUNCT
easat-9432	64	1	747	747	NUM
easat-9432	64	2	edelweiss	edelweiss	PROPN
easat-9432	64	3	applied	apply	VERB
easat-9432	64	4	science	science	NOUN
easat-9432	64	5	and	and	CCONJ
easat-9432	64	6	technology	technology	NOUN
easat-9432	64	7	issn	issn	PROPN
easat-9432	64	8	:	:	PUNCT
easat-9432	64	9	2576	2576	NUM
easat-9432	64	10	-	-	SYM
easat-9432	64	11	8484	8484	NUM
easat-9432	64	12	vol	vol	NOUN
easat-9432	64	13	.	.	PROPN
easat-9432	65	1	9	9	NUM
easat-9432	65	2	,	,	PUNCT
easat-9432	65	3	no	no	INTJ
easat-9432	65	4	.	.	NOUN
easat-9432	65	5	8	8	NUM
easat-9432	65	6	:	:	PUNCT
easat-9432	65	7	744	744	NUM
easat-9432	65	8	-	-	SYM
easat-9432	65	9	751	751	NUM
easat-9432	65	10	,	,	PUNCT
easat-9432	65	11	2025	2025	NUM
easat-9432	65	12	doi	doi	NOUN
easat-9432	65	13	:	:	PUNCT
easat-9432	65	14	10.55214/2576	10.55214/2576	NUM
easat-9432	65	15	-	-	SYM
easat-9432	65	16	8484.v9i8.9432	8484.v9i8.9432	NOUN
easat-9432	66	1	©	©	PROPN
easat-9432	66	2	2025	2025	NUM
easat-9432	66	3	by	by	ADP
easat-9432	66	4	the	the	DET
easat-9432	66	5	authors	author	NOUN
easat-9432	66	6	;	;	PUNCT
easat-9432	66	7	licensee	licensee	PROPN
easat-9432	66	8	learning	learn	VERB
easat-9432	66	9	gate	gate	NOUN
easat-9432	66	10	figure	figure	NOUN
easat-9432	66	11	4	4	NUM
easat-9432	66	12	.	.	PUNCT
easat-9432	67	1	the	the	DET
easat-9432	67	2	results	result	NOUN
easat-9432	67	3	of	of	ADP
easat-9432	67	4	the	the	DET
easat-9432	67	5	forceps	forceps	NOUN
easat-9432	67	6	biopsy	biopsy	NOUN
easat-9432	67	7	of	of	ADP
easat-9432	67	8	saiful	saiful	PROPN
easat-9432	67	9	anwar	anwar	PROPN
easat-9432	67	10	hospital	hospital	PROPN
easat-9432	67	11	on	on	ADP
easat-9432	67	12	09/05/2022	09/05/2022	NOUN
easat-9432	67	13	,	,	PUNCT
easat-9432	67	14	right	right	ADJ
easat-9432	67	15	lung	lung	NOUN
easat-9432	67	16	mass	mass	NOUN
easat-9432	67	17	showed	show	VERB
easat-9432	67	18	fungal	fungal	ADJ
easat-9432	67	19	infection	infection	NOUN
easat-9432	67	20	with	with	ADP
easat-9432	67	21	hyphal	hyphal	ADJ
easat-9432	67	22	walls	wall	NOUN
easat-9432	67	23	stained	stain	VERB
easat-9432	67	24	pink	pink	ADV
easat-9432	67	25	to	to	ADP
easat-9432	67	26	purple	purple	ADJ
easat-9432	67	27	,	,	PUNCT
easat-9432	67	28	suggestive	suggestive	ADJ
easat-9432	67	29	of	of	ADP
easat-9432	67	30	aspergillus	aspergillus	NOUN
easat-9432	67	31	.	.	PUNCT
easat-9432	68	1	figure	figure	NOUN
easat-9432	68	2	5	5	NUM
easat-9432	68	3	.	.	PUNCT
easat-9432	68	4	bronchoscopy	bronchoscopy	NOUN
easat-9432	68	5	results	result	NOUN
easat-9432	68	6	of	of	ADP
easat-9432	68	7	saiful	saiful	PROPN
easat-9432	68	8	anwar	anwar	PROPN
easat-9432	68	9	hospital	hospital	PROPN
easat-9432	68	10	on	on	ADP
easat-9432	68	11	april	april	PROPN
easat-9432	68	12	18	18	NUM
easat-9432	68	13	,	,	PUNCT
easat-9432	68	14	2022	2022	NUM
easat-9432	68	15	,	,	PUNCT
easat-9432	68	16	showed	show	VERB
easat-9432	68	17	a.	a.	NOUN
easat-9432	68	18	a.	a.	NOUN
easat-9432	68	19	plica	plica	PROPN
easat-9432	68	20	vocalis	vocalis	PROPN
easat-9432	68	21	with	with	ADP
easat-9432	68	22	a	a	DET
easat-9432	68	23	nodule	nodule	NOUN
easat-9432	68	24	on	on	ADP
easat-9432	68	25	the	the	DET
easat-9432	68	26	left	left	NOUN
easat-9432	68	27	,	,	PUNCT
easat-9432	68	28	b.	b.	PROPN
easat-9432	68	29	blunt	blunt	ADJ
easat-9432	68	30	main	main	ADJ
easat-9432	68	31	carina	carina	PROPN
easat-9432	68	32	,	,	PUNCT
easat-9432	68	33	c.	c.	PROPN
easat-9432	68	34	right	right	ADJ
easat-9432	68	35	main	main	ADJ
easat-9432	68	36	bronchus	bronchus	NOUN
easat-9432	68	37	covered	cover	VERB
easat-9432	68	38	with	with	ADP
easat-9432	68	39	intralumenal	intralumenal	ADJ
easat-9432	68	40	period	period	NOUN
easat-9432	68	41	,	,	PUNCT
easat-9432	68	42	d.	d.	PROPN
easat-9432	68	43	left	leave	VERB
easat-9432	68	44	main	main	ADJ
easat-9432	68	45	bronchus	bronchu	NOUN
easat-9432	68	46	within	within	ADP
easat-9432	68	47	normal	normal	ADJ
easat-9432	68	48	limits	limit	NOUN
easat-9432	68	49	.	.	PUNCT
easat-9432	69	1	the	the	DET
easat-9432	69	2	bronchoscopy	bronchoscopy	NOUN
easat-9432	69	3	conclusion	conclusion	NOUN
easat-9432	69	4	is	be	AUX
easat-9432	69	5	stenotic	stenotic	ADJ
easat-9432	69	6	obstruction	obstruction	NOUN
easat-9432	69	7	in	in	ADP
easat-9432	69	8	the	the	DET
easat-9432	69	9	right	right	ADJ
easat-9432	69	10	main	main	ADJ
easat-9432	69	11	bronchus	bronchus	NOUN
easat-9432	69	12	,	,	PUNCT
easat-9432	69	13	suggesting	suggest	VERB
easat-9432	69	14	malignancy	malignancy	NOUN
easat-9432	69	15	according	accord	VERB
easat-9432	69	16	to	to	ADP
easat-9432	69	17	t3n2m1b	t3n2m1b	PROPN
easat-9432	69	18	st	st	PROPN
easat-9432	69	19	ivb	ivb	PROPN
easat-9432	69	20	.	.	PUNCT
easat-9432	70	1	748	748	NUM
easat-9432	70	2	edelweiss	edelweiss	PROPN
easat-9432	70	3	applied	apply	VERB
easat-9432	70	4	science	science	NOUN
easat-9432	70	5	and	and	CCONJ
easat-9432	70	6	technology	technology	NOUN
easat-9432	70	7	issn	issn	PROPN
easat-9432	70	8	:	:	PUNCT
easat-9432	70	9	2576	2576	NUM
easat-9432	70	10	-	-	SYM
easat-9432	70	11	8484	8484	NUM
easat-9432	70	12	vol	vol	NOUN
easat-9432	70	13	.	.	PROPN
easat-9432	71	1	9	9	NUM
easat-9432	71	2	,	,	PUNCT
easat-9432	71	3	no	no	INTJ
easat-9432	71	4	.	.	NOUN
easat-9432	71	5	8	8	NUM
easat-9432	71	6	:	:	PUNCT
easat-9432	71	7	744	744	NUM
easat-9432	71	8	-	-	SYM
easat-9432	71	9	751	751	NUM
easat-9432	71	10	,	,	PUNCT
easat-9432	71	11	2025	2025	NUM
easat-9432	71	12	doi	doi	NOUN
easat-9432	71	13	:	:	PUNCT
easat-9432	71	14	10.55214/2576	10.55214/2576	NUM
easat-9432	71	15	-	-	SYM
easat-9432	71	16	8484.v9i8.9432	8484.v9i8.9432	NOUN
easat-9432	72	1	©	©	PROPN
easat-9432	72	2	2025	2025	NUM
easat-9432	72	3	by	by	ADP
easat-9432	72	4	the	the	DET
easat-9432	72	5	authors	author	NOUN
easat-9432	72	6	;	;	PUNCT
easat-9432	72	7	licensee	licensee	PROPN
easat-9432	72	8	learning	learn	VERB
easat-9432	72	9	gate	gate	NOUN
easat-9432	72	10	table	table	NOUN
easat-9432	72	11	3	3	NUM
easat-9432	72	12	.	.	PUNCT
easat-9432	72	13	response	response	NOUN
easat-9432	72	14	evaluation	evaluation	NOUN
easat-9432	72	15	criteria	criterion	NOUN
easat-9432	72	16	in	in	ADP
easat-9432	72	17	solid	solid	ADJ
easat-9432	72	18	tumors	tumor	NOUN
easat-9432	72	19	(	(	PUNCT
easat-9432	72	20	recist	recist	NOUN
easat-9432	72	21	)	)	PUNCT
easat-9432	72	22	data	datum	NOUN
easat-9432	72	23	ct	ct	PROPN
easat-9432	72	24	scan	scan	PROPN
easat-9432	72	25	thorax	thorax	PROPN
easat-9432	72	26	contrast	contrast	NOUN
easat-9432	72	27	until	until	ADP
easat-9432	72	28	may	may	PROPN
easat-9432	72	29	2024	2024	NUM
easat-9432	72	30	.	.	PUNCT
easat-9432	73	1	target	target	NOUN
easat-9432	73	2	lesson	lesson	NOUN
easat-9432	73	3	19/4/22	19/4/22	NUM
easat-9432	73	4	(	(	PUNCT
easat-9432	73	5	mm	mm	PROPN
easat-9432	73	6	)	)	PUNCT
easat-9432	73	7	16/8/22	16/8/22	NUM
easat-9432	73	8	(	(	PUNCT
easat-9432	73	9	mm	mm	INTJ
easat-9432	73	10	)	)	PUNCT
easat-9432	73	11	20/10/22	20/10/22	PROPN
easat-9432	73	12	(	(	PUNCT
easat-9432	73	13	mm	mm	INTJ
easat-9432	73	14	)	)	PUNCT
easat-9432	73	15	29/12/22	29/12/22	PROPN
easat-9432	73	16	(	(	PUNCT
easat-9432	73	17	mm	mm	NOUN
easat-9432	73	18	)	)	PUNCT
easat-9432	73	19	7/3/22	7/3/22	PROPN
easat-9432	73	20	(	(	PUNCT
easat-9432	73	21	mm	mm	NOUN
easat-9432	73	22	)	)	PUNCT
easat-9432	73	23	23/5/23	23/5/23	NUM
easat-9432	73	24	(	(	PUNCT
easat-9432	73	25	mm	mm	X
easat-9432	73	26	)	)	PUNCT
easat-9432	73	27	2/8/23	2/8/23	NUM
easat-9432	73	28	(	(	PUNCT
easat-9432	73	29	mm	mm	NOUN
easat-9432	73	30	)	)	PUNCT
easat-9432	73	31	9/10/23	9/10/23	PROPN
easat-9432	73	32	(	(	PUNCT
easat-9432	73	33	mm	mm	NOUN
easat-9432	73	34	)	)	PUNCT
easat-9432	73	35	12/12/23	12/12/23	PROPN
easat-9432	73	36	(	(	PUNCT
easat-9432	73	37	mm	mm	PROPN
easat-9432	73	38	)	)	PUNCT
easat-9432	73	39	21/2/24	21/2/24	NUM
easat-9432	73	40	(	(	PUNCT
easat-9432	73	41	mm	mm	NOUN
easat-9432	73	42	)	)	PUNCT
easat-9432	73	43	24/4/24	24/4/24	NUM
easat-9432	73	44	(	(	PUNCT
easat-9432	73	45	mm	mm	X
easat-9432	73	46	)	)	PUNCT
easat-9432	73	47	lung	lung	NOUN
easat-9432	73	48	mass	mass	NOUN
easat-9432	73	49	right	right	ADV
easat-9432	73	50	110	110	NUM
easat-9432	73	51	81	81	NUM
easat-9432	73	52	82	82	NUM
easat-9432	73	53	93	93	NUM
easat-9432	73	54	93	93	NUM
easat-9432	73	55	99	99	NUM
easat-9432	73	56	100	100	NUM
easat-9432	73	57	113	113	NUM
easat-9432	73	58	110	110	NUM
easat-9432	73	59	112	112	NUM
easat-9432	73	60	101	101	NUM
easat-9432	73	61	limphadenopat	limphadenopat	PROPN
easat-9432	73	62	hy	hy	PROPN
easat-9432	73	63	30	30	NUM
easat-9432	73	64	22	22	NUM
easat-9432	73	65	20	20	NUM
easat-9432	73	66	20	20	NUM
easat-9432	73	67	20	20	NUM
easat-9432	73	68	19	19	NUM
easat-9432	73	69	19	19	NUM
easat-9432	73	70	25	25	NUM
easat-9432	73	71	19	19	NUM
easat-9432	73	72	19	19	NUM
easat-9432	73	73	14	14	NUM
easat-9432	73	74	total	total	NOUN
easat-9432	73	75	140	140	NUM
easat-9432	73	76	103	103	NUM
easat-9432	73	77	102	102	NUM
easat-9432	73	78	113	113	NUM
easat-9432	73	79	113	113	NUM
easat-9432	73	80	118	118	NUM
easat-9432	73	81	119	119	NUM
easat-9432	73	82	132	132	NUM
easat-9432	73	83	129	129	NUM
easat-9432	73	84	131	131	NUM
easat-9432	73	85	115	115	NUM
easat-9432	73	86	non	non	ADJ
easat-9432	73	87	-	-	ADJ
easat-9432	73	88	target	target	ADJ
easat-9432	73	89	lesson	lesson	NOUN
easat-9432	73	90	pleural	pleural	ADJ
easat-9432	73	91	effusion	effusion	NOUN
easat-9432	73	92	right	right	ADJ
easat-9432	73	93	(	(	PUNCT
easat-9432	73	94	+	+	NOUN
easat-9432	73	95	)	)	PUNCT
easat-9432	73	96	(	(	PUNCT
easat-9432	73	97	+	+	NOUN
easat-9432	73	98	)	)	PUNCT
easat-9432	73	99	(	(	PUNCT
easat-9432	73	100	+	+	NOUN
easat-9432	73	101	)	)	PUNCT
easat-9432	73	102	(	(	PUNCT
easat-9432	73	103	+	+	NOUN
easat-9432	73	104	)	)	PUNCT
easat-9432	73	105	(	(	PUNCT
easat-9432	73	106	+	+	NOUN
easat-9432	73	107	)	)	PUNCT
easat-9432	73	108	(	(	PUNCT
easat-9432	73	109	+	+	NOUN
easat-9432	73	110	)	)	PUNCT
easat-9432	73	111	(	(	PUNCT
easat-9432	73	112	-	-	PUNCT
easat-9432	73	113	)	)	PUNCT
easat-9432	73	114	(	(	PUNCT
easat-9432	73	115	-	-	PUNCT
easat-9432	73	116	)	)	PUNCT
easat-9432	73	117	(	(	PUNCT
easat-9432	73	118	-	-	PUNCT
easat-9432	73	119	)	)	PUNCT
easat-9432	73	120	(	(	PUNCT
easat-9432	73	121	-	-	PUNCT
easat-9432	73	122	)	)	PUNCT
easat-9432	73	123	(	(	PUNCT
easat-9432	73	124	-	-	PUNCT
easat-9432	73	125	)	)	PUNCT
easat-9432	73	126	nodular	nodular	ADJ
easat-9432	73	127	pleura	pleura	NOUN
easat-9432	73	128	(	(	PUNCT
easat-9432	73	129	+	+	NOUN
easat-9432	73	130	)	)	PUNCT
easat-9432	73	131	(	(	PUNCT
easat-9432	73	132	+	+	NOUN
easat-9432	73	133	)	)	PUNCT
easat-9432	73	134	(	(	PUNCT
easat-9432	73	135	+	+	NOUN
easat-9432	73	136	)	)	PUNCT
easat-9432	73	137	(	(	PUNCT
easat-9432	73	138	-	-	PUNCT
easat-9432	73	139	)	)	PUNCT
easat-9432	73	140	(	(	PUNCT
easat-9432	73	141	-	-	PUNCT
easat-9432	73	142	)	)	PUNCT
easat-9432	73	143	(	(	PUNCT
easat-9432	73	144	-	-	PUNCT
easat-9432	73	145	)	)	PUNCT
easat-9432	73	146	(	(	PUNCT
easat-9432	73	147	-	-	PUNCT
easat-9432	73	148	)	)	PUNCT
easat-9432	73	149	(	(	PUNCT
easat-9432	73	150	-	-	PUNCT
easat-9432	73	151	)	)	PUNCT
easat-9432	73	152	(	(	PUNCT
easat-9432	73	153	-	-	PUNCT
easat-9432	73	154	)	)	PUNCT
easat-9432	73	155	(	(	PUNCT
easat-9432	73	156	+	+	NOUN
easat-9432	73	157	)	)	PUNCT
easat-9432	73	158	(	(	PUNCT
easat-9432	73	159	+	+	ADJ
easat-9432	73	160	)	)	PUNCT
easat-9432	73	161	recist	recist	NOUN
easat-9432	73	162	based	base	VERB
easat-9432	73	163	line	line	NOUN
easat-9432	73	164	stable	stable	ADJ
easat-9432	73	165	stable	stable	ADJ
easat-9432	73	166	stable	stable	ADJ
easat-9432	73	167	stable	stable	ADJ
easat-9432	73	168	stable	stable	ADJ
easat-9432	73	169	stable	stable	ADJ
easat-9432	73	170	stable	stable	ADJ
easat-9432	73	171	stable	stable	ADJ
easat-9432	73	172	stable	stable	ADJ
easat-9432	73	173	stable	stable	ADJ
easat-9432	73	174	target	target	NOUN
easat-9432	73	175	lesson	lesson	NOUN
easat-9432	73	176	:	:	PUNCT
easat-9432	73	177	stable	stable	ADJ
easat-9432	73	178	disease	disease	NOUN
easat-9432	73	179	non	non	PROPN
easat-9432	73	180	target	target	PROPN
easat-9432	73	181	lession	lession	NOUN
easat-9432	73	182	:	:	PUNCT
easat-9432	73	183	non	non	X
easat-9432	73	184	progresif	progresif	NOUN
easat-9432	73	185	disease	disease	NOUN
easat-9432	73	186	new	new	ADJ
easat-9432	73	187	lession	lession	NOUN
easat-9432	73	188	:	:	PUNCT
easat-9432	73	189	(	(	PUNCT
easat-9432	73	190	-	-	PUNCT
easat-9432	73	191	)	)	PUNCT
easat-9432	73	192	conclusion	conclusion	NOUN
easat-9432	73	193	:	:	PUNCT
easat-9432	73	194	stable	stable	ADJ
easat-9432	73	195	disease	disease	NOUN
easat-9432	73	196	749	749	NUM
easat-9432	73	197	edelweiss	edelweiss	PROPN
easat-9432	73	198	applied	apply	VERB
easat-9432	73	199	science	science	NOUN
easat-9432	73	200	and	and	CCONJ
easat-9432	73	201	technology	technology	NOUN
easat-9432	73	202	issn	issn	PROPN
easat-9432	73	203	:	:	PUNCT
easat-9432	73	204	2576	2576	NUM
easat-9432	73	205	-	-	SYM
easat-9432	73	206	8484	8484	NUM
easat-9432	73	207	vol	vol	NOUN
easat-9432	73	208	.	.	PROPN
easat-9432	74	1	9	9	NUM
easat-9432	74	2	,	,	PUNCT
easat-9432	74	3	no	no	INTJ
easat-9432	74	4	.	.	NOUN
easat-9432	74	5	8	8	NUM
easat-9432	74	6	:	:	PUNCT
easat-9432	74	7	744	744	NUM
easat-9432	74	8	-	-	SYM
easat-9432	74	9	751	751	NUM
easat-9432	74	10	,	,	PUNCT
easat-9432	74	11	2025	2025	NUM
easat-9432	74	12	doi	doi	NOUN
easat-9432	74	13	:	:	PUNCT
easat-9432	74	14	10.55214/2576	10.55214/2576	NUM
easat-9432	74	15	-	-	SYM
easat-9432	74	16	8484.v9i8.9432	8484.v9i8.9432	NOUN
easat-9432	75	1	©	©	PROPN
easat-9432	75	2	2025	2025	NUM
easat-9432	75	3	by	by	ADP
easat-9432	75	4	the	the	DET
easat-9432	75	5	authors	author	NOUN
easat-9432	75	6	;	;	PUNCT
easat-9432	75	7	licensee	licensee	PROPN
easat-9432	75	8	learning	learning	NOUN
easat-9432	75	9	gate	gate	NOUN
easat-9432	75	10	based	base	VERB
easat-9432	75	11	on	on	ADP
easat-9432	75	12	all	all	DET
easat-9432	75	13	examinations	examination	NOUN
easat-9432	75	14	,	,	PUNCT
easat-9432	75	15	patient	patient	NOUN
easat-9432	75	16	diagnosed	diagnose	VERB
easat-9432	75	17	with	with	ADP
easat-9432	75	18	right	right	ADJ
easat-9432	75	19	nsclc	nsclc	NOUN
easat-9432	75	20	(	(	PUNCT
easat-9432	75	21	pa	pa	NOUN
easat-9432	75	22	:	:	PUNCT
easat-9432	75	23	squamous	squamous	ADJ
easat-9432	75	24	cell	cell	NOUN
easat-9432	75	25	ca	ca	NOUN
easat-9432	75	26	)	)	PUNCT
easat-9432	75	27	,	,	PUNCT
easat-9432	75	28	t4n2m1a	t4n2m1a	PROPN
easat-9432	75	29	st	st	PROPN
easat-9432	75	30	.	.	PROPN
easat-9432	75	31	iv	iv	PROPN
easat-9432	75	32	a	a	PRON
easat-9432	75	33	,	,	PUNCT
easat-9432	75	34	ps	ps	PROPN
easat-9432	75	35	0	0	NUM
easat-9432	75	36	(	(	PUNCT
easat-9432	75	37	stable	stable	ADJ
easat-9432	75	38	disease	disease	NOUN
easat-9432	75	39	)	)	PUNCT
easat-9432	75	40	,	,	PUNCT
easat-9432	75	41	proven	prove	VERB
easat-9432	75	42	lung	lung	NOUN
easat-9432	75	43	mycosis	mycosis	NOUN
easat-9432	75	44	type	type	NOUN
easat-9432	75	45	aspergillosis	aspergillosis	NOUN
easat-9432	75	46	,	,	PUNCT
easat-9432	75	47	cancer	cancer	NOUN
easat-9432	75	48	pain	pain	NOUN
easat-9432	75	49	vas	vas	X
easat-9432	75	50	2/10	2/10	NUM
easat-9432	75	51	,	,	PUNCT
easat-9432	75	52	minimal	minimal	ADJ
easat-9432	75	53	right	right	ADJ
easat-9432	75	54	pleural	pleural	ADJ
easat-9432	75	55	effusion	effusion	NOUN
easat-9432	75	56	,	,	PUNCT
easat-9432	75	57	grade	grade	NOUN
easat-9432	75	58	i	i	PRON
easat-9432	75	59	hemoptoe	hemoptoe	VERB
easat-9432	75	60	,	,	PUNCT
easat-9432	75	61	stable	stable	ADJ
easat-9432	75	62	copd	copd	PROPN
easat-9432	75	63	group	group	PROPN
easat-9432	75	64	b	b	PROPN
easat-9432	75	65	,	,	PUNCT
easat-9432	75	66	and	and	CCONJ
easat-9432	75	67	history	history	NOUN
easat-9432	75	68	of	of	ADP
easat-9432	75	69	small	small	ADJ
easat-9432	75	70	cell	cell	NOUN
easat-9432	75	71	ca	ca	NOUN
easat-9432	75	72	in	in	ADP
easat-9432	75	73	2017	2017	NUM
easat-9432	75	74	lost	lose	VERB
easat-9432	75	75	to	to	PART
easat-9432	75	76	follow	follow	VERB
easat-9432	75	77	up	up	ADP
easat-9432	75	78	.	.	PUNCT
easat-9432	76	1	patients	patient	NOUN
easat-9432	76	2	received	receive	VERB
easat-9432	76	3	the	the	DET
easat-9432	76	4	main	main	ADJ
easat-9432	76	5	therapy	therapy	NOUN
easat-9432	76	6	of	of	ADP
easat-9432	76	7	first	first	ADJ
easat-9432	76	8	-	-	PUNCT
easat-9432	76	9	line	line	NOUN
easat-9432	76	10	chemotherapy	chemotherapy	NOUN
easat-9432	76	11	,	,	PUNCT
easat-9432	76	12	carboplatin	carboplatin	NOUN
easat-9432	76	13	+	+	CCONJ
easat-9432	76	14	paclitaxel	paclitaxel	PROPN
easat-9432	76	15	for	for	ADP
easat-9432	76	16	6	6	NUM
easat-9432	76	17	series	series	NOUN
easat-9432	76	18	,	,	PUNCT
easat-9432	76	19	followed	follow	VERB
easat-9432	76	20	by	by	ADP
easat-9432	76	21	maintenance	maintenance	NOUN
easat-9432	76	22	paclitaxel	paclitaxel	NOUN
easat-9432	76	23	until	until	ADP
easat-9432	76	24	may	may	PROPN
easat-9432	76	25	2024	2024	NUM
easat-9432	76	26	.	.	PUNCT
easat-9432	77	1	patients	patient	NOUN
easat-9432	77	2	also	also	ADV
easat-9432	77	3	received	receive	VERB
easat-9432	77	4	oral	oral	ADJ
easat-9432	77	5	fluconazole	fluconazole	NOUN
easat-9432	77	6	1x150	1x150	NUM
easat-9432	77	7	mg	mg	NOUN
easat-9432	77	8	for	for	ADP
easat-9432	77	9	14	14	NUM
easat-9432	77	10	days	day	NOUN
easat-9432	77	11	,	,	PUNCT
easat-9432	77	12	and	and	CCONJ
easat-9432	77	13	resolved	resolve	VERB
easat-9432	77	14	.	.	PUNCT
easat-9432	78	1	antifungal	antifungal	PROPN
easat-9432	78	2	administration	administration	NOUN
easat-9432	78	3	is	be	AUX
easat-9432	78	4	not	not	PART
easat-9432	78	5	based	base	VERB
easat-9432	78	6	on	on	ADP
easat-9432	78	7	the	the	DET
easat-9432	78	8	main	main	ADJ
easat-9432	78	9	guideline	guideline	NOUN
easat-9432	78	10	management	management	NOUN
easat-9432	78	11	due	due	ADP
easat-9432	78	12	to	to	ADP
easat-9432	78	13	the	the	DET
easat-9432	78	14	limited	limited	ADJ
easat-9432	78	15	availability	availability	NOUN
easat-9432	78	16	of	of	ADP
easat-9432	78	17	drugs	drug	NOUN
easat-9432	78	18	at	at	ADP
easat-9432	78	19	the	the	DET
easat-9432	78	20	treatment	treatment	NOUN
easat-9432	78	21	site	site	NOUN
easat-9432	78	22	.	.	PUNCT
easat-9432	79	1	based	base	VERB
easat-9432	79	2	on	on	ADP
easat-9432	79	3	the	the	DET
easat-9432	79	4	results	result	NOUN
easat-9432	79	5	of	of	ADP
easat-9432	79	6	the	the	DET
easat-9432	79	7	latest	late	ADJ
easat-9432	79	8	recist	recist	NOUN
easat-9432	79	9	thorax	thorax	NOUN
easat-9432	79	10	ct	ct	PROPN
easat-9432	79	11	-	-	PUNCT
easat-9432	79	12	scan	scan	ADJ
easat-9432	79	13	and	and	CCONJ
easat-9432	79	14	stable	stable	ADJ
easat-9432	79	15	condition	condition	NOUN
easat-9432	79	16	,	,	PUNCT
easat-9432	79	17	the	the	DET
easat-9432	79	18	patient	patient	NOUN
easat-9432	79	19	is	be	AUX
easat-9432	79	20	currently	currently	ADV
easat-9432	79	21	taking	take	VERB
easat-9432	79	22	a	a	DET
easat-9432	79	23	break	break	NOUN
easat-9432	79	24	from	from	ADP
easat-9432	79	25	chemo	chemo	NOUN
easat-9432	79	26	and	and	CCONJ
easat-9432	79	27	control	control	VERB
easat-9432	79	28	under	under	ADP
easat-9432	79	29	clinical	clinical	ADJ
easat-9432	79	30	control	control	NOUN
easat-9432	79	31	every	every	DET
easat-9432	79	32	3	3	NUM
easat-9432	79	33	months	month	NOUN
easat-9432	79	34	.	.	PUNCT
easat-9432	80	1	3	3	X
easat-9432	80	2	.	.	NOUN
easat-9432	80	3	results	result	NOUN
easat-9432	80	4	and	and	CCONJ
easat-9432	80	5	discussion	discussion	NOUN
easat-9432	80	6	sclc	sclc	PROPN
easat-9432	80	7	is	be	AUX
easat-9432	80	8	a	a	DET
easat-9432	80	9	distinct	distinct	ADJ
easat-9432	80	10	subtype	subtype	NOUN
easat-9432	80	11	of	of	ADP
easat-9432	80	12	lung	lung	NOUN
easat-9432	80	13	cancer	cancer	NOUN
easat-9432	80	14	with	with	ADP
easat-9432	80	15	poorly	poorly	ADV
easat-9432	80	16	differentiated	differentiate	VERB
easat-9432	80	17	neuroendocrine	neuroendocrine	NOUN
easat-9432	80	18	characteristics	characteristic	NOUN
easat-9432	80	19	characterized	characterize	VERB
easat-9432	80	20	by	by	ADP
easat-9432	80	21	rapid	rapid	ADJ
easat-9432	80	22	progression	progression	NOUN
easat-9432	80	23	and	and	CCONJ
easat-9432	80	24	early	early	ADJ
easat-9432	80	25	development	development	NOUN
easat-9432	80	26	of	of	ADP
easat-9432	80	27	extensive	extensive	ADJ
easat-9432	80	28	metastases	metastasis	NOUN
easat-9432	80	29	[	[	X
easat-9432	80	30	9	9	NUM
easat-9432	80	31	,	,	PUNCT
easat-9432	80	32	10	10	NUM
easat-9432	80	33	]	]	PUNCT
easat-9432	80	34	.	.	PUNCT
easat-9432	81	1	the	the	DET
easat-9432	81	2	main	main	ADJ
easat-9432	81	3	effective	effective	ADJ
easat-9432	81	4	chemotherapy	chemotherapy	NOUN
easat-9432	81	5	regimens	regimen	NOUN
easat-9432	81	6	in	in	ADP
easat-9432	81	7	the	the	DET
easat-9432	81	8	management	management	NOUN
easat-9432	81	9	of	of	ADP
easat-9432	81	10	sclc	sclc	PROPN
easat-9432	81	11	for	for	ADP
easat-9432	81	12	advanced	advanced	ADJ
easat-9432	81	13	sclc	sclc	PROPN
easat-9432	81	14	are	be	AUX
easat-9432	81	15	a	a	DET
easat-9432	81	16	combination	combination	NOUN
easat-9432	81	17	of	of	ADP
easat-9432	81	18	platinum	platinum	NOUN
easat-9432	81	19	-	-	PUNCT
easat-9432	81	20	based	base	VERB
easat-9432	81	21	(	(	PUNCT
easat-9432	81	22	cisplatin	cisplatin	NOUN
easat-9432	81	23	/	/	SYM
easat-9432	81	24	carboplatin	carboplatin	NOUN
easat-9432	81	25	)	)	PUNCT
easat-9432	81	26	with	with	ADP
easat-9432	81	27	etoposide	etoposide	NOUN
easat-9432	81	28	or	or	CCONJ
easat-9432	81	29	irinotecan	irinotecan	NOUN
easat-9432	81	30	for	for	ADP
easat-9432	81	31	4	4	NUM
easat-9432	81	32	-	-	SYM
easat-9432	81	33	6	6	NUM
easat-9432	81	34	cycles	cycle	NOUN
easat-9432	81	35	,	,	PUNCT
easat-9432	81	36	with	with	ADP
easat-9432	81	37	each	each	DET
easat-9432	81	38	cycle	cycle	NOUN
easat-9432	81	39	lasting	last	VERB
easat-9432	81	40	3	3	NUM
easat-9432	81	41	-	-	SYM
easat-9432	81	42	4	4	NUM
easat-9432	81	43	weeks	week	NOUN
easat-9432	81	44	.	.	PUNCT
easat-9432	82	1	sclc	sclc	PROPN
easat-9432	82	2	with	with	ADP
easat-9432	82	3	recist	recist	NOUN
easat-9432	82	4	stable	stable	ADJ
easat-9432	82	5	disease	disease	NOUN
easat-9432	82	6	evaluation	evaluation	NOUN
easat-9432	82	7	,	,	PUNCT
easat-9432	82	8	chemotherapy	chemotherapy	NOUN
easat-9432	82	9	is	be	AUX
easat-9432	82	10	stopped	stop	VERB
easat-9432	82	11	,	,	PUNCT
easat-9432	82	12	and	and	CCONJ
easat-9432	82	13	recist	recist	NOUN
easat-9432	82	14	contrast	contrast	NOUN
easat-9432	82	15	thorax	thorax	NOUN
easat-9432	82	16	ct	ct	PROPN
easat-9432	82	17	scan	scan	PROPN
easat-9432	82	18	evaluation	evaluation	NOUN
easat-9432	82	19	per	per	ADP
easat-9432	82	20	3	3	NUM
easat-9432	82	21	months	month	NOUN
easat-9432	82	22	.	.	PUNCT
easat-9432	83	1	if	if	SCONJ
easat-9432	83	2	progressive	progressive	ADJ
easat-9432	83	3	disease	disease	NOUN
easat-9432	83	4	is	be	AUX
easat-9432	83	5	found	find	VERB
easat-9432	83	6	more	more	ADJ
easat-9432	83	7	than	than	ADP
easat-9432	83	8	6	6	NUM
easat-9432	83	9	months	month	NOUN
easat-9432	83	10	after	after	ADP
easat-9432	83	11	treatment	treatment	NOUN
easat-9432	83	12	,	,	PUNCT
easat-9432	83	13	it	it	PRON
easat-9432	83	14	can	can	AUX
easat-9432	83	15	still	still	ADV
easat-9432	83	16	respond	respond	VERB
easat-9432	83	17	well	well	ADV
easat-9432	83	18	to	to	ADP
easat-9432	83	19	the	the	DET
easat-9432	83	20	first	first	ADJ
easat-9432	83	21	chemotherapy	chemotherapy	NOUN
easat-9432	83	22	regimen	regiman	NOUN
easat-9432	83	23	.	.	PUNCT
easat-9432	84	1	if	if	SCONJ
easat-9432	84	2	progressive	progressive	ADJ
easat-9432	84	3	disease	disease	NOUN
easat-9432	84	4	is	be	AUX
easat-9432	84	5	obtained	obtain	VERB
easat-9432	84	6	sometime	sometime	ADV
easat-9432	84	7	after	after	ADP
easat-9432	84	8	treatment	treatment	NOUN
easat-9432	84	9	,	,	PUNCT
easat-9432	84	10	the	the	DET
easat-9432	84	11	chemotherapy	chemotherapy	NOUN
easat-9432	84	12	regimen	regimen	NOUN
easat-9432	84	13	should	should	AUX
easat-9432	84	14	be	be	AUX
easat-9432	84	15	changed	change	VERB
easat-9432	84	16	.	.	PUNCT
easat-9432	85	1	in	in	ADP
easat-9432	85	2	advanced	advanced	ADJ
easat-9432	85	3	sclc	sclc	PROPN
easat-9432	85	4	,	,	PUNCT
easat-9432	85	5	the	the	DET
easat-9432	85	6	main	main	ADJ
easat-9432	85	7	choice	choice	NOUN
easat-9432	85	8	of	of	ADP
easat-9432	85	9	treatment	treatment	NOUN
easat-9432	85	10	modality	modality	NOUN
easat-9432	85	11	is	be	AUX
easat-9432	85	12	combination	combination	NOUN
easat-9432	85	13	chemotherapy	chemotherapy	NOUN
easat-9432	85	14	.	.	PUNCT
easat-9432	86	1	the	the	DET
easat-9432	86	2	preferred	preferred	ADJ
easat-9432	86	3	chemotherapy	chemotherapy	NOUN
easat-9432	86	4	regimens	regimen	NOUN
easat-9432	86	5	that	that	PRON
easat-9432	86	6	can	can	AUX
easat-9432	86	7	be	be	AUX
easat-9432	86	8	used	use	VERB
easat-9432	86	9	at	at	ADP
easat-9432	86	10	this	this	DET
easat-9432	86	11	stage	stage	NOUN
easat-9432	86	12	are	be	AUX
easat-9432	86	13	cisplatin	cisplatin	NOUN
easat-9432	86	14	/	/	SYM
easat-9432	86	15	carboplatin	carboplatin	NOUN
easat-9432	86	16	with	with	ADP
easat-9432	86	17	etoposide	etoposide	NOUN
easat-9432	86	18	or	or	CCONJ
easat-9432	86	19	cisplatin	cisplatin	NOUN
easat-9432	86	20	/	/	SYM
easat-9432	86	21	carboplatin	carboplatin	NOUN
easat-9432	86	22	with	with	ADP
easat-9432	86	23	irinotecan	irinotecan	PROPN
easat-9432	86	24	.	.	PUNCT
easat-9432	87	1	another	another	DET
easat-9432	87	2	option	option	NOUN
easat-9432	87	3	is	be	AUX
easat-9432	87	4	palliative	palliative	ADJ
easat-9432	87	5	radiation	radiation	NOUN
easat-9432	87	6	in	in	ADP
easat-9432	87	7	primary	primary	ADJ
easat-9432	87	8	lesions	lesion	NOUN
easat-9432	87	9	and	and	CCONJ
easat-9432	87	10	metastatic	metastatic	ADJ
easat-9432	87	11	lesions	lesion	NOUN
easat-9432	87	12	.	.	PUNCT
easat-9432	88	1	the	the	DET
easat-9432	88	2	regimen	regiman	NOUN
easat-9432	88	3	of	of	ADP
easat-9432	88	4	cisplatin	cisplatin	NOUN
easat-9432	88	5	combined	combine	VERB
easat-9432	88	6	with	with	ADP
easat-9432	88	7	etoposide	etoposide	NOUN
easat-9432	88	8	has	have	VERB
easat-9432	88	9	high	high	ADJ
easat-9432	88	10	efficacy	efficacy	NOUN
easat-9432	88	11	against	against	ADP
easat-9432	88	12	sclc	sclc	PROPN
easat-9432	88	13	[	[	X
easat-9432	88	14	11	11	NUM
easat-9432	88	15	]	]	PUNCT
easat-9432	88	16	.	.	PUNCT
easat-9432	89	1	the	the	DET
easat-9432	89	2	patient	patient	NOUN
easat-9432	89	3	works	work	VERB
easat-9432	89	4	as	as	ADP
easat-9432	89	5	a	a	DET
easat-9432	89	6	welder	welder	NOUN
easat-9432	89	7	and	and	CCONJ
easat-9432	89	8	factory	factory	NOUN
easat-9432	89	9	worker	worker	NOUN
easat-9432	89	10	with	with	ADP
easat-9432	89	11	a	a	DET
easat-9432	89	12	smoking	smoking	NOUN
easat-9432	89	13	habit	habit	NOUN
easat-9432	89	14	.	.	PUNCT
easat-9432	90	1	chronic	chronic	ADJ
easat-9432	90	2	exposure	exposure	NOUN
easat-9432	90	3	to	to	ADP
easat-9432	90	4	welding	weld	VERB
easat-9432	90	5	pollution	pollution	NOUN
easat-9432	90	6	can	can	AUX
easat-9432	90	7	cause	cause	VERB
easat-9432	90	8	oxidative	oxidative	ADJ
easat-9432	90	9	stress	stress	NOUN
easat-9432	90	10	and	and	CCONJ
easat-9432	90	11	increased	increase	VERB
easat-9432	90	12	chromosome	chromosome	NOUN
easat-9432	90	13	disruption	disruption	NOUN
easat-9432	90	14	and	and	CCONJ
easat-9432	90	15	dna	dna	NOUN
easat-9432	90	16	damage	damage	NOUN
easat-9432	90	17	in	in	ADP
easat-9432	90	18	lymphocytes	lymphocyte	NOUN
easat-9432	90	19	.	.	PUNCT
easat-9432	91	1	dna	dna	PROPN
easat-9432	91	2	damage	damage	NOUN
easat-9432	91	3	in	in	ADP
easat-9432	91	4	peripheral	peripheral	ADJ
easat-9432	91	5	blood	blood	NOUN
easat-9432	91	6	lymphocytes	lymphocyte	NOUN
easat-9432	91	7	may	may	AUX
easat-9432	91	8	be	be	AUX
easat-9432	91	9	an	an	DET
easat-9432	91	10	index	index	NOUN
easat-9432	91	11	of	of	ADP
easat-9432	91	12	genotoxicity	genotoxicity	NOUN
easat-9432	91	13	in	in	ADP
easat-9432	91	14	welding	welding	NOUN
easat-9432	91	15	.	.	PUNCT
easat-9432	92	1	chronic	chronic	ADJ
easat-9432	92	2	exposure	exposure	NOUN
easat-9432	92	3	may	may	AUX
easat-9432	92	4	lead	lead	VERB
easat-9432	92	5	to	to	ADP
easat-9432	92	6	tissue	tissue	NOUN
easat-9432	92	7	remodeling	remodeling	NOUN
easat-9432	92	8	and	and	CCONJ
easat-9432	92	9	fibrosis	fibrosis	NOUN
easat-9432	92	10	.	.	PUNCT
easat-9432	93	1	welding	welding	NOUN
easat-9432	93	2	workers	worker	NOUN
easat-9432	93	3	were	be	AUX
easat-9432	93	4	found	find	VERB
easat-9432	93	5	to	to	PART
easat-9432	93	6	have	have	VERB
easat-9432	93	7	a	a	DET
easat-9432	93	8	3.9	3.9	NUM
easat-9432	93	9	times	time	NOUN
easat-9432	93	10	higher	high	ADJ
easat-9432	93	11	risk	risk	NOUN
easat-9432	93	12	of	of	ADP
easat-9432	93	13	copd	copd	NOUN
easat-9432	94	1	[	[	X
easat-9432	94	2	12	12	NUM
easat-9432	94	3	]	]	PUNCT
easat-9432	94	4	.	.	PUNCT
easat-9432	95	1	cigarette	cigarette	NOUN
easat-9432	95	2	smoke	smoke	NOUN
easat-9432	95	3	exposure	exposure	NOUN
easat-9432	95	4	causes	cause	VERB
easat-9432	95	5	chronic	chronic	ADJ
easat-9432	95	6	inflammation	inflammation	NOUN
easat-9432	95	7	,	,	PUNCT
easat-9432	95	8	resulting	result	VERB
easat-9432	95	9	in	in	ADP
easat-9432	95	10	respiratory	respiratory	ADJ
easat-9432	95	11	epithelial	epithelial	ADJ
easat-9432	95	12	damage	damage	NOUN
easat-9432	95	13	[	[	X
easat-9432	95	14	13	13	NUM
easat-9432	95	15	]	]	PUNCT
easat-9432	95	16	.	.	PUNCT
easat-9432	96	1	exposure	exposure	NOUN
easat-9432	96	2	to	to	ADP
easat-9432	96	3	welding	weld	VERB
easat-9432	96	4	pollution	pollution	NOUN
easat-9432	96	5	and	and	CCONJ
easat-9432	96	6	cigarette	cigarette	NOUN
easat-9432	96	7	smoke	smoke	NOUN
easat-9432	96	8	was	be	AUX
easat-9432	96	9	concluded	conclude	VERB
easat-9432	96	10	to	to	PART
easat-9432	96	11	be	be	AUX
easat-9432	96	12	the	the	DET
easat-9432	96	13	cause	cause	NOUN
easat-9432	96	14	of	of	ADP
easat-9432	96	15	copd	copd	NOUN
easat-9432	96	16	and	and	CCONJ
easat-9432	96	17	lung	lung	NOUN
easat-9432	96	18	cancer	cancer	NOUN
easat-9432	96	19	in	in	ADP
easat-9432	96	20	patients	patient	NOUN
easat-9432	96	21	.	.	PUNCT
easat-9432	97	1	cigarettes	cigarette	NOUN
easat-9432	97	2	consist	consist	VERB
easat-9432	97	3	of	of	ADP
easat-9432	97	4	60	60	NUM
easat-9432	97	5	carcinogenic	carcinogenic	ADJ
easat-9432	97	6	ingredients	ingredient	NOUN
easat-9432	97	7	,	,	PUNCT
easat-9432	97	8	which	which	PRON
easat-9432	97	9	can	can	AUX
easat-9432	97	10	damage	damage	VERB
easat-9432	97	11	the	the	DET
easat-9432	97	12	p53	p53	NOUN
easat-9432	97	13	gene	gene	NOUN
easat-9432	97	14	,	,	PUNCT
easat-9432	97	15	mutate	mutate	ADJ
easat-9432	97	16	,	,	PUNCT
easat-9432	97	17	and	and	CCONJ
easat-9432	97	18	cause	cause	VERB
easat-9432	97	19	lung	lung	NOUN
easat-9432	97	20	cancer	cancer	NOUN
easat-9432	97	21	[	[	X
easat-9432	97	22	14	14	NUM
easat-9432	97	23	]	]	PUNCT
easat-9432	97	24	.	.	PUNCT
easat-9432	98	1	sclc	sclc	PROPN
easat-9432	98	2	cases	case	NOUN
easat-9432	98	3	are	be	AUX
easat-9432	98	4	15	15	NUM
easat-9432	98	5	%	%	NOUN
easat-9432	98	6	and	and	CCONJ
easat-9432	98	7	nsclc	nsclc	NOUN
easat-9432	98	8	is	be	AUX
easat-9432	98	9	85	85	NUM
easat-9432	98	10	%	%	NOUN
easat-9432	98	11	in	in	ADP
easat-9432	98	12	the	the	DET
easat-9432	98	13	form	form	NOUN
easat-9432	98	14	of	of	ADP
easat-9432	98	15	adenocarcinoma	adenocarcinoma	NOUN
easat-9432	98	16	,	,	PUNCT
easat-9432	98	17	squamous	squamous	ADJ
easat-9432	98	18	cell	cell	NOUN
easat-9432	98	19	carcinoma	carcinoma	NOUN
easat-9432	98	20	,	,	PUNCT
easat-9432	98	21	and	and	CCONJ
easat-9432	98	22	large	large	ADJ
easat-9432	98	23	cell	cell	NOUN
easat-9432	98	24	carcinoma	carcinoma	NOUN
easat-9432	98	25	.	.	PUNCT
easat-9432	99	1	frequent	frequent	ADJ
easat-9432	99	2	transformation	transformation	NOUN
easat-9432	99	3	of	of	ADP
easat-9432	99	4	nsclc	nsclc	NOUN
easat-9432	99	5	to	to	ADP
easat-9432	99	6	sclc	sclc	PROPN
easat-9432	99	7	,	,	PUNCT
easat-9432	99	8	especially	especially	ADV
easat-9432	99	9	the	the	DET
easat-9432	99	10	adenocarcinoma	adenocarcinoma	ADJ
easat-9432	99	11	type	type	NOUN
easat-9432	99	12	,	,	PUNCT
easat-9432	99	13	due	due	ADJ
easat-9432	99	14	to	to	ADP
easat-9432	99	15	egfr	egfr	ADJ
easat-9432	99	16	-	-	PUNCT
easat-9432	99	17	tki	tki	X
easat-9432	99	18	(	(	PUNCT
easat-9432	99	19	epidermal	epidermal	ADJ
easat-9432	99	20	growth	growth	NOUN
easat-9432	99	21	factor	factor	NOUN
easat-9432	99	22	-	-	PUNCT
easat-9432	99	23	tyrosine	tyrosine	NOUN
easat-9432	99	24	kinase	kinase	PROPN
easat-9432	99	25	inhibitor	inhibitor	PROPN
easat-9432	99	26	)	)	PUNCT
easat-9432	99	27	mutation	mutation	NOUN
easat-9432	99	28	,	,	PUNCT
easat-9432	99	29	was	be	AUX
easat-9432	99	30	3	3	NUM
easat-9432	99	31	-	-	SYM
easat-9432	99	32	14	14	NUM
easat-9432	99	33	%	%	NOUN
easat-9432	100	1	[	[	X
easat-9432	100	2	15	15	NUM
easat-9432	100	3	]	]	PUNCT
easat-9432	100	4	.	.	PUNCT
easat-9432	101	1	the	the	DET
easat-9432	101	2	transformation	transformation	NOUN
easat-9432	101	3	of	of	ADP
easat-9432	101	4	sclc	sclc	PROPN
easat-9432	101	5	into	into	ADP
easat-9432	101	6	nsclc	nsclc	NOUN
easat-9432	101	7	is	be	AUX
easat-9432	101	8	characterized	characterize	VERB
easat-9432	101	9	by	by	ADP
easat-9432	101	10	genetic	genetic	ADJ
easat-9432	101	11	and	and	CCONJ
easat-9432	101	12	molecular	molecular	ADJ
easat-9432	101	13	changes	change	NOUN
easat-9432	101	14	.	.	PUNCT
easat-9432	102	1	sclc	sclc	PROPN
easat-9432	102	2	transformation	transformation	NOUN
easat-9432	102	3	is	be	AUX
easat-9432	102	4	characterized	characterize	VERB
easat-9432	102	5	by	by	ADP
easat-9432	102	6	the	the	DET
easat-9432	102	7	mutation	mutation	NOUN
easat-9432	102	8	of	of	ADP
easat-9432	102	9	the	the	DET
easat-9432	102	10	tp53	tp53	PROPN
easat-9432	102	11	and	and	CCONJ
easat-9432	102	12	rb1	rb1	NOUN
easat-9432	102	13	genes	gene	NOUN
easat-9432	102	14	.	.	PUNCT
easat-9432	103	1	inactivation	inactivation	NOUN
easat-9432	103	2	of	of	ADP
easat-9432	103	3	rb1	rb1	NOUN
easat-9432	103	4	and	and	CCONJ
easat-9432	103	5	tp53	tp53	PROPN
easat-9432	103	6	is	be	AUX
easat-9432	103	7	the	the	DET
easat-9432	103	8	process	process	NOUN
easat-9432	103	9	of	of	ADP
easat-9432	103	10	combined	combined	ADJ
easat-9432	103	11	tumorigenesis	tumorigenesis	NOUN
easat-9432	103	12	of	of	ADP
easat-9432	103	13	sclc	sclc	PROPN
easat-9432	103	14	/	/	SYM
easat-9432	103	15	nsclc	nsclc	NOUN
easat-9432	103	16	[	[	X
easat-9432	103	17	16	16	NUM
easat-9432	103	18	]	]	PUNCT
easat-9432	103	19	.	.	PUNCT
easat-9432	104	1	during	during	ADP
easat-9432	104	2	transformation	transformation	NOUN
easat-9432	104	3	,	,	PUNCT
easat-9432	104	4	further	further	ADJ
easat-9432	104	5	changes	change	NOUN
easat-9432	104	6	in	in	ADP
easat-9432	104	7	mutations	mutation	NOUN
easat-9432	104	8	or	or	CCONJ
easat-9432	104	9	inactivation	inactivation	NOUN
easat-9432	104	10	of	of	ADP
easat-9432	104	11	these	these	DET
easat-9432	104	12	genes	gene	NOUN
easat-9432	104	13	may	may	AUX
easat-9432	104	14	trigger	trigger	VERB
easat-9432	104	15	histologic	histologic	ADJ
easat-9432	104	16	changes	change	NOUN
easat-9432	104	17	from	from	ADP
easat-9432	104	18	sclc	sclc	PROPN
easat-9432	104	19	to	to	ADP
easat-9432	104	20	nsclc	nsclc	NOUN
easat-9432	104	21	.	.	PUNCT
easat-9432	105	1	mutations	mutation	NOUN
easat-9432	105	2	in	in	ADP
easat-9432	105	3	the	the	DET
easat-9432	105	4	egfr	egfr	NOUN
easat-9432	105	5	,	,	PUNCT
easat-9432	105	6	alk	alk	VERB
easat-9432	105	7	,	,	PUNCT
easat-9432	105	8	and	and	CCONJ
easat-9432	105	9	ros1	ros1	PROPN
easat-9432	105	10	genes	gene	NOUN
easat-9432	105	11	associated	associate	VERB
easat-9432	105	12	with	with	ADP
easat-9432	105	13	nsclc	nsclc	NOUN
easat-9432	105	14	can	can	AUX
easat-9432	105	15	also	also	ADV
easat-9432	105	16	be	be	AUX
easat-9432	105	17	found	find	VERB
easat-9432	105	18	in	in	ADP
easat-9432	105	19	some	some	DET
easat-9432	105	20	cases	case	NOUN
easat-9432	105	21	of	of	ADP
easat-9432	105	22	this	this	DET
easat-9432	105	23	transformation	transformation	NOUN
easat-9432	105	24	[	[	X
easat-9432	105	25	17	17	NUM
easat-9432	105	26	]	]	PUNCT
easat-9432	105	27	.	.	PUNCT
easat-9432	106	1	sclc	sclc	PROPN
easat-9432	106	2	transformation	transformation	NOUN
easat-9432	106	3	is	be	AUX
easat-9432	106	4	also	also	ADV
easat-9432	106	5	characterized	characterize	VERB
easat-9432	106	6	by	by	ADP
easat-9432	106	7	the	the	DET
easat-9432	106	8	presence	presence	NOUN
easat-9432	106	9	of	of	ADP
easat-9432	106	10	smad4	smad4	NOUN
easat-9432	106	11	mutations	mutation	NOUN
easat-9432	106	12	that	that	PRON
easat-9432	106	13	contribute	contribute	VERB
easat-9432	106	14	to	to	ADP
easat-9432	106	15	small	small	ADJ
easat-9432	106	16	cell	cell	NOUN
easat-9432	106	17	transitions	transition	NOUN
easat-9432	106	18	,	,	PUNCT
easat-9432	106	19	mainly	mainly	ADV
easat-9432	106	20	by	by	ADP
easat-9432	106	21	affecting	affect	VERB
easat-9432	106	22	the	the	DET
easat-9432	106	23	neuroendocrine	neuroendocrine	ADJ
easat-9432	106	24	phenotype	phenotype	NOUN
easat-9432	106	25	by	by	ADP
easat-9432	106	26	inactivating	inactivate	VERB
easat-9432	106	27	tp53	tp53	PROPN
easat-9432	107	1	[	[	X
easat-9432	107	2	18	18	NUM
easat-9432	107	3	]	]	PUNCT
easat-9432	107	4	.	.	PUNCT
easat-9432	108	1	activation	activation	NOUN
easat-9432	108	2	of	of	ADP
easat-9432	108	3	oncogenes	oncogene	NOUN
easat-9432	108	4	such	such	ADJ
easat-9432	108	5	as	as	ADP
easat-9432	108	6	kras	kras	PROPN
easat-9432	108	7	,	,	PUNCT
easat-9432	108	8	egfr	egfr	NOUN
easat-9432	108	9	,	,	PUNCT
easat-9432	108	10	and	and	CCONJ
easat-9432	108	11	alk	alk	NOUN
easat-9432	108	12	may	may	AUX
easat-9432	108	13	play	play	VERB
easat-9432	108	14	a	a	DET
easat-9432	108	15	role	role	NOUN
easat-9432	108	16	in	in	ADP
easat-9432	108	17	the	the	DET
easat-9432	108	18	development	development	NOUN
easat-9432	108	19	and	and	CCONJ
easat-9432	108	20	transformation	transformation	NOUN
easat-9432	108	21	from	from	ADP
easat-9432	108	22	sclc	sclc	PROPN
easat-9432	108	23	to	to	ADP
easat-9432	108	24	nsclc	nsclc	NOUN
easat-9432	108	25	.	.	PUNCT
easat-9432	109	1	for	for	ADP
easat-9432	109	2	example	example	NOUN
easat-9432	109	3	,	,	PUNCT
easat-9432	109	4	treatment	treatment	NOUN
easat-9432	109	5	with	with	ADP
easat-9432	109	6	egfr	egfr	ADJ
easat-9432	109	7	inhibitors	inhibitor	NOUN
easat-9432	109	8	in	in	ADP
easat-9432	109	9	patients	patient	NOUN
easat-9432	109	10	who	who	PRON
easat-9432	109	11	initially	initially	ADV
easat-9432	109	12	have	have	VERB
easat-9432	109	13	sclc	sclc	PROPN
easat-9432	109	14	may	may	AUX
easat-9432	109	15	trigger	trigger	VERB
easat-9432	109	16	clonal	clonal	ADJ
easat-9432	109	17	selection	selection	NOUN
easat-9432	109	18	,	,	PUNCT
easat-9432	109	19	leading	lead	VERB
easat-9432	109	20	to	to	ADP
easat-9432	109	21	the	the	DET
easat-9432	109	22	emergence	emergence	NOUN
easat-9432	109	23	of	of	ADP
easat-9432	109	24	a	a	DET
easat-9432	109	25	subpopulation	subpopulation	NOUN
easat-9432	109	26	of	of	ADP
easat-9432	109	27	cancer	cancer	NOUN
easat-9432	109	28	cells	cell	NOUN
easat-9432	109	29	that	that	PRON
easat-9432	109	30	exhibit	exhibit	VERB
easat-9432	109	31	characteristics	characteristic	NOUN
easat-9432	109	32	of	of	ADP
easat-9432	109	33	nsclc	nsclc	NOUN
easat-9432	109	34	[	[	X
easat-9432	109	35	19	19	NUM
easat-9432	109	36	,	,	PUNCT
easat-9432	109	37	20	20	NUM
easat-9432	109	38	]	]	PUNCT
easat-9432	109	39	.	.	PUNCT
easat-9432	110	1	patients	patient	NOUN
easat-9432	110	2	with	with	ADP
easat-9432	110	3	lung	lung	NOUN
easat-9432	110	4	cancer	cancer	NOUN
easat-9432	110	5	undergoing	undergo	VERB
easat-9432	110	6	immunosuppressive	immunosuppressive	ADJ
easat-9432	110	7	therapies	therapy	NOUN
easat-9432	110	8	such	such	ADJ
easat-9432	110	9	as	as	ADP
easat-9432	110	10	chemotherapy	chemotherapy	NOUN
easat-9432	110	11	,	,	PUNCT
easat-9432	110	12	targeted	target	VERB
easat-9432	110	13	therapy	therapy	NOUN
easat-9432	110	14	,	,	PUNCT
easat-9432	110	15	or	or	CCONJ
easat-9432	110	16	immunotherapy	immunotherapy	NOUN
easat-9432	110	17	are	be	AUX
easat-9432	110	18	more	more	ADV
easat-9432	110	19	susceptible	susceptible	ADJ
easat-9432	110	20	to	to	ADP
easat-9432	110	21	fungal	fungal	ADJ
easat-9432	110	22	infections	infection	NOUN
easat-9432	110	23	.	.	PUNCT
easat-9432	111	1	fungal	fungal	ADJ
easat-9432	111	2	infections	infection	NOUN
easat-9432	111	3	,	,	PUNCT
easat-9432	111	4	such	such	ADJ
easat-9432	111	5	as	as	ADP
easat-9432	111	6	those	those	PRON
easat-9432	111	7	caused	cause	VERB
easat-9432	111	8	by	by	ADP
easat-9432	111	9	aspergillus	aspergillus	NOUN
easat-9432	111	10	,	,	PUNCT
easat-9432	111	11	candida	candida	PROPN
easat-9432	111	12	,	,	PUNCT
easat-9432	111	13	or	or	CCONJ
easat-9432	111	14	pneumocystis	pneumocystis	NOUN
easat-9432	111	15	jirovecii	jirovecii	NOUN
easat-9432	111	16	,	,	PUNCT
easat-9432	111	17	can	can	AUX
easat-9432	111	18	worsen	worsen	VERB
easat-9432	111	19	the	the	DET
easat-9432	111	20	patient	patient	NOUN
easat-9432	111	21	's	's	PART
easat-9432	111	22	condition	condition	NOUN
easat-9432	111	23	and	and	CCONJ
easat-9432	111	24	lead	lead	VERB
easat-9432	111	25	to	to	ADP
easat-9432	111	26	increased	increase	VERB
easat-9432	111	27	complications	complication	NOUN
easat-9432	111	28	[	[	X
easat-9432	111	29	21	21	NUM
easat-9432	111	30	]	]	PUNCT
easat-9432	111	31	.	.	PUNCT
easat-9432	112	1	immunosuppression	immunosuppression	NOUN
easat-9432	112	2	in	in	ADP
easat-9432	112	3	cancer	cancer	NOUN
easat-9432	112	4	patients	patient	NOUN
easat-9432	112	5	can	can	AUX
easat-9432	112	6	affect	affect	VERB
easat-9432	112	7	their	their	PRON
easat-9432	112	8	immune	immune	ADJ
easat-9432	112	9	response	response	NOUN
easat-9432	112	10	,	,	PUNCT
easat-9432	112	11	750	750	NUM
easat-9432	112	12	edelweiss	edelweiss	PROPN
easat-9432	112	13	applied	apply	VERB
easat-9432	112	14	science	science	NOUN
easat-9432	112	15	and	and	CCONJ
easat-9432	112	16	technology	technology	NOUN
easat-9432	112	17	issn	issn	PROPN
easat-9432	112	18	:	:	PUNCT
easat-9432	112	19	2576	2576	NUM
easat-9432	112	20	-	-	SYM
easat-9432	112	21	8484	8484	NUM
easat-9432	112	22	vol	vol	NOUN
easat-9432	112	23	.	.	PROPN
easat-9432	113	1	9	9	NUM
easat-9432	113	2	,	,	PUNCT
easat-9432	113	3	no	no	INTJ
easat-9432	113	4	.	.	NOUN
easat-9432	113	5	8	8	NUM
easat-9432	113	6	:	:	PUNCT
easat-9432	113	7	744	744	NUM
easat-9432	113	8	-	-	SYM
easat-9432	113	9	751	751	NUM
easat-9432	113	10	,	,	PUNCT
easat-9432	113	11	2025	2025	NUM
easat-9432	113	12	doi	doi	NOUN
easat-9432	113	13	:	:	PUNCT
easat-9432	113	14	10.55214/2576	10.55214/2576	NUM
easat-9432	113	15	-	-	SYM
easat-9432	113	16	8484.v9i8.9432	8484.v9i8.9432	NOUN
easat-9432	114	1	©	©	PROPN
easat-9432	114	2	2025	2025	NUM
easat-9432	114	3	by	by	ADP
easat-9432	114	4	the	the	DET
easat-9432	114	5	authors	author	NOUN
easat-9432	114	6	;	;	PUNCT
easat-9432	114	7	licensee	licensee	PROPN
easat-9432	114	8	learning	learning	NOUN
easat-9432	114	9	gate	gate	NOUN
easat-9432	114	10	which	which	PRON
easat-9432	114	11	can	can	AUX
easat-9432	114	12	lead	lead	VERB
easat-9432	114	13	to	to	ADP
easat-9432	114	14	opportunistic	opportunistic	ADJ
easat-9432	114	15	fungal	fungal	ADJ
easat-9432	114	16	infections	infection	NOUN
easat-9432	114	17	and	and	CCONJ
easat-9432	114	18	worsen	worsen	VERB
easat-9432	114	19	the	the	DET
easat-9432	114	20	histological	histological	ADJ
easat-9432	114	21	transformation	transformation	NOUN
easat-9432	114	22	of	of	ADP
easat-9432	114	23	the	the	DET
easat-9432	114	24	cancer	cancer	NOUN
easat-9432	114	25	,	,	PUNCT
easat-9432	114	26	potentially	potentially	ADV
easat-9432	114	27	accelerating	accelerate	VERB
easat-9432	114	28	the	the	DET
easat-9432	114	29	change	change	NOUN
easat-9432	114	30	from	from	ADP
easat-9432	114	31	sclc	sclc	PROPN
easat-9432	114	32	to	to	ADP
easat-9432	114	33	nsclc	nsclc	NOUN
easat-9432	114	34	or	or	CCONJ
easat-9432	114	35	adding	add	VERB
easat-9432	114	36	clinical	clinical	ADJ
easat-9432	114	37	complexity	complexity	NOUN
easat-9432	114	38	to	to	ADP
easat-9432	114	39	the	the	DET
easat-9432	114	40	treatment	treatment	NOUN
easat-9432	114	41	of	of	ADP
easat-9432	114	42	such	such	ADJ
easat-9432	114	43	cancers	cancer	NOUN
easat-9432	114	44	.	.	PUNCT
easat-9432	115	1	loss	loss	NOUN
easat-9432	115	2	of	of	ADP
easat-9432	115	3	function	function	NOUN
easat-9432	115	4	due	due	ADP
easat-9432	115	5	to	to	ADP
easat-9432	115	6	il12rb1	il12rb1	ADJ
easat-9432	115	7	mutation	mutation	NOUN
easat-9432	115	8	results	result	NOUN
easat-9432	115	9	in	in	ADP
easat-9432	115	10	impaired	impaired	ADJ
easat-9432	115	11	ifn	ifn	PROPN
easat-9432	115	12	-	-	PUNCT
easat-9432	115	13	γ	γ	NOUN
easat-9432	115	14	production	production	NOUN
easat-9432	115	15	,	,	PUNCT
easat-9432	115	16	so	so	SCONJ
easat-9432	115	17	that	that	SCONJ
easat-9432	115	18	macrophages	macrophage	NOUN
easat-9432	115	19	can	can	AUX
easat-9432	115	20	not	not	PART
easat-9432	115	21	eliminate	eliminate	VERB
easat-9432	115	22	intracellular	intracellular	ADJ
easat-9432	115	23	fungi	fungus	NOUN
easat-9432	115	24	.	.	PUNCT
easat-9432	116	1	fungal	fungal	ADJ
easat-9432	116	2	interaction	interaction	NOUN
easat-9432	116	3	with	with	ADP
easat-9432	116	4	integrin	integrin	NOUN
easat-9432	116	5	-	-	PUNCT
easat-9432	116	6	β1	β1	PROPN
easat-9432	116	7	on	on	ADP
easat-9432	116	8	alveolar	alveolar	ADJ
easat-9432	116	9	epithelial	epithelial	ADJ
easat-9432	116	10	cells	cell	NOUN
easat-9432	116	11	further	far	ADV
easat-9432	116	12	increases	increase	VERB
easat-9432	116	13	egfr	egfr	ADJ
easat-9432	116	14	activation	activation	NOUN
easat-9432	116	15	,	,	PUNCT
easat-9432	116	16	cell	cell	NOUN
easat-9432	116	17	damage	damage	NOUN
easat-9432	116	18	,	,	PUNCT
easat-9432	116	19	and	and	CCONJ
easat-9432	116	20	the	the	DET
easat-9432	116	21	development	development	NOUN
easat-9432	116	22	of	of	ADP
easat-9432	116	23	invasive	invasive	ADJ
easat-9432	116	24	fungi	fungus	NOUN
easat-9432	116	25	[	[	X
easat-9432	116	26	5	5	NUM
easat-9432	116	27	]	]	PUNCT
easat-9432	116	28	.	.	PUNCT
easat-9432	117	1	mycosis	mycosis	NOUN
easat-9432	117	2	occurring	occur	VERB
easat-9432	117	3	in	in	ADP
easat-9432	117	4	lung	lung	NOUN
easat-9432	117	5	cancer	cancer	NOUN
easat-9432	117	6	patients	patient	NOUN
easat-9432	117	7	may	may	AUX
easat-9432	117	8	increase	increase	VERB
easat-9432	117	9	levels	level	NOUN
easat-9432	117	10	of	of	ADP
easat-9432	117	11	pro	pro	ADJ
easat-9432	117	12	-	-	ADJ
easat-9432	117	13	inflammatory	inflammatory	ADJ
easat-9432	117	14	cytokines	cytokine	NOUN
easat-9432	117	15	and	and	CCONJ
easat-9432	117	16	growth	growth	NOUN
easat-9432	117	17	factors	factor	NOUN
easat-9432	117	18	that	that	PRON
easat-9432	117	19	may	may	AUX
easat-9432	117	20	influence	influence	VERB
easat-9432	117	21	cellular	cellular	ADJ
easat-9432	117	22	signaling	signal	VERB
easat-9432	117	23	pathways	pathway	NOUN
easat-9432	117	24	involved	involve	VERB
easat-9432	117	25	in	in	ADP
easat-9432	117	26	cancer	cancer	NOUN
easat-9432	117	27	cell	cell	NOUN
easat-9432	117	28	transition	transition	NOUN
easat-9432	117	29	,	,	PUNCT
easat-9432	117	30	such	such	ADJ
easat-9432	117	31	as	as	ADP
easat-9432	117	32	the	the	DET
easat-9432	117	33	change	change	NOUN
easat-9432	117	34	from	from	ADP
easat-9432	117	35	sclc	sclc	PROPN
easat-9432	117	36	to	to	ADP
easat-9432	117	37	nsclc	nsclc	NOUN
easat-9432	117	38	[	[	X
easat-9432	117	39	5	5	NUM
easat-9432	117	40	,	,	PUNCT
easat-9432	117	41	10	10	NUM
easat-9432	117	42	,	,	PUNCT
easat-9432	117	43	16	16	NUM
easat-9432	117	44	]	]	PUNCT
easat-9432	117	45	.	.	PUNCT
easat-9432	118	1	however	however	ADV
easat-9432	118	2	,	,	PUNCT
easat-9432	118	3	the	the	DET
easat-9432	118	4	exact	exact	ADJ
easat-9432	118	5	relationship	relationship	NOUN
easat-9432	118	6	between	between	ADP
easat-9432	118	7	mycosis	mycosis	NOUN
easat-9432	118	8	and	and	CCONJ
easat-9432	118	9	histologic	histologic	ADJ
easat-9432	118	10	transformation	transformation	NOUN
easat-9432	118	11	in	in	ADP
easat-9432	118	12	lung	lung	NOUN
easat-9432	118	13	cancer	cancer	NOUN
easat-9432	118	14	still	still	ADV
easat-9432	118	15	needs	need	VERB
easat-9432	118	16	to	to	PART
easat-9432	118	17	be	be	AUX
easat-9432	118	18	further	far	ADV
easat-9432	118	19	investigated	investigate	VERB
easat-9432	118	20	.	.	PUNCT
easat-9432	119	1	patients	patient	NOUN
easat-9432	119	2	with	with	ADP
easat-9432	119	3	invasive	invasive	ADJ
easat-9432	119	4	aspergillosis	aspergillosis	NOUN
easat-9432	119	5	should	should	AUX
easat-9432	119	6	first	first	ADV
easat-9432	119	7	be	be	AUX
easat-9432	119	8	given	give	VERB
easat-9432	119	9	oral	oral	ADJ
easat-9432	119	10	or	or	CCONJ
easat-9432	119	11	intravenous	intravenous	ADJ
easat-9432	119	12	voriconazole	voriconazole	NOUN
easat-9432	119	13	with	with	ADP
easat-9432	119	14	a	a	DET
easat-9432	119	15	loading	loading	NOUN
easat-9432	119	16	dose	dose	NOUN
easat-9432	119	17	of	of	ADP
easat-9432	119	18	6mg	6mg	PROPN
easat-9432	119	19	/	/	SYM
easat-9432	119	20	kg/12h	kg/12h	PROPN
easat-9432	119	21	on	on	ADP
easat-9432	119	22	the	the	DET
easat-9432	119	23	first	first	ADJ
easat-9432	119	24	day	day	NOUN
easat-9432	119	25	,	,	PUNCT
easat-9432	119	26	then	then	ADV
easat-9432	119	27	4mg	4mg	ADJ
easat-9432	119	28	/	/	SYM
easat-9432	119	29	kg/12h	kg/12h	PROPN
easat-9432	120	1	[	[	X
easat-9432	120	2	22	22	NUM
easat-9432	120	3	]	]	PUNCT
easat-9432	120	4	.	.	PUNCT
easat-9432	121	1	in	in	ADP
easat-9432	121	2	lung	lung	NOUN
easat-9432	121	3	cancer	cancer	NOUN
easat-9432	121	4	patients	patient	NOUN
easat-9432	121	5	,	,	PUNCT
easat-9432	121	6	fluconazole	fluconazole	NOUN
easat-9432	121	7	is	be	AUX
easat-9432	121	8	generally	generally	ADV
easat-9432	121	9	not	not	PART
easat-9432	121	10	fully	fully	ADV
easat-9432	121	11	effective	effective	ADJ
easat-9432	121	12	for	for	ADP
easat-9432	121	13	treating	treat	VERB
easat-9432	121	14	aspergillus	aspergillus	NOUN
easat-9432	121	15	infections	infection	NOUN
easat-9432	121	16	due	due	ADP
easat-9432	121	17	to	to	ADP
easat-9432	121	18	its	its	PRON
easat-9432	121	19	limited	limited	ADJ
easat-9432	121	20	effectiveness	effectiveness	NOUN
easat-9432	121	21	.	.	PUNCT
easat-9432	122	1	fluconazole	fluconazole	NOUN
easat-9432	122	2	is	be	AUX
easat-9432	122	3	an	an	DET
easat-9432	122	4	inhibitor	inhibitor	NOUN
easat-9432	122	5	of	of	ADP
easat-9432	122	6	ergosterol	ergosterol	NOUN
easat-9432	122	7	synthesis	synthesis	NOUN
easat-9432	122	8	,	,	PUNCT
easat-9432	122	9	which	which	PRON
easat-9432	122	10	is	be	AUX
easat-9432	122	11	essential	essential	ADJ
easat-9432	122	12	for	for	ADP
easat-9432	122	13	fungal	fungal	ADJ
easat-9432	122	14	cell	cell	NOUN
easat-9432	122	15	membranes	membrane	NOUN
easat-9432	122	16	.	.	PUNCT
easat-9432	123	1	aspergillus	aspergillus	NOUN
easat-9432	123	2	can	can	AUX
easat-9432	123	3	develop	develop	VERB
easat-9432	123	4	resistance	resistance	NOUN
easat-9432	123	5	to	to	ADP
easat-9432	123	6	fluconazole	fluconazole	NOUN
easat-9432	123	7	due	due	ADJ
easat-9432	123	8	to	to	ADP
easat-9432	123	9	variations	variation	NOUN
easat-9432	123	10	in	in	ADP
easat-9432	123	11	its	its	PRON
easat-9432	123	12	target	target	NOUN
easat-9432	123	13	protein	protein	NOUN
easat-9432	123	14	(	(	PUNCT
easat-9432	123	15	lanosterol	lanosterol	PROPN
easat-9432	123	16	14α	14α	NUM
easat-9432	123	17	-	-	PUNCT
easat-9432	123	18	demethylase	demethylase	NOUN
easat-9432	123	19	)	)	PUNCT
easat-9432	123	20	.	.	PUNCT
easat-9432	124	1	however	however	ADV
easat-9432	124	2	,	,	PUNCT
easat-9432	124	3	some	some	DET
easat-9432	124	4	studies	study	NOUN
easat-9432	124	5	have	have	AUX
easat-9432	124	6	shown	show	VERB
easat-9432	124	7	that	that	SCONJ
easat-9432	124	8	platinum	platinum	NOUN
easat-9432	124	9	-	-	PUNCT
easat-9432	124	10	based	base	VERB
easat-9432	124	11	chemotherapy	chemotherapy	NOUN
easat-9432	124	12	is	be	AUX
easat-9432	124	13	effective	effective	ADJ
easat-9432	124	14	in	in	ADP
easat-9432	124	15	increasing	increase	VERB
easat-9432	124	16	life	life	NOUN
easat-9432	124	17	expectancy	expectancy	NOUN
easat-9432	124	18	and	and	CCONJ
easat-9432	124	19	fluconazole	fluconazole	NOUN
easat-9432	124	20	in	in	ADP
easat-9432	124	21	treating	treat	VERB
easat-9432	124	22	pulmonary	pulmonary	ADJ
easat-9432	124	23	mycosis	mycosis	NOUN
easat-9432	124	24	in	in	ADP
easat-9432	124	25	cancer	cancer	NOUN
easat-9432	124	26	patients	patient	NOUN
easat-9432	124	27	[	[	X
easat-9432	124	28	23	23	NUM
easat-9432	124	29	]	]	PUNCT
easat-9432	124	30	.	.	PUNCT
easat-9432	125	1	in	in	ADP
easat-9432	125	2	advanced	advanced	ADJ
easat-9432	125	3	nsclc	nsclc	NOUN
easat-9432	125	4	,	,	PUNCT
easat-9432	125	5	management	management	NOUN
easat-9432	125	6	may	may	AUX
easat-9432	125	7	include	include	VERB
easat-9432	125	8	chemotherapy	chemotherapy	NOUN
easat-9432	125	9	,	,	PUNCT
easat-9432	125	10	immunotherapy	immunotherapy	NOUN
easat-9432	125	11	,	,	PUNCT
easat-9432	125	12	targeted	target	VERB
easat-9432	125	13	therapy	therapy	NOUN
easat-9432	125	14	,	,	PUNCT
easat-9432	125	15	radiotherapy	radiotherapy	NOUN
easat-9432	125	16	,	,	PUNCT
easat-9432	125	17	and	and	CCONJ
easat-9432	125	18	palliative	palliative	ADJ
easat-9432	125	19	care	care	NOUN
easat-9432	125	20	,	,	PUNCT
easat-9432	125	21	depending	depend	VERB
easat-9432	125	22	on	on	ADP
easat-9432	125	23	the	the	DET
easat-9432	125	24	patient	patient	NOUN
easat-9432	125	25	's	's	PART
easat-9432	125	26	response	response	NOUN
easat-9432	125	27	and	and	CCONJ
easat-9432	125	28	clinical	clinical	ADJ
easat-9432	125	29	condition	condition	NOUN
easat-9432	125	30	.	.	PUNCT
easat-9432	126	1	platinumbased	platinumbase	VERB
easat-9432	126	2	regimen	regimen	NOUN
easat-9432	126	3	combination	combination	NOUN
easat-9432	126	4	of	of	ADP
easat-9432	126	5	cisplatin	cisplatin	NOUN
easat-9432	126	6	or	or	CCONJ
easat-9432	126	7	carboplatin	carboplatin	NOUN
easat-9432	126	8	with	with	ADP
easat-9432	126	9	other	other	ADJ
easat-9432	126	10	chemotherapeutic	chemotherapeutic	ADJ
easat-9432	126	11	agents	agent	NOUN
easat-9432	126	12	such	such	ADJ
easat-9432	126	13	as	as	ADP
easat-9432	126	14	paclitaxel	paclitaxel	NOUN
easat-9432	126	15	,	,	PUNCT
easat-9432	126	16	gemcitabine	gemcitabine	NOUN
easat-9432	126	17	,	,	PUNCT
easat-9432	126	18	or	or	CCONJ
easat-9432	126	19	docetaxel	docetaxel	NOUN
easat-9432	126	20	is	be	AUX
easat-9432	126	21	the	the	DET
easat-9432	126	22	first	first	ADJ
easat-9432	126	23	-	-	PUNCT
easat-9432	126	24	line	line	NOUN
easat-9432	126	25	treatment	treatment	NOUN
easat-9432	126	26	in	in	ADP
easat-9432	126	27	many	many	ADJ
easat-9432	126	28	patients	patient	NOUN
easat-9432	126	29	with	with	ADP
easat-9432	126	30	stage	stage	NOUN
easat-9432	126	31	iv	iv	NUM
easat-9432	126	32	lung	lung	NOUN
easat-9432	126	33	cancer	cancer	NOUN
easat-9432	126	34	.	.	PUNCT
easat-9432	127	1	this	this	DET
easat-9432	127	2	regimen	regimen	NOUN
easat-9432	127	3	is	be	AUX
easat-9432	127	4	effective	effective	ADJ
easat-9432	127	5	at	at	ADP
easat-9432	127	6	reducing	reduce	VERB
easat-9432	127	7	tumor	tumor	NOUN
easat-9432	127	8	size	size	NOUN
easat-9432	127	9	and	and	CCONJ
easat-9432	127	10	slowing	slow	VERB
easat-9432	127	11	disease	disease	NOUN
easat-9432	127	12	progression	progression	NOUN
easat-9432	127	13	,	,	PUNCT
easat-9432	127	14	although	although	SCONJ
easat-9432	127	15	it	it	PRON
easat-9432	127	16	does	do	AUX
easat-9432	127	17	not	not	PART
easat-9432	127	18	provide	provide	VERB
easat-9432	127	19	a	a	DET
easat-9432	127	20	permanent	permanent	ADJ
easat-9432	127	21	cure	cure	NOUN
easat-9432	127	22	[	[	X
easat-9432	127	23	24	24	NUM
easat-9432	127	24	]	]	PUNCT
easat-9432	127	25	.	.	PUNCT
easat-9432	128	1	as	as	ADP
easat-9432	128	2	a	a	DET
easat-9432	128	3	conclusion	conclusion	NOUN
easat-9432	128	4	is	be	AUX
easat-9432	128	5	sclc	sclc	PROPN
easat-9432	128	6	transformation	transformation	NOUN
easat-9432	128	7	can	can	AUX
easat-9432	128	8	be	be	AUX
easat-9432	128	9	triggered	trigger	VERB
easat-9432	128	10	by	by	ADP
easat-9432	128	11	gene	gene	NOUN
easat-9432	128	12	mutations	mutation	NOUN
easat-9432	128	13	due	due	ADJ
easat-9432	128	14	to	to	ADP
easat-9432	128	15	various	various	ADJ
easat-9432	128	16	causes	cause	NOUN
easat-9432	128	17	such	such	ADJ
easat-9432	128	18	as	as	ADP
easat-9432	128	19	fungal	fungal	ADJ
easat-9432	128	20	infections	infection	NOUN
easat-9432	128	21	and	and	CCONJ
easat-9432	128	22	vice	vice	NOUN
easat-9432	128	23	versa	versa	ADV
easat-9432	128	24	.	.	PUNCT
easat-9432	129	1	ct	ct	PROPN
easat-9432	129	2	thorax	thorax	PROPN
easat-9432	129	3	recist	recist	NOUN
easat-9432	129	4	is	be	AUX
easat-9432	129	5	an	an	DET
easat-9432	129	6	important	important	ADJ
easat-9432	129	7	evaluation	evaluation	NOUN
easat-9432	129	8	for	for	ADP
easat-9432	129	9	lung	lung	NOUN
easat-9432	129	10	cancer	cancer	NOUN
easat-9432	129	11	prognosis	prognosis	NOUN
easat-9432	129	12	.	.	PUNCT
easat-9432	130	1	transparency	transparency	NOUN
easat-9432	130	2	:	:	PUNCT
easat-9432	130	3	the	the	DET
easat-9432	130	4	authors	author	NOUN
easat-9432	130	5	confirm	confirm	VERB
easat-9432	130	6	that	that	SCONJ
easat-9432	130	7	the	the	DET
easat-9432	130	8	manuscript	manuscript	NOUN
easat-9432	130	9	is	be	AUX
easat-9432	130	10	an	an	DET
easat-9432	130	11	honest	honest	ADJ
easat-9432	130	12	,	,	PUNCT
easat-9432	130	13	accurate	accurate	ADJ
easat-9432	130	14	,	,	PUNCT
easat-9432	130	15	and	and	CCONJ
easat-9432	130	16	transparent	transparent	ADJ
easat-9432	130	17	account	account	NOUN
easat-9432	130	18	of	of	ADP
easat-9432	130	19	the	the	DET
easat-9432	130	20	study	study	NOUN
easat-9432	130	21	;	;	PUNCT
easat-9432	130	22	that	that	SCONJ
easat-9432	130	23	no	no	DET
easat-9432	130	24	vital	vital	ADJ
easat-9432	130	25	features	feature	NOUN
easat-9432	130	26	of	of	ADP
easat-9432	130	27	the	the	DET
easat-9432	130	28	study	study	NOUN
easat-9432	130	29	have	have	AUX
easat-9432	130	30	been	be	AUX
easat-9432	130	31	omitted	omit	VERB
easat-9432	130	32	;	;	PUNCT
easat-9432	130	33	and	and	CCONJ
easat-9432	130	34	that	that	SCONJ
easat-9432	130	35	any	any	DET
easat-9432	130	36	discrepancies	discrepancy	NOUN
easat-9432	130	37	from	from	ADP
easat-9432	130	38	the	the	DET
easat-9432	130	39	study	study	NOUN
easat-9432	130	40	as	as	SCONJ
easat-9432	130	41	planned	plan	VERB
easat-9432	130	42	have	have	AUX
easat-9432	130	43	been	be	AUX
easat-9432	130	44	explained	explain	VERB
easat-9432	130	45	.	.	PUNCT
easat-9432	131	1	this	this	DET
easat-9432	131	2	study	study	NOUN
easat-9432	131	3	followed	follow	VERB
easat-9432	131	4	all	all	DET
easat-9432	131	5	ethical	ethical	ADJ
easat-9432	131	6	practices	practice	NOUN
easat-9432	131	7	during	during	ADP
easat-9432	131	8	writing	writing	NOUN
easat-9432	131	9	.	.	PUNCT
easat-9432	132	1	acknowledgment	acknowledgment	NOUN
easat-9432	132	2	:	:	PUNCT
easat-9432	132	3	the	the	DET
easat-9432	132	4	authors	author	NOUN
easat-9432	132	5	would	would	AUX
easat-9432	132	6	like	like	VERB
easat-9432	132	7	to	to	PART
easat-9432	132	8	thank	thank	VERB
easat-9432	132	9	saiful	saiful	PROPN
easat-9432	132	10	anwar	anwar	PROPN
easat-9432	132	11	hospital	hospital	PROPN
easat-9432	132	12	for	for	ADP
easat-9432	132	13	permitting	permit	VERB
easat-9432	132	14	them	they	PRON
easat-9432	132	15	to	to	PART
easat-9432	132	16	follow	follow	VERB
easat-9432	132	17	the	the	DET
easat-9432	132	18	patient	patient	NOUN
easat-9432	132	19	's	's	PART
easat-9432	132	20	treatment	treatment	NOUN
easat-9432	132	21	.	.	PUNCT
easat-9432	133	1	we	we	PRON
easat-9432	133	2	also	also	ADV
easat-9432	133	3	thank	thank	VERB
easat-9432	133	4	the	the	DET
easat-9432	133	5	patient	patient	NOUN
easat-9432	133	6	for	for	ADP
easat-9432	133	7	his	his	PRON
easat-9432	133	8	support	support	NOUN
easat-9432	133	9	in	in	ADP
easat-9432	133	10	the	the	DET
easat-9432	133	11	treatment	treatment	NOUN
easat-9432	133	12	process	process	NOUN
easat-9432	133	13	so	so	SCONJ
easat-9432	133	14	that	that	SCONJ
easat-9432	133	15	we	we	PRON
easat-9432	133	16	can	can	AUX
easat-9432	133	17	follow	follow	VERB
easat-9432	133	18	the	the	DET
easat-9432	133	19	good	good	ADJ
easat-9432	133	20	progress	progress	NOUN
easat-9432	133	21	of	of	ADP
easat-9432	133	22	his	his	PRON
easat-9432	133	23	disease	disease	NOUN
easat-9432	133	24	.	.	PUNCT
easat-9432	134	1	copyright	copyright	NOUN
easat-9432	134	2	:	:	PUNCT
easat-9432	134	3	©	©	PROPN
easat-9432	134	4	2025	2025	NUM
easat-9432	134	5	by	by	ADP
easat-9432	134	6	the	the	DET
easat-9432	134	7	authors	author	NOUN
easat-9432	134	8	.	.	PUNCT
easat-9432	135	1	this	this	DET
easat-9432	135	2	open	open	ADJ
easat-9432	135	3	-	-	PUNCT
easat-9432	135	4	access	access	NOUN
easat-9432	135	5	article	article	NOUN
easat-9432	135	6	is	be	AUX
easat-9432	135	7	distributed	distribute	VERB
easat-9432	135	8	under	under	ADP
easat-9432	135	9	the	the	DET
easat-9432	135	10	terms	term	NOUN
easat-9432	135	11	and	and	CCONJ
easat-9432	135	12	conditions	condition	NOUN
easat-9432	135	13	of	of	ADP
easat-9432	135	14	the	the	DET
easat-9432	135	15	creative	creative	ADJ
easat-9432	135	16	commons	common	NOUN
easat-9432	135	17	attribution	attribution	NOUN
easat-9432	135	18	(	(	PUNCT
easat-9432	135	19	cc	cc	NOUN
easat-9432	135	20	by	by	ADP
easat-9432	135	21	)	)	PUNCT
easat-9432	135	22	license	license	NOUN
easat-9432	135	23	(	(	PUNCT
easat-9432	135	24	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-9432	135	25	)	)	PUNCT
easat-9432	135	26	.	.	PUNCT
easat-9432	136	1	references	reference	NOUN
easat-9432	136	2	[	[	X
easat-9432	136	3	1	1	X
easat-9432	136	4	]	]	PUNCT
easat-9432	136	5	s.	s.	PROPN
easat-9432	136	6	pratiwi	pratiwi	PROPN
easat-9432	136	7	,	,	PUNCT
easat-9432	136	8	u.	u.	NOUN
easat-9432	136	9	a.	a.	NOUN
easat-9432	136	10	setyawan	setyawan	PROPN
easat-9432	136	11	,	,	PUNCT
easat-9432	136	12	a.	a.	NOUN
easat-9432	136	13	listyoko	listyoko	PROPN
easat-9432	136	14	,	,	PUNCT
easat-9432	136	15	and	and	CCONJ
easat-9432	136	16	i.	i.	PROPN
easat-9432	136	17	kirana	kirana	PROPN
easat-9432	136	18	,	,	PUNCT
easat-9432	136	19	"	"	PUNCT
easat-9432	136	20	pulmonary	pulmonary	ADJ
easat-9432	136	21	function	function	NOUN
easat-9432	136	22	characteristics	characteristic	NOUN
easat-9432	136	23	based	base	VERB
easat-9432	136	24	on	on	ADP
easat-9432	136	25	spirometry	spirometry	NOUN
easat-9432	136	26	examination	examination	NOUN
easat-9432	136	27	in	in	ADP
easat-9432	136	28	patients	patient	NOUN
easat-9432	136	29	suspected	suspect	VERB
easat-9432	136	30	of	of	ADP
easat-9432	136	31	lung	lung	NOUN
easat-9432	136	32	and	and	CCONJ
easat-9432	136	33	mediastinal	mediastinal	ADJ
easat-9432	136	34	tumors	tumor	NOUN
easat-9432	136	35	,	,	PUNCT
easat-9432	136	36	"	"	PUNCT
easat-9432	136	37	jurnal	jurnal	PROPN
easat-9432	136	38	klinik	klinik	PROPN
easat-9432	136	39	dan	dan	PROPN
easat-9432	136	40	riset	riset	PROPN
easat-9432	136	41	kesehatan	kesehatan	PROPN
easat-9432	136	42	,	,	PUNCT
easat-9432	136	43	vol	vol	NOUN
easat-9432	136	44	.	.	PROPN
easat-9432	137	1	1	1	NUM
easat-9432	137	2	,	,	PUNCT
easat-9432	137	3	no	no	INTJ
easat-9432	137	4	.	.	NOUN
easat-9432	137	5	3	3	NUM
easat-9432	137	6	,	,	PUNCT
easat-9432	137	7	pp	pp	ADJ
easat-9432	137	8	.	.	PUNCT
easat-9432	138	1	156	156	NUM
easat-9432	138	2	-	-	SYM
easat-9432	138	3	162	162	NUM
easat-9432	138	4	,	,	PUNCT
easat-9432	138	5	2022	2022	NUM
easat-9432	138	6	.	.	PUNCT
easat-9432	139	1	https://doi.org/10.11594/jk-risk.01.3.3	https://doi.org/10.11594/jk-risk.01.3.3	NOUN
easat-9432	139	2	[	[	X
easat-9432	139	3	2	2	NUM
easat-9432	139	4	]	]	PUNCT
easat-9432	139	5	c.	c.	PROPN
easat-9432	139	6	m.	m.	PROPN
easat-9432	139	7	rudin	rudin	PROPN
easat-9432	139	8	,	,	PUNCT
easat-9432	139	9	e.	e.	PROPN
easat-9432	139	10	brambilla	brambilla	PROPN
easat-9432	139	11	,	,	PUNCT
easat-9432	139	12	c.	c.	PROPN
easat-9432	139	13	faivre	faivre	PROPN
easat-9432	139	14	-	-	PUNCT
easat-9432	139	15	finn	finn	PROPN
easat-9432	139	16	,	,	PUNCT
easat-9432	139	17	and	and	CCONJ
easat-9432	139	18	j.	j.	PROPN
easat-9432	139	19	sage	sage	PROPN
easat-9432	139	20	,	,	PUNCT
easat-9432	139	21	"	"	PUNCT
easat-9432	139	22	small	small	ADJ
easat-9432	139	23	-	-	PUNCT
easat-9432	139	24	cell	cell	NOUN
easat-9432	139	25	lung	lung	NOUN
easat-9432	139	26	cancer	cancer	NOUN
easat-9432	139	27	,	,	PUNCT
easat-9432	139	28	"	"	PUNCT
easat-9432	139	29	nature	nature	NOUN
easat-9432	139	30	reviews	review	NOUN
easat-9432	139	31	disease	disease	NOUN
easat-9432	139	32	primers	primer	NOUN
easat-9432	139	33	,	,	PUNCT
easat-9432	139	34	vol	vol	NOUN
easat-9432	139	35	.	.	PROPN
easat-9432	139	36	7	7	NUM
easat-9432	139	37	,	,	PUNCT
easat-9432	139	38	no	no	INTJ
easat-9432	139	39	.	.	NOUN
easat-9432	139	40	1	1	NUM
easat-9432	139	41	,	,	PUNCT
easat-9432	139	42	p.	p.	NOUN
easat-9432	139	43	3	3	NUM
easat-9432	139	44	,	,	PUNCT
easat-9432	139	45	2021	2021	NUM
easat-9432	139	46	.	.	PUNCT
easat-9432	140	1	https://doi.org/10.1038/s41572-020-00235-0	https://doi.org/10.1038/s41572-020-00235-0	NUM
easat-9432	141	1	[	[	X
easat-9432	141	2	3	3	NUM
easat-9432	141	3	]	]	PUNCT
easat-9432	141	4	a.	a.	NOUN
easat-9432	141	5	suraya	suraya	PROPN
easat-9432	141	6	et	et	PROPN
easat-9432	141	7	al	al	PROPN
easat-9432	141	8	.	.	PROPN
easat-9432	141	9	,	,	PUNCT
easat-9432	141	10	"	"	PUNCT
easat-9432	141	11	asbestos	asbestos	NOUN
easat-9432	141	12	-	-	PUNCT
easat-9432	141	13	related	relate	VERB
easat-9432	141	14	lung	lung	NOUN
easat-9432	141	15	cancer	cancer	NOUN
easat-9432	141	16	:	:	PUNCT
easat-9432	141	17	a	a	DET
easat-9432	141	18	hospital	hospital	NOUN
easat-9432	141	19	-	-	PUNCT
easat-9432	141	20	based	base	VERB
easat-9432	141	21	case	case	NOUN
easat-9432	141	22	-	-	PUNCT
easat-9432	141	23	control	control	NOUN
easat-9432	141	24	study	study	NOUN
easat-9432	141	25	in	in	ADP
easat-9432	141	26	indonesia	indonesia	PROPN
easat-9432	141	27	,	,	PUNCT
easat-9432	141	28	"	"	PUNCT
easat-9432	141	29	international	international	ADJ
easat-9432	141	30	journal	journal	NOUN
easat-9432	141	31	of	of	ADP
easat-9432	141	32	environmental	environmental	ADJ
easat-9432	141	33	research	research	NOUN
easat-9432	141	34	and	and	CCONJ
easat-9432	141	35	public	public	ADJ
easat-9432	141	36	health	health	NOUN
easat-9432	141	37	,	,	PUNCT
easat-9432	141	38	vol	vol	NOUN
easat-9432	141	39	.	.	PROPN
easat-9432	141	40	17	17	NUM
easat-9432	141	41	,	,	PUNCT
easat-9432	141	42	no	no	INTJ
easat-9432	141	43	.	.	NOUN
easat-9432	141	44	2	2	NUM
easat-9432	141	45	,	,	PUNCT
easat-9432	141	46	p.	p.	NOUN
easat-9432	141	47	591	591	NUM
easat-9432	141	48	,	,	PUNCT
easat-9432	141	49	2020	2020	NUM
easat-9432	141	50	.	.	PUNCT
easat-9432	142	1	https://doi.org/10.3390/ijerph17020591	https://doi.org/10.3390/ijerph17020591	PROPN
easat-9432	143	1	[	[	X
easat-9432	143	2	4	4	NUM
easat-9432	143	3	]	]	X
easat-9432	143	4	i.	i.	PROPN
easat-9432	143	5	n.	n.	PROPN
easat-9432	143	6	chozin	chozin	PROPN
easat-9432	143	7	,	,	PUNCT
easat-9432	143	8	u.	u.	NOUN
easat-9432	143	9	setyawan	setyawan	NOUN
easat-9432	143	10	,	,	PUNCT
easat-9432	143	11	and	and	CCONJ
easat-9432	143	12	s.	s.	PROPN
easat-9432	143	13	rakhma	rakhma	PROPN
easat-9432	143	14	,	,	PUNCT
easat-9432	143	15	"	"	PUNCT
easat-9432	143	16	the	the	DET
easat-9432	143	17	relationship	relationship	NOUN
easat-9432	143	18	between	between	ADP
easat-9432	143	19	chemotherapy	chemotherapy	NOUN
easat-9432	143	20	status	status	NOUN
easat-9432	143	21	,	,	PUNCT
easat-9432	143	22	neutrophil	neutrophil	ADJ
easat-9432	143	23	count	count	VERB
easat-9432	143	24	with	with	ADP
easat-9432	143	25	igm	igm	PROPN
easat-9432	143	26	and	and	CCONJ
easat-9432	143	27	igg	igg	PROPN
easat-9432	143	28	antimannan	antimannan	PROPN
easat-9432	143	29	in	in	ADP
easat-9432	143	30	lung	lung	NOUN
easat-9432	143	31	cancer	cancer	NOUN
easat-9432	143	32	patients	patient	NOUN
easat-9432	143	33	colonized	colonize	VERB
easat-9432	143	34	by	by	ADP
easat-9432	143	35	candida	candida	PROPN
easat-9432	143	36	,	,	PUNCT
easat-9432	143	37	"	"	PUNCT
easat-9432	143	38	jurnal	jurnal	PROPN
easat-9432	143	39	klinik	klinik	PROPN
easat-9432	143	40	dan	dan	PROPN
easat-9432	143	41	riset	riset	PROPN
easat-9432	143	42	kesehatan	kesehatan	PROPN
easat-9432	143	43	,	,	PUNCT
easat-9432	143	44	vol	vol	NOUN
easat-9432	143	45	.	.	PROPN
easat-9432	143	46	1	1	NUM
easat-9432	143	47	,	,	PUNCT
easat-9432	143	48	no	no	INTJ
easat-9432	143	49	.	.	NOUN
easat-9432	143	50	2	2	NUM
easat-9432	143	51	,	,	PUNCT
easat-9432	143	52	pp	pp	ADJ
easat-9432	143	53	.	.	PUNCT
easat-9432	144	1	79	79	NUM
easat-9432	144	2	-	-	SYM
easat-9432	144	3	86	86	NUM
easat-9432	144	4	,	,	PUNCT
easat-9432	144	5	2022	2022	NUM
easat-9432	144	6	.	.	PUNCT
easat-9432	145	1	https://doi.org/10.11594/jk-risk.01.2.2	https://doi.org/10.11594/jk-risk.01.2.2	PROPN
easat-9432	145	2	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-9432	145	3	https://doi.org/10.11594/jk-risk.01.3.3	https://doi.org/10.11594/jk-risk.01.3.3	NOUN
easat-9432	145	4	https://doi.org/10.1038/s41572-020-00235-0	https://doi.org/10.1038/s41572-020-00235-0	NUM
easat-9432	145	5	https://doi.org/10.3390/ijerph17020591	https://doi.org/10.3390/ijerph17020591	VERB
easat-9432	145	6	https://doi.org/10.11594/jk-risk.01.2.2	https://doi.org/10.11594/jk-risk.01.2.2	ADJ
easat-9432	145	7	751	751	NUM
easat-9432	145	8	edelweiss	edelweiss	PROPN
easat-9432	145	9	applied	apply	VERB
easat-9432	145	10	science	science	NOUN
easat-9432	145	11	and	and	CCONJ
easat-9432	145	12	technology	technology	NOUN
easat-9432	145	13	issn	issn	PROPN
easat-9432	145	14	:	:	PUNCT
easat-9432	145	15	2576	2576	NUM
easat-9432	145	16	-	-	SYM
easat-9432	145	17	8484	8484	NUM
easat-9432	145	18	vol	vol	NOUN
easat-9432	145	19	.	.	PROPN
easat-9432	146	1	9	9	NUM
easat-9432	146	2	,	,	PUNCT
easat-9432	146	3	no	no	INTJ
easat-9432	146	4	.	.	NOUN
easat-9432	146	5	8	8	NUM
easat-9432	146	6	:	:	PUNCT
easat-9432	146	7	744	744	NUM
easat-9432	146	8	-	-	SYM
easat-9432	146	9	751	751	NUM
easat-9432	146	10	,	,	PUNCT
easat-9432	146	11	2025	2025	NUM
easat-9432	146	12	doi	doi	NOUN
easat-9432	146	13	:	:	PUNCT
easat-9432	146	14	10.55214/2576	10.55214/2576	NUM
easat-9432	146	15	-	-	SYM
easat-9432	146	16	8484.v9i8.9432	8484.v9i8.9432	NOUN
easat-9432	147	1	©	©	PROPN
easat-9432	147	2	2025	2025	NUM
easat-9432	147	3	by	by	ADP
easat-9432	147	4	the	the	DET
easat-9432	147	5	authors	author	NOUN
easat-9432	147	6	;	;	PUNCT
easat-9432	147	7	licensee	licensee	PROPN
easat-9432	147	8	learning	learning	NOUN
easat-9432	147	9	gate	gate	NOUN
easat-9432	148	1	[	[	X
easat-9432	148	2	5	5	NUM
easat-9432	148	3	]	]	PUNCT
easat-9432	148	4	m.	m.	NOUN
easat-9432	148	5	park	park	NOUN
easat-9432	148	6	,	,	PUNCT
easat-9432	148	7	d.	d.	PROPN
easat-9432	148	8	y.	y.	PROPN
easat-9432	148	9	ho	ho	PROPN
easat-9432	148	10	,	,	PUNCT
easat-9432	148	11	h.	h.	PROPN
easat-9432	148	12	a.	a.	PROPN
easat-9432	148	13	wakelee	wakelee	PROPN
easat-9432	148	14	,	,	PUNCT
easat-9432	148	15	and	and	CCONJ
easat-9432	148	16	j.	j.	PROPN
easat-9432	148	17	w.	w.	PROPN
easat-9432	148	18	neal	neal	PROPN
easat-9432	148	19	,	,	PUNCT
easat-9432	148	20	"	"	PUNCT
easat-9432	148	21	opportunistic	opportunistic	ADJ
easat-9432	148	22	invasive	invasive	ADJ
easat-9432	148	23	fungal	fungal	ADJ
easat-9432	148	24	infections	infection	NOUN
easat-9432	148	25	mimicking	mimic	VERB
easat-9432	148	26	progression	progression	NOUN
easat-9432	148	27	of	of	ADP
easat-9432	148	28	non	non	ADJ
easat-9432	148	29	–	–	ADJ
easat-9432	148	30	small	small	ADJ
easat-9432	148	31	-	-	PUNCT
easat-9432	148	32	cell	cell	NOUN
easat-9432	148	33	lung	lung	NOUN
easat-9432	148	34	cancer	cancer	NOUN
easat-9432	148	35	,	,	PUNCT
easat-9432	148	36	"	"	PUNCT
easat-9432	148	37	clinical	clinical	ADJ
easat-9432	148	38	lung	lung	NOUN
easat-9432	148	39	cancer	cancer	NOUN
easat-9432	148	40	,	,	PUNCT
easat-9432	148	41	vol	vol	NOUN
easat-9432	148	42	.	.	PROPN
easat-9432	148	43	22	22	NUM
easat-9432	148	44	,	,	PUNCT
easat-9432	148	45	no	no	INTJ
easat-9432	148	46	.	.	NOUN
easat-9432	148	47	2	2	NUM
easat-9432	148	48	,	,	PUNCT
easat-9432	148	49	pp	pp	ADJ
easat-9432	148	50	.	.	PUNCT
easat-9432	149	1	e193	e193	PROPN
easat-9432	149	2	-	-	PUNCT
easat-9432	149	3	e200	e200	PROPN
easat-9432	149	4	,	,	PUNCT
easat-9432	149	5	2021	2021	NUM
easat-9432	149	6	.	.	PUNCT
easat-9432	150	1	https://doi.org/10.1016/j.cllc.2020.10.001	https://doi.org/10.1016/j.cllc.2020.10.001	NOUN
easat-9432	151	1	[	[	X
easat-9432	151	2	6	6	NUM
easat-9432	151	3	]	]	PUNCT
easat-9432	151	4	z.	z.	PROPN
easat-9432	151	5	li	li	PROPN
easat-9432	151	6	et	et	PROPN
easat-9432	151	7	al	al	PROPN
easat-9432	151	8	.	.	PROPN
easat-9432	151	9	,	,	PUNCT
easat-9432	151	10	"	"	PUNCT
easat-9432	151	11	trends	trend	NOUN
easat-9432	151	12	of	of	ADP
easat-9432	151	13	pulmonary	pulmonary	ADJ
easat-9432	151	14	fungal	fungal	ADJ
easat-9432	151	15	infections	infection	NOUN
easat-9432	151	16	from	from	ADP
easat-9432	151	17	2013	2013	NUM
easat-9432	151	18	to	to	ADP
easat-9432	151	19	2019	2019	NUM
easat-9432	151	20	:	:	PUNCT
easat-9432	151	21	an	an	DET
easat-9432	151	22	ai	ai	NOUN
easat-9432	151	23	-	-	PUNCT
easat-9432	151	24	based	base	VERB
easat-9432	151	25	real	real	ADJ
easat-9432	151	26	-	-	PUNCT
easat-9432	151	27	world	world	NOUN
easat-9432	151	28	observational	observational	ADJ
easat-9432	151	29	study	study	NOUN
easat-9432	151	30	in	in	ADP
easat-9432	151	31	guangzhou	guangzhou	PROPN
easat-9432	151	32	,	,	PUNCT
easat-9432	151	33	china	china	PROPN
easat-9432	151	34	,	,	PUNCT
easat-9432	151	35	"	"	PUNCT
easat-9432	151	36	emerging	emerge	VERB
easat-9432	151	37	microbes	microbe	NOUN
easat-9432	151	38	&	&	CCONJ
easat-9432	151	39	infections	infection	NOUN
easat-9432	151	40	,	,	PUNCT
easat-9432	151	41	vol	vol	NOUN
easat-9432	151	42	.	.	PROPN
easat-9432	151	43	10	10	NUM
easat-9432	151	44	,	,	PUNCT
easat-9432	151	45	no	no	INTJ
easat-9432	151	46	.	.	NOUN
easat-9432	151	47	1	1	NUM
easat-9432	151	48	,	,	PUNCT
easat-9432	151	49	pp	pp	ADJ
easat-9432	151	50	.	.	PUNCT
easat-9432	152	1	450	450	NUM
easat-9432	152	2	-	-	SYM
easat-9432	152	3	460	460	NUM
easat-9432	152	4	,	,	PUNCT
easat-9432	152	5	2021	2021	NUM
easat-9432	152	6	.	.	PUNCT
easat-9432	153	1	https://doi.org/10.1080/22221751.2021.1894902	https://doi.org/10.1080/22221751.2021.1894902	PROPN
easat-9432	154	1	[	[	X
easat-9432	154	2	7	7	NUM
easat-9432	154	3	]	]	PUNCT
easat-9432	154	4	y.-s	y.-	NOUN
easat-9432	154	5	.	.	PUNCT
easat-9432	155	1	chang	chang	PROPN
easat-9432	155	2	et	et	PROPN
easat-9432	155	3	al	al	PROPN
easat-9432	155	4	.	.	PROPN
easat-9432	155	5	,	,	PUNCT
easat-9432	155	6	"	"	PUNCT
easat-9432	155	7	mutation	mutation	NOUN
easat-9432	155	8	profile	profile	NOUN
easat-9432	155	9	of	of	ADP
easat-9432	155	10	non	non	ADJ
easat-9432	155	11	-	-	ADJ
easat-9432	155	12	small	small	ADJ
easat-9432	155	13	cell	cell	NOUN
easat-9432	155	14	lung	lung	NOUN
easat-9432	155	15	cancer	cancer	NOUN
easat-9432	155	16	revealed	reveal	VERB
easat-9432	155	17	by	by	ADP
easat-9432	155	18	next	next	ADJ
easat-9432	155	19	generation	generation	NOUN
easat-9432	155	20	sequencing	sequence	VERB
easat-9432	155	21	,	,	PUNCT
easat-9432	155	22	"	"	PUNCT
easat-9432	155	23	respiratory	respiratory	ADJ
easat-9432	155	24	research	research	NOUN
easat-9432	155	25	,	,	PUNCT
easat-9432	155	26	vol	vol	NOUN
easat-9432	155	27	.	.	PROPN
easat-9432	156	1	22	22	NUM
easat-9432	156	2	,	,	PUNCT
easat-9432	156	3	no	no	INTJ
easat-9432	156	4	.	.	NOUN
easat-9432	156	5	1	1	NUM
easat-9432	156	6	,	,	PUNCT
easat-9432	156	7	p.	p.	NOUN
easat-9432	156	8	3	3	NUM
easat-9432	156	9	,	,	PUNCT
easat-9432	156	10	2021	2021	NUM
easat-9432	156	11	.	.	PUNCT
easat-9432	157	1	https://doi.org/10.1186/s12931-020-01608-5	https://doi.org/10.1186/s12931-020-01608-5	PROPN
easat-9432	158	1	[	[	X
easat-9432	158	2	8	8	NUM
easat-9432	158	3	]	]	PUNCT
easat-9432	158	4	x.	x.	NOUN
easat-9432	158	5	yin	yin	PROPN
easat-9432	158	6	et	et	PROPN
easat-9432	158	7	al	al	PROPN
easat-9432	158	8	.	.	PROPN
easat-9432	158	9	,	,	PUNCT
easat-9432	158	10	"	"	PUNCT
easat-9432	158	11	small	small	ADJ
easat-9432	158	12	cell	cell	NOUN
easat-9432	158	13	lung	lung	NOUN
easat-9432	158	14	cancer	cancer	NOUN
easat-9432	158	15	transformation	transformation	NOUN
easat-9432	158	16	:	:	PUNCT
easat-9432	158	17	from	from	ADP
easat-9432	158	18	pathogenesis	pathogenesis	NOUN
easat-9432	158	19	to	to	ADP
easat-9432	158	20	treatment	treatment	NOUN
easat-9432	158	21	,	,	PUNCT
easat-9432	158	22	"	"	PUNCT
easat-9432	158	23	2022	2022	NUM
easat-9432	158	24	,	,	PUNCT
easat-9432	158	25	vol	vol	NOUN
easat-9432	158	26	.	.	PUNCT
easat-9432	158	27	86	86	NUM
easat-9432	158	28	:	:	PUNCT
easat-9432	158	29	elsevier	elsevier	NOUN
easat-9432	158	30	,	,	PUNCT
easat-9432	158	31	pp	pp	PROPN
easat-9432	158	32	.	.	PUNCT
easat-9432	159	1	595	595	NUM
easat-9432	159	2	-	-	SYM
easat-9432	159	3	606	606	NUM
easat-9432	159	4	,	,	PUNCT
easat-9432	159	5	doi	doi	NOUN
easat-9432	159	6	:	:	PUNCT
easat-9432	159	7	https://doi.org/10.1016/j.semcancer.2022.03.006	https://doi.org/10.1016/j.semcancer.2022.03.006	NOUN
easat-9432	159	8	.	.	PUNCT
easat-9432	160	1	[	[	X
easat-9432	160	2	9	9	NUM
easat-9432	160	3	]	]	SYM
easat-9432	160	4	i.	i.	PROPN
easat-9432	160	5	azar	azar	PROPN
easat-9432	160	6	et	et	PROPN
easat-9432	160	7	al	al	PROPN
easat-9432	160	8	.	.	PROPN
easat-9432	160	9	,	,	PUNCT
easat-9432	160	10	"	"	PUNCT
easat-9432	160	11	comparison	comparison	NOUN
easat-9432	160	12	of	of	ADP
easat-9432	160	13	carboplatin	carboplatin	NOUN
easat-9432	160	14	with	with	ADP
easat-9432	160	15	cisplatin	cisplatin	NOUN
easat-9432	160	16	in	in	ADP
easat-9432	160	17	small	small	ADJ
easat-9432	160	18	cell	cell	NOUN
easat-9432	160	19	lung	lung	NOUN
easat-9432	160	20	cancer	cancer	NOUN
easat-9432	160	21	in	in	ADP
easat-9432	160	22	us	us	PROPN
easat-9432	160	23	veterans	veteran	NOUN
easat-9432	160	24	,	,	PUNCT
easat-9432	160	25	"	"	PUNCT
easat-9432	160	26	jama	jama	PROPN
easat-9432	160	27	network	network	NOUN
easat-9432	160	28	open	open	VERB
easat-9432	160	29	,	,	PUNCT
easat-9432	160	30	vol	vol	NOUN
easat-9432	160	31	.	.	PROPN
easat-9432	160	32	5	5	NUM
easat-9432	160	33	,	,	PUNCT
easat-9432	160	34	no	no	INTJ
easat-9432	160	35	.	.	NOUN
easat-9432	160	36	10	10	NUM
easat-9432	160	37	,	,	PUNCT
easat-9432	160	38	p.	p.	PROPN
easat-9432	160	39	e2237699	e2237699	PROPN
easat-9432	160	40	,	,	PUNCT
easat-9432	160	41	2022	2022	NUM
easat-9432	160	42	.	.	PUNCT
easat-9432	161	1	https://doi.org/10.1001/jamanetworkopen.2022.37699	https://doi.org/10.1001/jamanetworkopen.2022.37699	PROPN
easat-9432	162	1	[	[	X
easat-9432	162	2	10	10	NUM
easat-9432	162	3	]	]	X
easat-9432	162	4	c.-k	c.-k	PROPN
easat-9432	162	5	.	.	PUNCT
easat-9432	163	1	park	park	NOUN
easat-9432	163	2	,	,	PUNCT
easat-9432	163	3	i.-j	i.-j	PROPN
easat-9432	163	4	.	.	PUNCT
easat-9432	164	1	oh	oh	INTJ
easat-9432	164	2	,	,	PUNCT
easat-9432	164	3	and	and	CCONJ
easat-9432	164	4	y.-c	y.-c	PROPN
easat-9432	164	5	.	.	PUNCT
easat-9432	165	1	kim	kim	PROPN
easat-9432	165	2	,	,	PUNCT
easat-9432	165	3	"	"	PUNCT
easat-9432	165	4	is	be	AUX
easat-9432	165	5	transformed	transform	VERB
easat-9432	165	6	small	small	ADJ
easat-9432	165	7	cell	cell	NOUN
easat-9432	165	8	lung	lung	NOUN
easat-9432	165	9	cancer	cancer	NOUN
easat-9432	165	10	(	(	PUNCT
easat-9432	165	11	sclc	sclc	PROPN
easat-9432	165	12	)	)	PUNCT
easat-9432	165	13	different	different	ADJ
easat-9432	165	14	from	from	ADP
easat-9432	165	15	de	de	PROPN
easat-9432	165	16	novo	novo	PROPN
easat-9432	165	17	sclc	sclc	PROPN
easat-9432	165	18	?	?	PROPN
easat-9432	165	19	,	,	PUNCT
easat-9432	165	20	"	"	PUNCT
easat-9432	165	21	translational	translational	ADJ
easat-9432	165	22	cancer	cancer	NOUN
easat-9432	165	23	research	research	NOUN
easat-9432	165	24	,	,	PUNCT
easat-9432	165	25	vol	vol	NOUN
easat-9432	165	26	.	.	PROPN
easat-9432	165	27	8	8	NUM
easat-9432	165	28	,	,	PUNCT
easat-9432	165	29	no	no	INTJ
easat-9432	165	30	.	.	NOUN
easat-9432	165	31	2	2	NUM
easat-9432	165	32	,	,	PUNCT
easat-9432	165	33	pp	pp	ADJ
easat-9432	165	34	.	.	PUNCT
easat-9432	166	1	346	346	NUM
easat-9432	166	2	-	-	SYM
easat-9432	166	3	349	349	NUM
easat-9432	166	4	,	,	PUNCT
easat-9432	166	5	2019	2019	NUM
easat-9432	166	6	.	.	PUNCT
easat-9432	167	1	https://doi.org/10.21037/tcr.2019.03.22	https://doi.org/10.21037/tcr.2019.03.22	NOUN
easat-9432	167	2	[	[	X
easat-9432	167	3	11	11	NUM
easat-9432	167	4	]	]	PUNCT
easat-9432	167	5	z.	z.	PROPN
easat-9432	167	6	wang	wang	PROPN
easat-9432	167	7	,	,	PUNCT
easat-9432	167	8	s.	s.	PROPN
easat-9432	167	9	mai	mai	PROPN
easat-9432	167	10	,	,	PUNCT
easat-9432	167	11	p.	p.	PROPN
easat-9432	167	12	lv	lv	PROPN
easat-9432	167	13	,	,	PUNCT
easat-9432	167	14	l.	l.	PROPN
easat-9432	167	15	xu	xu	PROPN
easat-9432	167	16	,	,	PUNCT
easat-9432	167	17	and	and	CCONJ
easat-9432	167	18	y.	y.	PROPN
easat-9432	167	19	wang	wang	PROPN
easat-9432	167	20	,	,	PUNCT
easat-9432	167	21	"	"	PUNCT
easat-9432	167	22	etoposide	etoposide	NOUN
easat-9432	167	23	plus	plus	CCONJ
easat-9432	167	24	cisplatin	cisplatin	NOUN
easat-9432	167	25	chemotherapy	chemotherapy	NOUN
easat-9432	167	26	improves	improve	VERB
easat-9432	167	27	the	the	DET
easat-9432	167	28	efficacy	efficacy	NOUN
easat-9432	167	29	and	and	CCONJ
easat-9432	167	30	safety	safety	NOUN
easat-9432	167	31	of	of	ADP
easat-9432	167	32	small	small	ADJ
easat-9432	167	33	cell	cell	NOUN
easat-9432	167	34	lung	lung	NOUN
easat-9432	167	35	cancer	cancer	NOUN
easat-9432	167	36	,	,	PUNCT
easat-9432	167	37	"	"	PUNCT
easat-9432	167	38	american	american	ADJ
easat-9432	167	39	journal	journal	PROPN
easat-9432	167	40	of	of	ADP
easat-9432	167	41	translational	translational	ADJ
easat-9432	167	42	research	research	NOUN
easat-9432	167	43	,	,	PUNCT
easat-9432	167	44	vol	vol	NOUN
easat-9432	167	45	.	.	PROPN
easat-9432	167	46	13	13	NUM
easat-9432	167	47	,	,	PUNCT
easat-9432	167	48	no	no	INTJ
easat-9432	167	49	.	.	NOUN
easat-9432	167	50	11	11	NUM
easat-9432	167	51	,	,	PUNCT
easat-9432	167	52	p.	p.	NOUN
easat-9432	167	53	12825	12825	NUM
easat-9432	167	54	,	,	PUNCT
easat-9432	167	55	2021	2021	NUM
easat-9432	167	56	.	.	PUNCT
easat-9432	168	1	[	[	X
easat-9432	168	2	12	12	NUM
easat-9432	168	3	]	]	PUNCT
easat-9432	168	4	m.	m.	NOUN
easat-9432	168	5	g.	g.	PROPN
easat-9432	168	6	riccelli	riccelli	PROPN
easat-9432	168	7	,	,	PUNCT
easat-9432	168	8	m.	m.	NOUN
easat-9432	168	9	goldoni	goldoni	PROPN
easat-9432	168	10	,	,	PUNCT
easat-9432	168	11	d.	d.	PROPN
easat-9432	168	12	poli	poli	PROPN
easat-9432	168	13	,	,	PUNCT
easat-9432	168	14	p.	p.	PROPN
easat-9432	168	15	mozzoni	mozzoni	PROPN
easat-9432	168	16	,	,	PUNCT
easat-9432	168	17	d.	d.	PROPN
easat-9432	168	18	cavallo	cavallo	PROPN
easat-9432	168	19	,	,	PUNCT
easat-9432	168	20	and	and	CCONJ
easat-9432	168	21	m.	m.	NOUN
easat-9432	168	22	corradi	corradi	NOUN
easat-9432	168	23	,	,	PUNCT
easat-9432	168	24	"	"	PUNCT
easat-9432	168	25	welding	weld	VERB
easat-9432	168	26	fumes	fume	NOUN
easat-9432	168	27	,	,	PUNCT
easat-9432	168	28	a	a	DET
easat-9432	168	29	risk	risk	NOUN
easat-9432	168	30	factor	factor	NOUN
easat-9432	168	31	for	for	ADP
easat-9432	168	32	lung	lung	NOUN
easat-9432	168	33	diseases	disease	NOUN
easat-9432	168	34	,	,	PUNCT
easat-9432	168	35	"	"	PUNCT
easat-9432	168	36	international	international	ADJ
easat-9432	168	37	journal	journal	NOUN
easat-9432	168	38	of	of	ADP
easat-9432	168	39	environmental	environmental	ADJ
easat-9432	168	40	research	research	NOUN
easat-9432	168	41	and	and	CCONJ
easat-9432	168	42	public	public	ADJ
easat-9432	168	43	health	health	NOUN
easat-9432	168	44	,	,	PUNCT
easat-9432	168	45	vol	vol	NOUN
easat-9432	168	46	.	.	PROPN
easat-9432	168	47	17	17	NUM
easat-9432	168	48	,	,	PUNCT
easat-9432	168	49	no	no	INTJ
easat-9432	168	50	.	.	NOUN
easat-9432	168	51	7	7	NUM
easat-9432	168	52	,	,	PUNCT
easat-9432	168	53	p.	p.	NOUN
easat-9432	168	54	2552	2552	NUM
easat-9432	168	55	,	,	PUNCT
easat-9432	168	56	2020	2020	NUM
easat-9432	168	57	.	.	PUNCT
easat-9432	169	1	https://doi.org/10.3390/ijerph17072552	https://doi.org/10.3390/ijerph17072552	NOUN
easat-9432	170	1	[	[	X
easat-9432	170	2	13	13	NUM
easat-9432	170	3	]	]	PUNCT
easat-9432	170	4	m.	m.	NOUN
easat-9432	170	5	hikichi	hikichi	PROPN
easat-9432	170	6	,	,	PUNCT
easat-9432	170	7	k.	k.	PROPN
easat-9432	170	8	mizumura	mizumura	PROPN
easat-9432	170	9	,	,	PUNCT
easat-9432	170	10	s.	s.	PROPN
easat-9432	170	11	maruoka	maruoka	PROPN
easat-9432	170	12	,	,	PUNCT
easat-9432	170	13	and	and	CCONJ
easat-9432	170	14	y.	y.	PROPN
easat-9432	170	15	gon	gon	PROPN
easat-9432	170	16	,	,	PUNCT
easat-9432	170	17	"	"	PUNCT
easat-9432	170	18	pathogenesis	pathogenesis	NOUN
easat-9432	170	19	of	of	ADP
easat-9432	170	20	chronic	chronic	ADJ
easat-9432	170	21	obstructive	obstructive	ADJ
easat-9432	170	22	pulmonary	pulmonary	ADJ
easat-9432	170	23	disease	disease	NOUN
easat-9432	170	24	(	(	PUNCT
easat-9432	170	25	copd	copd	NOUN
easat-9432	170	26	)	)	PUNCT
easat-9432	170	27	induced	induce	VERB
easat-9432	170	28	by	by	ADP
easat-9432	170	29	cigarette	cigarette	NOUN
easat-9432	170	30	smoke	smoke	NOUN
easat-9432	170	31	,	,	PUNCT
easat-9432	170	32	"	"	PUNCT
easat-9432	170	33	journal	journal	NOUN
easat-9432	170	34	of	of	ADP
easat-9432	170	35	thoracic	thoracic	NOUN
easat-9432	170	36	disease	disease	NOUN
easat-9432	170	37	,	,	PUNCT
easat-9432	170	38	vol	vol	NOUN
easat-9432	170	39	.	.	PROPN
easat-9432	170	40	11	11	NUM
easat-9432	170	41	,	,	PUNCT
easat-9432	170	42	no	no	INTJ
easat-9432	170	43	.	.	PUNCT
easat-9432	171	1	suppl	suppl	PROPN
easat-9432	171	2	17	17	NUM
easat-9432	171	3	,	,	PUNCT
easat-9432	172	1	p.	p.	NOUN
easat-9432	172	2	s2129	s2129	PROPN
easat-9432	172	3	,	,	PUNCT
easat-9432	172	4	2019	2019	NUM
easat-9432	172	5	.	.	PUNCT
easat-9432	173	1	https://doi.org/10.21037/jtd.2019.10.43	https://doi.org/10.21037/jtd.2019.10.43	X
easat-9432	174	1	[	[	X
easat-9432	174	2	14	14	NUM
easat-9432	174	3	]	]	X
easat-9432	174	4	w.	w.	PROPN
easat-9432	174	5	filipiak	filipiak	PROPN
easat-9432	174	6	et	et	PROPN
easat-9432	174	7	al	al	PROPN
easat-9432	174	8	.	.	PROPN
easat-9432	174	9	,	,	PUNCT
easat-9432	174	10	"	"	PUNCT
easat-9432	174	11	dependence	dependence	NOUN
easat-9432	174	12	of	of	ADP
easat-9432	174	13	exhaled	exhale	VERB
easat-9432	174	14	breath	breath	NOUN
easat-9432	174	15	composition	composition	NOUN
easat-9432	174	16	on	on	ADP
easat-9432	174	17	exogenous	exogenous	ADJ
easat-9432	174	18	factors	factor	NOUN
easat-9432	174	19	,	,	PUNCT
easat-9432	174	20	smoking	smoking	NOUN
easat-9432	174	21	habits	habit	NOUN
easat-9432	174	22	and	and	CCONJ
easat-9432	174	23	exposure	exposure	NOUN
easat-9432	174	24	to	to	ADP
easat-9432	174	25	air	air	NOUN
easat-9432	174	26	pollutants	pollutant	NOUN
easat-9432	174	27	,	,	PUNCT
easat-9432	174	28	"	"	PUNCT
easat-9432	174	29	journal	journal	NOUN
easat-9432	174	30	of	of	ADP
easat-9432	174	31	breath	breath	PROPN
easat-9432	174	32	research	research	NOUN
easat-9432	174	33	,	,	PUNCT
easat-9432	174	34	vol	vol	NOUN
easat-9432	174	35	.	.	PROPN
easat-9432	174	36	6	6	NUM
easat-9432	174	37	,	,	PUNCT
easat-9432	174	38	no	no	INTJ
easat-9432	174	39	.	.	NOUN
easat-9432	174	40	3	3	NUM
easat-9432	174	41	,	,	PUNCT
easat-9432	174	42	p.	p.	NOUN
easat-9432	174	43	036008	036008	NUM
easat-9432	174	44	,	,	PUNCT
easat-9432	174	45	2012	2012	NUM
easat-9432	174	46	.	.	PUNCT
easat-9432	175	1	https://doi.org/10.1088/17527155/6/3/036008	https://doi.org/10.1088/17527155/6/3/036008	NOUN
easat-9432	176	1	[	[	X
easat-9432	176	2	15	15	NUM
easat-9432	176	3	]	]	X
easat-9432	176	4	l.	l.	PROPN
easat-9432	176	5	lai	lai	PROPN
easat-9432	176	6	et	et	PROPN
easat-9432	176	7	al	al	PROPN
easat-9432	176	8	.	.	PROPN
easat-9432	176	9	,	,	PUNCT
easat-9432	176	10	"	"	PUNCT
easat-9432	176	11	transformation	transformation	NOUN
easat-9432	176	12	of	of	ADP
easat-9432	176	13	nsclc	nsclc	NOUN
easat-9432	176	14	to	to	ADP
easat-9432	176	15	sclc	sclc	PROPN
easat-9432	176	16	after	after	ADP
easat-9432	176	17	1st	1st	ADJ
easat-9432	176	18	-	-	PUNCT
easat-9432	176	19	and	and	CCONJ
easat-9432	176	20	3rd	3rd	ADJ
easat-9432	176	21	-	-	PUNCT
easat-9432	176	22	generation	generation	NOUN
easat-9432	176	23	egfr	egfr	ADJ
easat-9432	176	24	-	-	PUNCT
easat-9432	176	25	tki	tki	NOUN
easat-9432	176	26	resistance	resistance	NOUN
easat-9432	176	27	and	and	CCONJ
easat-9432	176	28	response	response	NOUN
easat-9432	176	29	to	to	ADP
easat-9432	176	30	ep	ep	PROPN
easat-9432	176	31	regimen	regiman	NOUN
easat-9432	176	32	and	and	CCONJ
easat-9432	176	33	erlotinib	erlotinib	NOUN
easat-9432	176	34	:	:	PUNCT
easat-9432	176	35	2	2	NUM
easat-9432	176	36	care	care	NOUN
easat-9432	176	37	-	-	PUNCT
easat-9432	176	38	compliant	compliant	NOUN
easat-9432	176	39	case	case	NOUN
easat-9432	176	40	reports	report	VERB
easat-9432	176	41	,	,	PUNCT
easat-9432	176	42	"	"	PUNCT
easat-9432	176	43	medicine	medicine	NOUN
easat-9432	176	44	,	,	PUNCT
easat-9432	176	45	vol	vol	NOUN
easat-9432	176	46	.	.	PROPN
easat-9432	176	47	100	100	NUM
easat-9432	176	48	,	,	PUNCT
easat-9432	176	49	no	no	INTJ
easat-9432	176	50	.	.	NOUN
easat-9432	176	51	10	10	NUM
easat-9432	176	52	,	,	PUNCT
easat-9432	176	53	p.	p.	NOUN
easat-9432	176	54	e25046	e25046	PROPN
easat-9432	176	55	,	,	PUNCT
easat-9432	176	56	2021	2021	NUM
easat-9432	176	57	.	.	PUNCT
easat-9432	177	1	https://doi.org/10.1097/md.0000000000025046	https://doi.org/10.1097/md.0000000000025046	ADV
easat-9432	177	2	[	[	X
easat-9432	177	3	16	16	NUM
easat-9432	177	4	]	]	PUNCT
easat-9432	177	5	m.	m.	NOUN
easat-9432	177	6	offin	offin	PROPN
easat-9432	177	7	et	et	PROPN
easat-9432	177	8	al	al	PROPN
easat-9432	177	9	.	.	PROPN
easat-9432	177	10	,	,	PUNCT
easat-9432	177	11	"	"	PUNCT
easat-9432	177	12	concurrent	concurrent	ADJ
easat-9432	177	13	rb1	rb1	NOUN
easat-9432	177	14	and	and	CCONJ
easat-9432	177	15	tp53	tp53	PROPN
easat-9432	177	16	alterations	alteration	NOUN
easat-9432	177	17	define	define	VERB
easat-9432	177	18	a	a	DET
easat-9432	177	19	subset	subset	NOUN
easat-9432	177	20	of	of	ADP
easat-9432	177	21	egfr	egfr	ADJ
easat-9432	177	22	-	-	PUNCT
easat-9432	177	23	mutant	mutant	NOUN
easat-9432	177	24	lung	lung	NOUN
easat-9432	177	25	cancers	cancer	NOUN
easat-9432	177	26	at	at	ADP
easat-9432	177	27	risk	risk	NOUN
easat-9432	177	28	for	for	ADP
easat-9432	177	29	histologic	histologic	ADJ
easat-9432	177	30	transformation	transformation	NOUN
easat-9432	177	31	and	and	CCONJ
easat-9432	177	32	inferior	inferior	ADJ
easat-9432	177	33	clinical	clinical	ADJ
easat-9432	177	34	outcomes	outcome	NOUN
easat-9432	177	35	,	,	PUNCT
easat-9432	177	36	"	"	PUNCT
easat-9432	177	37	journal	journal	NOUN
easat-9432	177	38	of	of	ADP
easat-9432	177	39	thoracic	thoracic	NOUN
easat-9432	177	40	oncology	oncology	NOUN
easat-9432	177	41	,	,	PUNCT
easat-9432	177	42	vol	vol	NOUN
easat-9432	177	43	.	.	PROPN
easat-9432	177	44	14	14	NUM
easat-9432	177	45	,	,	PUNCT
easat-9432	177	46	no	no	INTJ
easat-9432	177	47	.	.	NOUN
easat-9432	177	48	10	10	NUM
easat-9432	177	49	,	,	PUNCT
easat-9432	177	50	pp	pp	ADJ
easat-9432	177	51	.	.	PUNCT
easat-9432	178	1	1784	1784	NUM
easat-9432	178	2	-	-	SYM
easat-9432	178	3	1793	1793	NUM
easat-9432	178	4	,	,	PUNCT
easat-9432	178	5	2019	2019	NUM
easat-9432	178	6	.	.	PUNCT
easat-9432	179	1	https://doi.org/10.1016/j.jtho.2019.06.002	https://doi.org/10.1016/j.jtho.2019.06.002	NOUN
easat-9432	179	2	[	[	X
easat-9432	179	3	17	17	NUM
easat-9432	179	4	]	]	PUNCT
easat-9432	179	5	j.	j.	PROPN
easat-9432	179	6	p.	p.	PROPN
easat-9432	179	7	robichaux	robichaux	PROPN
easat-9432	179	8	et	et	PROPN
easat-9432	179	9	al	al	PROPN
easat-9432	179	10	.	.	PROPN
easat-9432	179	11	,	,	PUNCT
easat-9432	179	12	"	"	PUNCT
easat-9432	179	13	structure	structure	NOUN
easat-9432	179	14	-	-	PUNCT
easat-9432	179	15	based	base	VERB
easat-9432	179	16	classification	classification	NOUN
easat-9432	179	17	predicts	predict	VERB
easat-9432	179	18	drug	drug	NOUN
easat-9432	179	19	response	response	NOUN
easat-9432	179	20	in	in	ADP
easat-9432	179	21	egfr	egfr	ADJ
easat-9432	179	22	-	-	PUNCT
easat-9432	179	23	mutant	mutant	NOUN
easat-9432	179	24	nsclc	nsclc	NOUN
easat-9432	179	25	,	,	PUNCT
easat-9432	179	26	"	"	PUNCT
easat-9432	179	27	nature	nature	NOUN
easat-9432	179	28	,	,	PUNCT
easat-9432	179	29	vol	vol	NOUN
easat-9432	179	30	.	.	PROPN
easat-9432	180	1	597	597	NUM
easat-9432	180	2	,	,	PUNCT
easat-9432	180	3	no	no	INTJ
easat-9432	180	4	.	.	NOUN
easat-9432	181	1	7878	7878	NUM
easat-9432	181	2	,	,	PUNCT
easat-9432	181	3	pp	pp	ADV
easat-9432	181	4	.	.	PUNCT
easat-9432	182	1	732	732	NUM
easat-9432	182	2	-	-	SYM
easat-9432	182	3	737	737	NUM
easat-9432	182	4	,	,	PUNCT
easat-9432	182	5	2021	2021	NUM
easat-9432	182	6	.	.	PUNCT
easat-9432	182	7	https://doi.org/10.1038/s41586-021-03821-8	https://doi.org/10.1038/s41586-021-03821-8	X
easat-9432	183	1	[	[	X
easat-9432	183	2	18	18	NUM
easat-9432	183	3	]	]	PUNCT
easat-9432	183	4	x.	x.	NOUN
easat-9432	183	5	ding	ding	PROPN
easat-9432	183	6	et	et	PROPN
easat-9432	183	7	al	al	PROPN
easat-9432	183	8	.	.	PROPN
easat-9432	183	9	,	,	PUNCT
easat-9432	183	10	"	"	PUNCT
easat-9432	183	11	transformation	transformation	NOUN
easat-9432	183	12	to	to	ADP
easat-9432	183	13	small	small	ADJ
easat-9432	183	14	cell	cell	NOUN
easat-9432	183	15	lung	lung	NOUN
easat-9432	183	16	cancer	cancer	NOUN
easat-9432	183	17	is	be	AUX
easat-9432	183	18	irrespective	irrespective	ADJ
easat-9432	183	19	of	of	ADP
easat-9432	183	20	egfr	egfr	NOUN
easat-9432	183	21	and	and	CCONJ
easat-9432	183	22	accelerated	accelerate	VERB
easat-9432	183	23	by	by	ADP
easat-9432	183	24	smad4mediated	smad4mediate	VERB
easat-9432	183	25	ascl1	ascl1	ADJ
easat-9432	183	26	transcription	transcription	NOUN
easat-9432	183	27	independently	independently	ADV
easat-9432	183	28	of	of	ADP
easat-9432	183	29	rb1	rb1	NOUN
easat-9432	183	30	in	in	ADP
easat-9432	183	31	non	non	ADJ
easat-9432	183	32	-	-	ADJ
easat-9432	183	33	small	small	ADJ
easat-9432	183	34	cell	cell	NOUN
easat-9432	183	35	lung	lung	NOUN
easat-9432	183	36	cancer	cancer	NOUN
easat-9432	183	37	,	,	PUNCT
easat-9432	183	38	"	"	PUNCT
easat-9432	183	39	cell	cell	NOUN
easat-9432	183	40	communication	communication	NOUN
easat-9432	183	41	and	and	CCONJ
easat-9432	183	42	signaling	signal	VERB
easat-9432	183	43	,	,	PUNCT
easat-9432	183	44	vol	vol	NOUN
easat-9432	183	45	.	.	PROPN
easat-9432	184	1	22	22	NUM
easat-9432	184	2	,	,	PUNCT
easat-9432	184	3	no	no	INTJ
easat-9432	184	4	.	.	NOUN
easat-9432	184	5	1	1	NUM
easat-9432	184	6	,	,	PUNCT
easat-9432	184	7	p.	p.	NOUN
easat-9432	184	8	45	45	NUM
easat-9432	184	9	,	,	PUNCT
easat-9432	184	10	2024	2024	NUM
easat-9432	184	11	.	.	PUNCT
easat-9432	185	1	https://doi.org/10.1186/s12964-023-01260-8	https://doi.org/10.1186/s12964-023-01260-8	NUM
easat-9432	185	2	[	[	X
easat-9432	185	3	19	19	NUM
easat-9432	185	4	]	]	PUNCT
easat-9432	185	5	l.	l.	PROPN
easat-9432	185	6	r.	r.	PROPN
easat-9432	185	7	baden	baden	PROPN
easat-9432	185	8	et	et	PROPN
easat-9432	185	9	al	al	PROPN
easat-9432	185	10	.	.	PROPN
easat-9432	185	11	,	,	PUNCT
easat-9432	185	12	"	"	PUNCT
easat-9432	185	13	prevention	prevention	NOUN
easat-9432	185	14	and	and	CCONJ
easat-9432	185	15	treatment	treatment	NOUN
easat-9432	185	16	of	of	ADP
easat-9432	185	17	cancer	cancer	NOUN
easat-9432	185	18	-	-	PUNCT
easat-9432	185	19	related	relate	VERB
easat-9432	185	20	infections	infection	NOUN
easat-9432	185	21	,	,	PUNCT
easat-9432	185	22	version	version	NOUN
easat-9432	185	23	3.2024	3.2024	NUM
easat-9432	185	24	,	,	PUNCT
easat-9432	185	25	nccn	nccn	ADJ
easat-9432	185	26	clinical	clinical	ADJ
easat-9432	185	27	practice	practice	NOUN
easat-9432	185	28	guidelines	guideline	NOUN
easat-9432	185	29	in	in	ADP
easat-9432	185	30	oncology	oncology	NOUN
easat-9432	185	31	,	,	PUNCT
easat-9432	185	32	"	"	PUNCT
easat-9432	185	33	journal	journal	NOUN
easat-9432	185	34	of	of	ADP
easat-9432	185	35	the	the	DET
easat-9432	185	36	national	national	ADJ
easat-9432	185	37	comprehensive	comprehensive	ADJ
easat-9432	185	38	cancer	cancer	NOUN
easat-9432	185	39	network	network	NOUN
easat-9432	185	40	,	,	PUNCT
easat-9432	185	41	vol	vol	NOUN
easat-9432	185	42	.	.	PROPN
easat-9432	185	43	22	22	NUM
easat-9432	185	44	,	,	PUNCT
easat-9432	185	45	no	no	INTJ
easat-9432	185	46	.	.	NOUN
easat-9432	185	47	9	9	NUM
easat-9432	185	48	,	,	PUNCT
easat-9432	185	49	pp	pp	ADJ
easat-9432	185	50	.	.	PUNCT
easat-9432	186	1	617	617	NUM
easat-9432	186	2	-	-	SYM
easat-9432	186	3	644	644	NUM
easat-9432	186	4	,	,	PUNCT
easat-9432	186	5	2024	2024	NUM
easat-9432	186	6	.	.	PUNCT
easat-9432	187	1	https://doi.org/10.6004/jnccn.2024.0056	https://doi.org/10.6004/jnccn.2024.0056	PROPN
easat-9432	187	2	[	[	X
easat-9432	187	3	20	20	NUM
easat-9432	187	4	]	]	X
easat-9432	187	5	c.	c.	PROPN
easat-9432	187	6	martínez	martínez	PROPN
easat-9432	187	7	-	-	PUNCT
easat-9432	187	8	ruiz	ruiz	PROPN
easat-9432	187	9	et	et	PROPN
easat-9432	187	10	al	al	PROPN
easat-9432	187	11	.	.	PROPN
easat-9432	187	12	,	,	PUNCT
easat-9432	187	13	"	"	PUNCT
easat-9432	187	14	genomic	genomic	ADJ
easat-9432	187	15	–	–	PUNCT
easat-9432	187	16	transcriptomic	transcriptomic	ADJ
easat-9432	187	17	evolution	evolution	NOUN
easat-9432	187	18	in	in	ADP
easat-9432	187	19	lung	lung	NOUN
easat-9432	187	20	cancer	cancer	NOUN
easat-9432	187	21	and	and	CCONJ
easat-9432	187	22	metastasis	metastasis	NOUN
easat-9432	187	23	,	,	PUNCT
easat-9432	187	24	"	"	PUNCT
easat-9432	187	25	nature	nature	NOUN
easat-9432	187	26	,	,	PUNCT
easat-9432	187	27	vol	vol	NOUN
easat-9432	187	28	.	.	PROPN
easat-9432	187	29	616	616	NUM
easat-9432	187	30	,	,	PUNCT
easat-9432	187	31	no	no	INTJ
easat-9432	187	32	.	.	NOUN
easat-9432	187	33	7957	7957	NUM
easat-9432	187	34	,	,	PUNCT
easat-9432	187	35	pp	pp	ADJ
easat-9432	187	36	.	.	PUNCT
easat-9432	188	1	543	543	NUM
easat-9432	188	2	-	-	SYM
easat-9432	188	3	552	552	NUM
easat-9432	188	4	,	,	PUNCT
easat-9432	188	5	2023	2023	NUM
easat-9432	188	6	.	.	PUNCT
easat-9432	189	1	[	[	X
easat-9432	189	2	21	21	NUM
easat-9432	189	3	]	]	X
easat-9432	189	4	r.	r.	PROPN
easat-9432	189	5	a.	a.	PROPN
easat-9432	189	6	taplitz	taplitz	PROPN
easat-9432	189	7	et	et	PROPN
easat-9432	189	8	al	al	PROPN
easat-9432	189	9	.	.	PROPN
easat-9432	189	10	,	,	PUNCT
easat-9432	189	11	"	"	PUNCT
easat-9432	189	12	antimicrobial	antimicrobial	ADJ
easat-9432	189	13	prophylaxis	prophylaxis	NOUN
easat-9432	189	14	for	for	ADP
easat-9432	189	15	adult	adult	NOUN
easat-9432	189	16	patients	patient	NOUN
easat-9432	189	17	with	with	ADP
easat-9432	189	18	cancer	cancer	NOUN
easat-9432	189	19	-	-	PUNCT
easat-9432	189	20	related	relate	VERB
easat-9432	189	21	immunosuppression	immunosuppression	NOUN
easat-9432	189	22	:	:	PUNCT
easat-9432	189	23	asco	asco	NOUN
easat-9432	189	24	and	and	CCONJ
easat-9432	189	25	idsa	idsa	PRON
easat-9432	189	26	clinical	clinical	ADJ
easat-9432	189	27	practice	practice	NOUN
easat-9432	189	28	guideline	guideline	NOUN
easat-9432	189	29	update	update	NOUN
easat-9432	189	30	,	,	PUNCT
easat-9432	189	31	"	"	PUNCT
easat-9432	189	32	journal	journal	NOUN
easat-9432	189	33	of	of	ADP
easat-9432	189	34	clinical	clinical	ADJ
easat-9432	189	35	oncology	oncology	NOUN
easat-9432	189	36	,	,	PUNCT
easat-9432	189	37	vol	vol	NOUN
easat-9432	189	38	.	.	PROPN
easat-9432	189	39	36	36	NUM
easat-9432	189	40	,	,	PUNCT
easat-9432	189	41	no	no	INTJ
easat-9432	189	42	.	.	NOUN
easat-9432	189	43	30	30	NUM
easat-9432	189	44	,	,	PUNCT
easat-9432	189	45	pp	pp	ADJ
easat-9432	189	46	.	.	PUNCT
easat-9432	189	47	3043	3043	NUM
easat-9432	189	48	-	-	SYM
easat-9432	189	49	3054	3054	NUM
easat-9432	189	50	,	,	PUNCT
easat-9432	189	51	2018	2018	NUM
easat-9432	189	52	.	.	PUNCT
easat-9432	190	1	[	[	X
easat-9432	190	2	22	22	NUM
easat-9432	190	3	]	]	PUNCT
easat-9432	190	4	m.	m.	PROPN
easat-9432	190	5	lang	lang	PROPN
easat-9432	190	6	,	,	PUNCT
easat-9432	190	7	a.	a.	PROPN
easat-9432	190	8	l.	l.	PROPN
easat-9432	190	9	lang	lang	PROPN
easat-9432	190	10	,	,	PUNCT
easat-9432	190	11	n.	n.	PROPN
easat-9432	190	12	chauhan	chauhan	PROPN
easat-9432	190	13	,	,	PUNCT
easat-9432	190	14	and	and	CCONJ
easat-9432	190	15	a.	a.	NOUN
easat-9432	190	16	gill	gill	PROPN
easat-9432	190	17	,	,	PUNCT
easat-9432	190	18	"	"	PUNCT
easat-9432	190	19	non	non	ADJ
easat-9432	190	20	-	-	ADJ
easat-9432	190	21	surgical	surgical	ADJ
easat-9432	190	22	treatment	treatment	NOUN
easat-9432	190	23	options	option	NOUN
easat-9432	190	24	for	for	ADP
easat-9432	190	25	pulmonary	pulmonary	ADJ
easat-9432	190	26	aspergilloma	aspergilloma	NOUN
easat-9432	190	27	,	,	PUNCT
easat-9432	190	28	"	"	PUNCT
easat-9432	190	29	respiratory	respiratory	ADJ
easat-9432	190	30	medicine	medicine	NOUN
easat-9432	190	31	,	,	PUNCT
easat-9432	190	32	vol	vol	NOUN
easat-9432	190	33	.	.	NOUN
easat-9432	190	34	164	164	NUM
easat-9432	190	35	,	,	PUNCT
easat-9432	190	36	p.	p.	NOUN
easat-9432	190	37	105903	105903	NUM
easat-9432	190	38	,	,	PUNCT
easat-9432	190	39	2020	2020	NUM
easat-9432	190	40	.	.	PUNCT
easat-9432	191	1	[	[	X
easat-9432	191	2	23	23	NUM
easat-9432	191	3	]	]	PUNCT
easat-9432	191	4	a.	a.	PROPN
easat-9432	191	5	wahab	wahab	PROPN
easat-9432	191	6	,	,	PUNCT
easat-9432	191	7	d.	d.	PROPN
easat-9432	191	8	sanborn	sanborn	PROPN
easat-9432	191	9	,	,	PUNCT
easat-9432	191	10	p.	p.	PROPN
easat-9432	191	11	vergidis	vergidis	PROPN
easat-9432	191	12	,	,	PUNCT
easat-9432	191	13	r.	r.	PROPN
easat-9432	191	14	razonable	razonable	PROPN
easat-9432	191	15	,	,	PUNCT
easat-9432	191	16	h.	h.	PROPN
easat-9432	191	17	yadav	yadav	PROPN
easat-9432	191	18	,	,	PUNCT
easat-9432	191	19	and	and	CCONJ
easat-9432	191	20	k.	k.	PROPN
easat-9432	191	21	m.	m.	PROPN
easat-9432	191	22	pennington	pennington	PROPN
easat-9432	191	23	,	,	PUNCT
easat-9432	191	24	"	"	PUNCT
easat-9432	191	25	diagnosis	diagnosis	NOUN
easat-9432	191	26	and	and	CCONJ
easat-9432	191	27	prevention	prevention	NOUN
easat-9432	191	28	of	of	ADP
easat-9432	191	29	invasive	invasive	ADJ
easat-9432	191	30	fungal	fungal	ADJ
easat-9432	191	31	infections	infection	NOUN
easat-9432	191	32	in	in	ADP
easat-9432	191	33	the	the	DET
easat-9432	191	34	immunocompromised	immunocompromise	VERB
easat-9432	191	35	host	host	NOUN
easat-9432	191	36	,	,	PUNCT
easat-9432	191	37	"	"	PUNCT
easat-9432	191	38	chest	chest	NOUN
easat-9432	191	39	,	,	PUNCT
easat-9432	191	40	vol	vol	NOUN
easat-9432	191	41	.	.	PROPN
easat-9432	192	1	167	167	NUM
easat-9432	192	2	,	,	PUNCT
easat-9432	192	3	no	no	INTJ
easat-9432	192	4	.	.	NOUN
easat-9432	192	5	2	2	NUM
easat-9432	192	6	,	,	PUNCT
easat-9432	192	7	pp	pp	ADJ
easat-9432	192	8	.	.	PUNCT
easat-9432	193	1	374	374	NUM
easat-9432	193	2	-	-	SYM
easat-9432	193	3	386	386	NUM
easat-9432	193	4	,	,	PUNCT
easat-9432	193	5	2025	2025	NUM
easat-9432	193	6	.	.	PUNCT
easat-9432	194	1	https://doi.org/10.1016/j.chest.2024.08.046	https://doi.org/10.1016/j.chest.2024.08.046	ADJ
easat-9432	194	2	[	[	X
easat-9432	194	3	24	24	NUM
easat-9432	194	4	]	]	X
easat-9432	194	5	pdpi	pdpi	PROPN
easat-9432	194	6	,	,	PUNCT
easat-9432	194	7	lung	lung	NOUN
easat-9432	194	8	cancer	cancer	NOUN
easat-9432	194	9	.	.	PUNCT
easat-9432	195	1	jakarta	jakarta	PROPN
easat-9432	195	2	,	,	PUNCT
easat-9432	195	3	indonesia	indonesia	PROPN
easat-9432	195	4	:	:	PUNCT
easat-9432	195	5	pdpi	pdpi	PROPN
easat-9432	195	6	,	,	PUNCT
easat-9432	195	7	2019	2019	NUM
easat-9432	195	8	.	.	PUNCT
easat-9432	196	1	https://doi.org/10.1016/j.cllc.2020.10.001	https://doi.org/10.1016/j.cllc.2020.10.001	NOUN
easat-9432	196	2	https://doi.org/10.1080/22221751.2021.1894902	https://doi.org/10.1080/22221751.2021.1894902	PROPN
easat-9432	196	3	https://doi.org/10.1186/s12931-020-01608-5	https://doi.org/10.1186/s12931-020-01608-5	NUM
easat-9432	196	4	https://doi.org/10.1016/j.semcancer.2022.03.006	https://doi.org/10.1016/j.semcancer.2022.03.006	PROPN
easat-9432	196	5	https://doi.org/10.1001/jamanetworkopen.2022.37699	https://doi.org/10.1001/jamanetworkopen.2022.37699	PROPN
easat-9432	196	6	https://doi.org/10.21037/tcr.2019.03.22	https://doi.org/10.21037/tcr.2019.03.22	X
easat-9432	196	7	https://doi.org/10.3390/ijerph17072552	https://doi.org/10.3390/ijerph17072552	NOUN
easat-9432	196	8	https://doi.org/10.21037/jtd.2019.10.43	https://doi.org/10.21037/jtd.2019.10.43	ADJ
easat-9432	196	9	https://doi.org/10.1088/1752-7155/6/3/036008	https://doi.org/10.1088/1752-7155/6/3/036008	NOUN
easat-9432	196	10	https://doi.org/10.1088/1752-7155/6/3/036008	https://doi.org/10.1088/1752-7155/6/3/036008	NOUN
easat-9432	196	11	https://doi.org/10.1097/md.0000000000025046	https://doi.org/10.1097/md.0000000000025046	AUX
easat-9432	196	12	https://doi.org/10.1016/j.jtho.2019.06.002	https://doi.org/10.1016/j.jtho.2019.06.002	VERB
easat-9432	196	13	https://doi.org/10.1038/s41586-021-03821-8	https://doi.org/10.1038/s41586-021-03821-8	NOUN
easat-9432	196	14	https://doi.org/10.1186/s12964-023-01260-8	https://doi.org/10.1186/s12964-023-01260-8	NUM
easat-9432	197	1	https://doi.org/10.6004/jnccn.2024.0056	https://doi.org/10.6004/jnccn.2024.0056	PROPN
easat-9432	197	2	https://doi.org/10.1016/j.chest.2024.08.046	https://doi.org/10.1016/j.chest.2024.08.046	VERB